[go: up one dir, main page]

TWI808127B - Laminated body and manufacturing method thereof - Google Patents

Laminated body and manufacturing method thereof Download PDF

Info

Publication number
TWI808127B
TWI808127B TW108104558A TW108104558A TWI808127B TW I808127 B TWI808127 B TW I808127B TW 108104558 A TW108104558 A TW 108104558A TW 108104558 A TW108104558 A TW 108104558A TW I808127 B TWI808127 B TW I808127B
Authority
TW
Taiwan
Prior art keywords
liquid crystal
film
cured film
crystal cured
vertically aligned
Prior art date
Application number
TW108104558A
Other languages
Chinese (zh)
Other versions
TW201936908A (en
Inventor
葛西辰昌
幡中伸行
Original Assignee
日商住友化學股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商住友化學股份有限公司 filed Critical 日商住友化學股份有限公司
Publication of TW201936908A publication Critical patent/TW201936908A/en
Application granted granted Critical
Publication of TWI808127B publication Critical patent/TWI808127B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/10Esters
    • C08F20/38Esters containing sulfur
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/54Silicon-containing compounds
    • C08K5/541Silicon-containing compounds containing oxygen
    • C08K5/5415Silicon-containing compounds containing oxygen containing at least one Si—O bond
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/38Polymers
    • C09K19/3833Polymers with mesogenic groups in the side chain
    • C09K19/3842Polyvinyl derivatives
    • C09K19/3852Poly(meth)acrylate derivatives
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B5/00Optical elements other than lenses
    • G02B5/30Polarising elements
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K59/00Integrated devices, or assemblies of multiple devices, comprising at least one organic light-emitting element covered by group H10K50/00
    • H10K59/80Constructional details
    • H10K59/8791Arrangements for improving contrast, e.g. preventing reflection of ambient light

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • General Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Polarising Elements (AREA)
  • Liquid Crystal (AREA)
  • Laminated Bodies (AREA)
  • Electroluminescent Light Sources (AREA)
  • Devices For Indicating Variable Information By Combining Individual Elements (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)

Abstract

本發明之積層體係依以下順序包含基材、垂直配向液晶硬化膜、水平配向膜及水平配向液晶硬化膜者, 上述垂直配向液晶硬化膜係聚合性液晶化合物於相對於該液晶硬化膜平面朝垂直方向配向之狀態下硬化而成的聚合性液晶組合物之硬化物,上述水平配向液晶硬化膜係聚合性液晶化合物於相對於該液晶硬化膜平面朝水平方向配向之狀態下硬化而成的聚合性液晶組合物之硬化物, 上述垂直配向液晶硬化膜含有垂直配向促進劑,上述水平配向膜為由(甲基)丙烯酸系聚合物形成而成之光配向膜,且 自上述垂直配向液晶硬化膜之基材側之面至水平配向液晶硬化膜之與水平配向膜為相反側之面的總膜厚為10 μm以下。The laminated system of the present invention comprises a substrate, a vertically aligned liquid crystal cured film, a horizontally aligned liquid crystal cured film, and a horizontally aligned liquid crystal cured film in the following order, The vertically aligned liquid crystal cured film is a cured product of a polymerizable liquid crystal composition formed by curing a polymerizable liquid crystal compound in a state aligned vertically relative to the plane of the liquid crystal cured film, and the horizontally aligned liquid crystal cured film is a cured product of a polymerizable liquid crystal composition formed by curing a polymerizable liquid crystal compound in a state aligned horizontally relative to the plane of the liquid crystal cured film, The vertical alignment liquid crystal cured film contains a vertical alignment accelerator, the horizontal alignment film is a photo-alignment film formed of a (meth)acrylic polymer, and The total film thickness from the substrate-side surface of the vertical alignment cured liquid crystal film to the surface of the horizontal alignment cured liquid crystal film opposite to the horizontal alignment film is 10 μm or less.

Description

積層體及其製造方法Laminated body and manufacturing method thereof

本發明係關於一種包含垂直配向液晶硬化膜及水平配向液晶硬化膜之積層體、包含上述積層體之橢圓偏光板及有機EL顯示裝置。又,本發明亦關於一種上述積層體之製造方法。The present invention relates to a laminate comprising a vertically aligned liquid crystal cured film and a horizontally aligned liquid crystal cured film, an elliptical polarizer comprising the above laminate, and an organic EL display device. Moreover, this invention also relates to the manufacturing method of the said laminated body.

橢圓偏光板係偏光板與相位差板積層而成之光學構件,例如於有機EL圖像顯示裝置等以平面狀態顯示圖像的裝置中,用於防止於構成該裝置之電極上之光反射。作為構成該橢圓偏光板之相位差板,一般使用所謂λ/4板。An elliptical polarizer is an optical member formed by laminating a polarizer and a retardation plate. For example, in a device that displays images in a flat state, such as an organic EL image display device, it is used to prevent light reflection on the electrodes constituting the device. As a retardation plate constituting the elliptically polarizing plate, a so-called λ/4 plate is generally used.

於在可見光之廣泛波長範圍內容易發揮均勻之相位差性能之方面上,作為構成橢圓偏光板之相位差板,較佳為顯示逆波長分散性者。作為此種相位差板,已知有包含水平配向液晶硬化膜之相位差板,該水平配向液晶硬化膜係使顯示逆波長分散性之聚合性液晶化合物於在與相位差板之平面水平之方向上配向之狀態下進行聚合,並使之硬化而成。又,已知藉由進而將垂直配向液晶硬化膜組入至具備水平配向液晶硬化膜之橢圓偏光板,可抑制將該橢圓偏光板用於有機EL顯示裝置之情形時之黑顯示時之斜向色相變化,於專利文獻1中記載有包含垂直配向膜上所形成之垂直配向液晶硬化膜、與水平配向膜上所形成之水平配向液晶硬化膜的積層體。 [先前技術文獻] [專利文獻]In terms of easily exhibiting uniform retardation performance in a wide wavelength range of visible light, as a retardation plate constituting an elliptically polarizing plate, one showing reverse wavelength dispersion is preferable. As such a retardation plate, there is known a retardation plate including a horizontally aligned liquid crystal cured film obtained by polymerizing and curing a polymerizable liquid crystal compound exhibiting reverse wavelength dispersion in a state aligned in a direction horizontal to the plane of the retardation plate. Furthermore, it is known that by further incorporating a vertically aligned liquid crystal cured film into an elliptical polarizing plate having a horizontally aligned liquid crystal cured film, it is possible to suppress oblique hue changes during black display when the elliptical polarizing plate is used in an organic EL display device. Patent Document 1 describes a laminate comprising a vertically aligned liquid crystal cured film formed on a vertically aligned film and a horizontally aligned liquid crystal cured film formed on a horizontally aligned film. [Prior Art Literature] [Patent Document]

[專利文獻1]日本專利特開2015-163935號公報[Patent Document 1] Japanese Patent Laid-Open No. 2015-163935

[發明所欲解決之問題][Problem to be solved by the invention]

然而,如上述專利文獻所記載之包含垂直配向液晶硬化膜與水平配向液晶硬化膜之積層體先前大多藉由如下方式製造:分別獨立地製作垂直配向液晶硬化膜與水平配向液晶硬化膜後,將兩者藉由黏接著劑等進行貼合。又,先前於垂直配向液晶硬化膜之製造時,需要用以將聚合性液晶化合物於垂直方向上進行配向之垂直配向膜,且需於垂直配向液晶硬化膜之形成前形成垂直配向膜。因此,包含垂直配向液晶硬化膜與水平配向液晶硬化膜之先前之積層體之製造步驟容易變得繁雜,而生產性容易降低。However, the laminates including the vertically aligned liquid crystal cured film and the horizontally aligned liquid crystal cured film described in the above-mentioned patent documents are usually manufactured by the following method: After the vertically aligned liquid crystal cured film and the horizontally aligned liquid crystal cured film are independently produced, the two are bonded together with an adhesive or the like. In addition, in the manufacture of the vertically aligned liquid crystal cured film, a vertically aligned film for aligning the polymerizable liquid crystal compound in the vertical direction is required, and the vertically aligned film needs to be formed before the formation of the vertically aligned liquid crystal cured film. Therefore, the manufacturing steps of the conventional laminate including the vertically aligned liquid crystal cured film and the horizontally aligned liquid crystal cured film tend to become complicated, and productivity tends to decrease.

因此,本發明之目的在於針對上述問題而提供一種新穎之解決方法,即能夠不形成垂直配向膜而形成垂直配向液晶硬化膜,進而連續地形成水平配向液晶硬化膜之積層體、及其製造方法。Therefore, the purpose of the present invention is to provide a novel solution to the above problems, that is, to form a vertically aligned liquid crystal cured film without forming a vertically aligned film, and to continuously form a laminate of horizontally aligned liquid crystal cured films, and its manufacturing method.

進而,於本發明人等之上述解決方法之研究中,已明確於不形成垂直配向膜而形成垂直配向液晶硬化膜之情形時,其液晶配向性容易降低;又,於垂直配向液晶硬化膜上經由水平配向膜形成水平液晶硬化膜之情形時,與藉由黏接著劑層將垂直配向液晶硬化膜與水平配向液晶硬化膜貼合而成之積層體相比,垂直配向液晶硬化膜與水平配向液晶硬化膜之密接性容易降低。Furthermore, in the study of the above-mentioned solution by the present inventors, it has been clarified that when a vertically aligned liquid crystal cured film is formed without forming a vertically aligned film, its liquid crystal alignment is likely to decrease; and when a horizontally aligned liquid crystal cured film is formed on a vertically aligned liquid crystal cured film via a horizontally aligned film, the adhesion between the vertically aligned liquid crystal cured film and the horizontally aligned liquid crystal cured film is likely to decrease compared with a laminate formed by bonding the vertically aligned liquid crystal cured film and the horizontally aligned liquid crystal cured film through an adhesive layer.

因此,本發明亦目的在於:於包含積層於無垂直配向膜地形成之垂直配向液晶硬化膜上之水平配向液晶硬化膜的積層體中,使液晶配向性提高;及使垂直配向液晶硬化膜、與在該垂直配向液晶硬化膜上經由水平配向膜形成之水平配向液晶硬化膜的密接性。 [解決問題之技術手段]Therefore, the present invention also aims to improve the alignment of liquid crystals in a laminate including a horizontally aligned liquid crystal cured film laminated on a vertically aligned liquid crystal cured film formed without a vertically aligned liquid crystal film; and to improve the adhesion between the vertically aligned liquid crystal cured film and the horizontally aligned liquid crystal cured film formed on the vertically aligned liquid crystal cured film via a horizontal alignment film. [Technical means to solve the problem]

本發明人等為了解決上述課題而進行了銳意研究,結果完成本發明。即,本發明包含以下之態樣。 [1]一種積層體,其係依以下順序包含基材、垂直配向液晶硬化膜、水平配向膜及水平配向液晶硬化膜者, 上述垂直配向液晶硬化膜係聚合性液晶化合物於相對於該液晶硬化膜平面朝垂直方向配向之狀態下硬化而成的聚合性液晶組合物的硬化物,上述水平配向液晶硬化膜係聚合性液晶化合物於相對於該液晶硬化膜平面朝水平方向配向之狀態下硬化而成的聚合性液晶組合物的硬化物, 上述垂直配向液晶硬化膜含有垂直配向促進劑,上述水平配向膜係由(甲基)丙烯酸系聚合物形成而成之光配向膜, 自上述垂直配向液晶硬化膜之基材側之面至水平配向液晶硬化膜之與水平配向膜相反之側之面的總膜厚為10 μm以下。 [2]如上述[1]所記載之積層體,其中基材為能夠剝離之基材。 [3]如上述[1]或[2]所記載之積層體,其中基材、垂直配向液晶硬化膜、水平配向膜、水平配向液晶硬化膜依此順序鄰接地存在。 [4]如上述[1]至[3]中任一項所記載之積層體,其中水平配向膜之膜厚為10~5000 nm。 [5]如上述[1]至[4]中任一項所記載之積層體,其中水平配向膜為由具有偶氮基或桂皮醯基之聚合物形成而成之光配向膜。 [6]如上述[1]至[5]中任一項所記載之積層體,其中水平配向液晶硬化膜於波長300~400 nm之間具有至少1個以上之極大吸收。 [7]如上述[1]至[6]中任一項所記載之積層體,其中水平配向液晶硬化膜滿足下述式(1): ReA(450)/ReA(550)≦1 (1) [式(1)中,ReA(450)表示水平配向液晶硬化膜之面內方向之波長450 nm下之面內相位差值,ReA(550)表示水平配向液晶硬化膜之面內方向之波長550 nm下之面內相位差值]。 [8]如上述[1]至[7]中任一項所記載之積層體,其中垂直配向液晶硬化膜含有非離子性矽烷化合物作為垂直配向促進劑。 [9]如上述[1]至[8]中任一項所記載之積層體,其中垂直配向液晶硬化膜含有非離子性矽烷化合物作為垂直配向促進劑,且上述非離子性矽烷化合物為矽烷偶合劑。 [10]如上述[1]至[9]中任一項所記載之積層體,其中垂直配向液晶硬化膜含有包含非金屬原子之離子性化合物作為垂直配向促進劑。 [11]如上述[1]至[10]中任一項所記載之積層體,其中垂直配向液晶硬化膜含有包含非金屬原子之離子性化合物作為垂直配向促進劑,且該離子性化合物之分子量為100以上10,000以下。 [12]如上述[1]至[11]中任一項所記載之積層體,其中垂直配向液晶硬化膜含有非離子性矽烷化合物及包含非金屬原子之離子性化合物作為垂直配向促進劑。 [13]如上述[1]至[12]中任一項所記載之積層體,其中水平配向液晶硬化膜係具有至少1個自由基聚合性基之聚合性液晶化合物於相對於該液晶硬化膜之面內方向水平地配向之狀態下硬化而成之液晶硬化膜,且垂直配向液晶硬化膜係具有至少1個自由基聚合性基之聚合性液晶化合物於相對於該液晶硬化膜之面內方向垂直地配向之狀態下硬化而成之液晶硬化膜。 [14]如上述[1]至[13]中任一項所記載之積層體,其中垂直配向液晶硬化膜於波長300~400 nm之間具有至少1個極大吸收。 [15]如上述[1]至[14]中任一項所記載之積層體,其中垂直配向液晶硬化膜滿足下述式(2): RthC(450)/RthC(550)≦1 (2) [式(2)中,RthC(450)表示垂直配向液晶硬化膜於波長450 nm下之厚度方向之相位差值,RthC(550)表示垂直配向液晶硬化膜於波長550 nm下之厚度方向之相位差值]。 [16]一種橢圓偏光板,其包含如上述[1]至[15]中任一項所記載之積層體與偏光膜。 [17]一種橢圓偏光板,其包含自如上述[1]至[15]中任一項所記載之積層體去除基材所得之積層體與偏光膜。 [18]如上述[16]或[17]所記載之橢圓偏光板,其中構成積層體之水平配向液晶硬化膜之遲相軸與偏光膜之吸收軸所成之角為45±5°。 [19]一種有機EL顯示裝置,其包含如上述[16]至[18]中任一項所記載之橢圓偏光板。 [20]一種如上述[1]至[15]中任一項所記載之積層體之製造方法,其依以下順序包括如下步驟: 形成含有聚合性液晶化合物之垂直配向液晶硬化膜形成用聚合性液晶組合物之塗膜,由該塗膜形成垂直配向液晶硬化膜; 形成水平配向膜形成用組合物之塗膜,由該塗膜形成水平配向膜;及 形成含有聚合性液晶化合物之水平配向液晶硬化膜形成用聚合性液晶組合物之塗膜,由該塗膜形成水平配向液晶硬化膜。 [21]如上述[20]所記載之製造方法,其依以下順序連續地實施形成垂直配向液晶硬化膜之步驟、形成水平配向膜之步驟及形成水平配向液晶硬化膜之步驟。 [發明之效果]The inventors of the present invention conducted earnest research to solve the above-mentioned problems, and as a result, completed the present invention. That is, the present invention includes the following aspects. [1] A laminate comprising a substrate, a vertically aligned liquid crystal cured film, a horizontally aligned liquid crystal cured film, and a horizontally aligned liquid crystal cured film in the following order, The vertically aligned liquid crystal curable film is a cured product of a polymerizable liquid crystal composition cured in a state where a polymerizable liquid crystal compound is aligned perpendicular to the plane of the liquid crystal cured film, and the horizontally aligned liquid crystal cured film is a cured product of a polymerizable liquid crystal composition that is cured in a state where a polymerizable liquid crystal compound is aligned horizontally with respect to the plane of the liquid crystal cured film, The vertical alignment liquid crystal cured film contains a vertical alignment promoter, and the horizontal alignment film is a photo-alignment film formed of (meth)acrylic polymer, The total film thickness from the substrate-side surface of the vertical alignment cured liquid crystal film to the surface of the horizontal alignment cured liquid crystal film opposite to the horizontal alignment film is 10 μm or less. [2] The laminate as described in [1] above, wherein the substrate is a peelable substrate. [3] The laminate described in [1] or [2] above, wherein the substrate, the vertically aligned liquid crystal cured film, the horizontally aligned liquid crystal cured film, and the horizontally aligned liquid crystal cured film are present adjacent to each other in this order. [4] The laminate according to any one of the above [1] to [3], wherein the film thickness of the horizontal alignment film is 10 to 5000 nm. [5] The laminate according to any one of [1] to [4] above, wherein the horizontal alignment film is a photo-alignment film formed of a polymer having an azo group or a cinnamonyl group. [6] The laminate according to any one of [1] to [5] above, wherein the horizontally aligned liquid crystal cured film has at least one maximum absorption at a wavelength of 300 to 400 nm. [7] The laminate described in any one of [1] to [6] above, wherein the horizontally aligned liquid crystal cured film satisfies the following formula (1): ReA(450)/ReA(550)≦1 (1) [In the formula (1), ReA(450) represents the in-plane retardation value under the wavelength 450 nm in the in-plane direction of the horizontally aligned liquid crystal cured film, and ReA(550) represents the in-plane retardation value under the wavelength 550 nm in the in-plane direction of the horizontally aligned liquid crystal cured film]. [8] The laminate according to any one of the above [1] to [7], wherein the vertical alignment liquid crystal cured film contains a nonionic silane compound as a vertical alignment promoter. [9] The laminate according to any one of [1] to [8] above, wherein the vertically aligned liquid crystal cured film contains a nonionic silane compound as a vertical alignment promoter, and the nonionic silane compound is a silane coupling agent. [10] The laminate according to any one of [1] to [9] above, wherein the vertically aligned liquid crystal cured film contains an ionic compound containing a non-metal atom as a vertical alignment accelerator. [11] The laminate according to any one of [1] to [10] above, wherein the vertically aligned liquid crystal cured film contains an ionic compound containing non-metal atoms as a vertical alignment promoter, and the molecular weight of the ionic compound is 100 to 10,000. [12] The laminate according to any one of [1] to [11] above, wherein the vertically aligned liquid crystal cured film contains a nonionic silane compound and an ionic compound containing a nonmetal atom as a vertical alignment accelerator. [13] The laminate according to any one of [1] to [12] above, wherein the horizontally aligned liquid crystal cured film is a cured liquid crystal film formed by curing a polymerizable liquid crystal compound having at least one radically polymerizable group in a state aligned horizontally with respect to the in-plane direction of the liquid crystal cured film, and the vertically aligned liquid crystal cured film is a cured liquid crystal film formed by curing a polymerizable liquid crystal compound having at least one radically polymerizable group in a state aligned vertically with respect to the in-plane direction of the liquid crystal cured film. [14] The laminate according to any one of [1] to [13] above, wherein the vertically aligned liquid crystal cured film has at least one absorption maximum at a wavelength of 300 to 400 nm. [15] The laminate described in any one of [1] to [14] above, wherein the vertically aligned liquid crystal cured film satisfies the following formula (2): RthC(450)/RthC(550)≦1 (2) [In formula (2), RthC(450) represents the retardation value of the vertically aligned liquid crystal cured film in the thickness direction at a wavelength of 450 nm, and RthC(550) represents the retardation value of the vertically aligned liquid crystal cured film in the thickness direction at a wavelength of 550 nm]. [16] An elliptically polarizing plate comprising the laminate described in any one of [1] to [15] above and a polarizing film. [17] An elliptically polarizing plate comprising a laminate obtained by removing a substrate from the laminate described in any one of [1] to [15] above, and a polarizing film. [18] The elliptically polarizing plate described in [16] or [17] above, wherein the angle formed by the slow axis of the horizontally aligned liquid crystal cured film constituting the laminate and the absorption axis of the polarizing film is 45±5°. [19] An organic EL display device comprising the elliptically polarizing plate according to any one of the above-mentioned [16] to [18]. [20] A method for manufacturing the laminate described in any one of the above [1] to [15], which includes the following steps in the following order: Forming a coating film of a polymerizable liquid crystal composition for forming a vertical alignment liquid crystal cured film containing a polymerizable liquid crystal compound, and forming a vertical alignment liquid crystal cured film from the coating film; forming a coating film of the composition for forming a horizontal alignment film, and forming a horizontal alignment film from the coating film; and A coating film of a polymerizable liquid crystal composition for forming a horizontal alignment liquid crystal cured film containing a polymerizable liquid crystal compound is formed, and a horizontal alignment liquid crystal cured film is formed from the coating film. [21] The production method described in [20] above, wherein the step of forming a vertically aligned liquid crystal cured film, the step of forming a horizontally aligned liquid crystal film, and the step of forming a horizontally aligned liquid crystal cured film are continuously performed in the following order. [Effect of Invention]

根據本發明,可提供一種能夠不形成垂直配向膜而形成垂直配向液晶硬化膜,進而於上述垂直配向液晶硬化膜上經由水平配向膜而連續地形成水平配向液晶硬化膜之積層體、及其製造方法。進而,上述積層體可提高液晶配向性;及可提高垂直配向液晶硬化膜、與於該垂直配向液晶硬化膜上經由水平配向膜所形成之水平配向液晶硬化膜之密接性。According to the present invention, it is possible to provide a laminate capable of forming a vertically aligned liquid crystal cured film without forming a vertically aligned liquid crystal film, and further forming a horizontally aligned liquid crystal cured film on the vertically aligned liquid crystal cured film via a horizontal alignment film, and a manufacturing method thereof. Furthermore, the above-mentioned laminate can improve the liquid crystal alignment; and can improve the adhesion between the vertically aligned liquid crystal cured film and the horizontally aligned liquid crystal cured film formed on the vertically aligned liquid crystal cured film via the horizontally aligned film.

本發明之積層體依以下順序包含基材、垂直配向液晶硬化膜、水平配向膜及水平配向液晶硬化膜。以下,基於圖1~3對本發明之積層體之層構成之一例進行說明,但本發明之積層體並不限定於該等態樣。The laminate of the present invention comprises a base material, a vertical alignment liquid crystal cured film, a horizontal alignment film, and a horizontal alignment liquid crystal cured film in the following order. Hereinafter, an example of the layer configuration of the laminate of the present invention will be described based on FIGS. 1 to 3 , but the laminate of the present invention is not limited to these aspects.

圖1所示之積層體11係依序積層基材1、垂直配向液晶硬化膜2、水平配向膜3及水平配向液晶硬化膜4而成。於圖1所示之積層體11中,垂直配向液晶硬化膜2係不介隔具有垂直配向限制力之層(以下,亦稱為「垂直配向膜」)而直接形成於基材1上,基材1與垂直配向液晶硬化膜2鄰接地存在。本發明之積層體除包含基材、垂直配向液晶硬化膜、水平配向膜及水平配向液晶硬化膜以外,亦可於不會對本發明之效果造成影響之範圍內進而包含其他層而構成。作為其他層,例如可列舉:保護層或硬塗層等硬化樹脂層、進而用以將水平配向液晶硬化膜、本發明之積層體與偏光膜等進行接著之黏接著劑層等。The laminate 11 shown in FIG. 1 is formed by sequentially laminating a substrate 1 , a vertically aligned liquid crystal cured film 2 , a horizontally aligned liquid crystal cured film 3 , and a horizontally aligned liquid crystal cured film 4 . In the laminated body 11 shown in FIG. 1 , the vertical alignment liquid crystal cured film 2 is directly formed on the substrate 1 without interposing a layer having a vertical alignment restriction force (hereinafter, also referred to as “vertical alignment film”), and the substrate 1 and the vertical alignment liquid crystal cured film 2 exist adjacently. In addition to the substrate, the vertically aligned liquid crystal cured film, the horizontally aligned liquid crystal cured film, and the horizontally aligned liquid crystal cured film, the laminate of the present invention may further include other layers within the range that does not affect the effect of the present invention. Examples of other layers include a cured resin layer such as a protective layer or a hard coat layer, and an adhesive layer for bonding a horizontally aligned liquid crystal cured film, the laminate of the present invention, and a polarizing film.

作為包含其他層之積層體,例如作為本發明之另一態樣之圖2所示之積層體11係將基材1與垂直配向液晶硬化膜2經由硬化樹脂層5進行積層,於該垂直配向液晶硬化膜2上積層水平配向膜3及水平配向液晶硬化膜4而成。進而,作為本發明之另一態樣之圖3所示之積層體11係將基材1與垂直配向液晶硬化膜2經由硬化樹脂層5進行積層,進而將上述垂直配向液晶硬化膜2與水平配向膜3經由硬化樹脂層5進行積層,於該水平配向膜3上積層水平配向液晶硬化膜4而成。可藉由經由黏接著劑層貼合積層體11與偏光膜而獲得橢圓偏光板。此時,亦可將積層體11之垂直配向液晶硬化膜2及水平配向液晶硬化膜4之任一側與偏光膜貼合,例如,可於將圖1之積層體11之基材1剝離後,將垂直配向液晶硬化膜2經由黏接著劑層與偏光膜貼合,又,亦可將圖1之積層體11之水平配向液晶硬化膜4與偏光膜經由黏接著劑層進行貼合。再者,以下,於本說明書中,亦將本發明之積層體之層構成中,依以下順序包含基材、垂直配向液晶硬化膜、水平配向膜及水平配向液晶硬化膜之最小層構成稱為「基本層構成(I)」。即,例如於本發明之積層體由基材、垂直配向液晶硬化膜、水平配向膜、第1水平配向液晶硬化膜及第2水平配向液晶硬化膜構成之情形時,自基材至最遠離基材側之水平配向液晶硬化膜(於該情形時,第1水平配向液晶硬化膜)成為本發明之積層體之基本層構成(I)。As a laminate including other layers, for example, a laminate 11 shown in FIG. 2 as another aspect of the present invention is formed by laminating a substrate 1 and a vertical alignment liquid crystal cured film 2 through a cured resin layer 5, and laminating a horizontal alignment film 3 and a horizontal alignment liquid crystal cured film 4 on the vertical alignment liquid crystal cured film 2. Furthermore, as another aspect of the present invention, the laminated body 11 shown in FIG. 3 is formed by laminating the base material 1 and the vertically aligned liquid crystal cured film 2 via the cured resin layer 5 , further laminating the above-mentioned vertically aligned liquid crystal cured film 2 and the horizontal alignment film 3 via the cured resin layer 5 , and laminating the horizontally aligned liquid crystal cured film 4 on the horizontally aligned film 3 . An elliptically polarizing plate can be obtained by bonding the laminate 11 and a polarizing film through an adhesive layer. At this time, either side of the vertically aligned liquid crystal cured film 2 and the horizontally aligned liquid crystal cured film 4 of the laminate 11 can also be attached to the polarizing film. For example, after the substrate 1 of the laminated body 11 in FIG. Furthermore, hereinafter, in this specification, the minimum layer configuration including a base material, a vertical alignment liquid crystal cured film, a horizontal alignment film, and a horizontal alignment liquid crystal cured film in the following order among the layer configurations of the laminate of the present invention is referred to as "basic layer configuration (I)". That is, for example, when the laminate of the present invention is composed of a substrate, a vertically aligned liquid crystal cured film, a horizontally aligned film, a first horizontally aligned liquid crystal cured film, and a second horizontally aligned liquid crystal cured film, the horizontally aligned liquid crystal cured film (in this case, the first horizontally aligned liquid crystal cured film) from the substrate to the side farthest from the substrate becomes the basic layer configuration (I) of the laminate of the present invention.

於本發明之積層體中,自垂直配向液晶硬化膜之基材側之面至水平配向液晶硬化膜之與水平配向膜為相反側之面的總膜厚(圖1~3中之a-b間之厚度,以下,亦稱為「總膜厚T1」)為10 μm以下。本發明之積層體由於可於垂直配向液晶硬化膜上經由水平配向膜而直接形成水平配向液晶硬化膜,故而與將垂直配向液晶硬化膜與水平配向液晶硬化膜分開製作後,將兩者藉由黏著劑或接著劑進行貼合所獲得之先前積層體相比,可使總膜厚T1變薄。積層體之總膜厚T1之薄膜化亦可有助於積層體整體、及包含該積層體之橢圓偏光板等之薄膜化。本發明之積層體之上述總膜厚T1較佳為7 μm以下,更佳為5 μm以下。上述總膜厚T1之下限值並無特別限定,通常可為1 μm以上,例如為1.5 μm以上。再者,於本發明之積層體於基本層構成(I)之水平配向液晶硬化膜之與水平配向膜相反側進而具備垂直配向液晶硬化膜及/或水平配向液晶硬化膜之情形時,上述總膜厚T1意指自構成基本層構成(I)之垂直配向液晶硬化膜之基材側之面至水平配向液晶硬化膜之與水平配向膜為相反側之面的總膜厚。In the laminate of the present invention, the total film thickness from the substrate-side surface of the vertically aligned liquid crystal cured film to the surface of the horizontally aligned liquid crystal cured film opposite to the horizontal alignment film (thickness between a-b in FIGS. Since the laminate of the present invention can directly form a horizontal alignment cured film on the vertical alignment cured film via a horizontal alignment film, it can make the total film thickness T1 thinner compared with the previous laminate obtained by separately manufacturing the vertical alignment cured film and the horizontal alignment cured film and laminating them together with an adhesive or an adhesive. The thinning of the total film thickness T1 of the laminate also contributes to the thinning of the entire laminate and the elliptically polarizing plate including the laminate. The above-mentioned total film thickness T1 of the laminate of the present invention is preferably 7 μm or less, more preferably 5 μm or less. The lower limit of the above-mentioned total film thickness T1 is not particularly limited, and may generally be greater than 1 μm, for example, greater than 1.5 μm. Furthermore, when the layered body of the present invention has a vertically aligned liquid crystal cured film and/or a horizontally aligned liquid crystal cured film on the opposite side of the horizontally aligned liquid crystal cured film of the basic layer configuration (I), the above-mentioned total film thickness T1 means the total film thickness from the surface on the substrate side of the vertically aligned liquid crystal cured film constituting the basic layer constituted (I) to the surface of the horizontally aligned liquid crystal cured film on the opposite side to the horizontal alignment film.

於本發明之積層體中,垂直配向液晶硬化膜可不介隔垂直配向膜而形成於基材上或設置於基材上之不具有垂直配向限制力之層上。本發明之積層體中,垂直配向液晶硬化膜可無垂直配向膜而形成,因此成為積層體之製造步驟數變少,可生產性良好地進行製造之積層體。即,於本發明之積層體之一態樣中,基材與垂直配向液晶硬化膜不介隔垂直配向膜而積層,於更佳之一態樣中,本發明之積層體係基材、垂直配向液晶硬化膜、水平配向膜及水平配向液晶硬化膜依此順序鄰接地存在而成。具有此種層構成之本發明之積層體可無垂直配向膜而與基材上形成垂直配向液晶硬化膜,進而可於該垂直配向液晶硬化膜上經由水平配向膜而連續地形成水平配向液晶硬化膜,因此成為可生產性更良好地進行製造之積層體。In the laminate of the present invention, the vertically aligned liquid crystal cured film may be formed on the substrate without intervening the vertical alignment film or on a layer having no vertical alignment restriction force on the substrate. In the laminate of the present invention, since the vertical alignment liquid crystal cured film can be formed without the vertical alignment film, the number of manufacturing steps of the laminate is reduced, and the laminate can be manufactured with good productivity. That is, in one aspect of the laminated body of the present invention, the base material and the vertical alignment liquid crystal cured film are laminated without intervening the vertical alignment film. In a more preferable aspect, the laminate system substrate of the present invention, the vertical alignment liquid crystal cured film, the horizontal alignment film, and the horizontal alignment liquid crystal cured film are adjacently present in this order. The laminate of the present invention having such a layer structure can form a vertically aligned cured liquid crystal film on the substrate without a vertically aligned film, and can further form a horizontally aligned cured liquid crystal film on the vertically aligned liquid crystal cured film via a horizontally aligned film. Therefore, it becomes a laminate that can be manufactured with better productivity.

以下,對本發明之積層體之各構成詳細地進行說明。 [垂直配向液晶硬化膜] 構成本發明之積層體之垂直配向液晶硬化膜係聚合性液晶化合物於相對於該液晶硬化膜平面朝垂直方向配向之狀態下硬化而成的聚合性液晶組合物之硬化物。本發明中,垂直配向液晶硬化膜含有垂直配向促進劑。即,於本發明中,形成垂直配向液晶硬化膜之聚合性液晶組合物含有垂直配向促進劑。本發明中,垂直配向促進劑意指使聚合性液晶化合物之液晶配向朝與膜平面垂直之方向促進之材料。藉由使垂直配向液晶硬化膜含有垂直配向促進劑,可無垂直配向膜而形成垂直配向液晶硬化膜。藉此,於本發明之積層體中,無需形成垂直配向液晶硬化膜,積層體之製造步驟得到簡化而可生產性良好地製造積層體。再者,於在該垂直配向液晶硬化膜上形成水平配向膜、及水平配向液晶硬化膜之情形時,有水平配向液晶硬化膜之配向性容易變差之傾向。理由並未確定,但推測:由於垂直配向液晶硬化膜中所含有之調平劑等添加劑而表面能量降低,而於上層形成水平配向液晶硬化膜時液晶化合物之配向性容易受損。尤其是於無垂直配向膜而形成垂直配向液晶硬化膜之情形時,由於進而含有配向促進劑,故而其影響變得更為顯著。Hereinafter, each structure of the laminated body of this invention is demonstrated in detail. [Vertical Alignment Liquid Crystal Curing Film] The vertical alignment liquid crystal cured film constituting the laminate of the present invention is a cured product of a polymeric liquid crystal composition formed by curing a polymerizable liquid crystal compound in a state of being aligned in a vertical direction with respect to the plane of the liquid crystal cured film. In this invention, a vertical alignment liquid crystal cured film contains a vertical alignment promoter. That is, in this invention, the polymeric liquid crystal composition which forms a vertical alignment liquid crystal cured film contains a vertical alignment promoter. In the present invention, the vertical alignment promoter means a material that promotes the liquid crystal alignment of the polymerizable liquid crystal compound in a direction perpendicular to the film plane. By making a vertical alignment liquid crystal cured film contain a vertical alignment promoter, a vertical alignment liquid crystal cured film can be formed without a vertical alignment film. Thereby, in the laminated body of this invention, it is not necessary to form a vertical alignment liquid crystal cured film, the manufacturing process of a laminated body is simplified, and a laminated body can be manufactured with good productivity. Furthermore, when a horizontal alignment film and a horizontal alignment cured liquid crystal film are formed on this vertical alignment liquid crystal cured film, the orientation of the horizontal alignment liquid crystal cured film tends to deteriorate easily. The reason has not been determined, but it is speculated that the surface energy decreases due to additives such as leveling agents contained in the vertically aligned liquid crystal cured film, and the alignment of the liquid crystal compound is easily damaged when the horizontally aligned liquid crystal cured film is formed on the upper layer. In particular, when forming a vertically aligned liquid crystal cured film without a vertically aligned film, since an alignment promoter is further contained, the influence becomes more remarkable.

作為促進聚合性液晶化合物向垂直方向進行配向之垂直配向促進劑,可列舉:非離子性矽烷化合物及包含非金屬原子之離子性化合物等。垂直配向液晶硬化膜較佳為含有非離子性矽烷化合物及包含非金屬原子之離子性化合物中之至少1種,更佳為均含有非離子性矽烷化合物及包含非金屬原子之離子性化合物。Examples of the vertical alignment promoter that promotes the alignment of the polymerizable liquid crystal compound in the vertical direction include nonionic silane compounds and ionic compounds containing nonmetal atoms. The vertical alignment liquid crystal cured film preferably contains at least one of a nonionic silane compound and an ionic compound containing a nonmetal atom, and more preferably contains both a nonionic silane compound and an ionic compound containing a nonmetal atom.

若形成垂直配向液晶硬化膜之聚合性液晶組合物含有非離子性矽烷化合物,則非離子性矽烷化合物使聚合性液晶組合物之表面張力降低,由該聚合性液晶組合物形成之乾燥塗膜有在乾燥塗膜與空氣之界面偏集存在非離子性矽烷化合物之傾向,而有提高對於聚合性液晶化合物之垂直配向限制力,從而於乾燥塗膜內聚合性液晶化合物在與膜平面垂直之方向上配向之傾向。藉此,可保持聚合性液晶化合物垂直配向之狀態而形成液晶硬化膜。If the polymerizable liquid crystal composition forming the vertically aligned liquid crystal cured film contains a nonionic silane compound, the nonionic silane compound reduces the surface tension of the polymerizable liquid crystal composition, and the dry coating film formed by the polymerizable liquid crystal composition tends to concentrate the nonionic silane compound at the interface between the dry coating film and the air, and increases the vertical alignment restriction force for the polymerizable liquid crystal compound, so that the polymerizable liquid crystal compound in the dry coating film tends to be aligned in a direction perpendicular to the film plane. Thereby, the state of vertical alignment of the polymerizable liquid crystal compound can be maintained to form a liquid crystal cured film.

非離子性矽烷化合物係非離子性且包含Si元素之化合物。作為非離子性矽烷化合物,例如可列舉:聚矽烷之類之矽聚合物、聚矽氧油及聚矽氧樹脂之類之聚矽氧樹脂、以及聚矽氧低聚物、倍半矽氧烷及烷氧基矽烷之類之有機無機矽烷化合物(更具體而言,矽烷偶合劑等)等。 該等非離子性矽烷化合物可單獨使用1種,或者組合2種以上使用。其中,就更為提高與鄰接之層之密接性之觀點而言,較佳為矽烷偶合劑。The nonionic silane compound is a nonionic compound containing Si element. Examples of nonionic silane compounds include silicone polymers such as polysilanes, silicone resins such as silicone oils and silicone resins, organoinorganic silane compounds such as polysiloxane oligomers, silsesquioxanes, and alkoxysilanes (more specifically, silane coupling agents, etc.). These nonionic silane compounds may be used alone or in combination of two or more. Among them, a silane coupling agent is preferable from the viewpoint of further improving the adhesiveness with the adjacent layer.

非離子性矽烷化合物可為聚矽氧單體型,亦可為聚矽氧低聚物(聚合物)型。若以(單體)-(單體)共聚物之形式表示聚矽氧低聚物,則可列舉:3-巰基丙基三甲氧基矽烷-四甲氧基矽烷共聚物、3-巰基丙基三甲氧基矽烷-四乙氧基矽烷共聚物、3-巰基丙基三乙氧基矽烷-四甲氧基矽烷共聚物及3-巰基丙基三乙氧基矽烷-四乙氧基矽烷共聚物之類之含巰基丙基之共聚物;巰基甲基三甲氧基矽烷-四甲氧基矽烷共聚物、巰基甲基三甲氧基矽烷-四乙氧基矽烷共聚物、巰基甲基三乙氧基矽烷-四甲氧基矽烷共聚物及巰基甲基三乙氧基矽烷-四乙氧基矽烷共聚物之類之含巰基甲基之共聚物;3-甲基丙烯醯氧基丙基三甲氧基矽烷-四甲氧基矽烷共聚物、3-甲基丙烯醯氧基丙基三甲氧基矽烷-四乙氧基矽烷共聚物、3-甲基丙烯醯氧基丙基三乙氧基矽烷-四甲氧基矽烷共聚物、3-甲基丙烯醯氧基丙基三乙氧基矽烷-四乙氧基矽烷共聚物、3-甲基丙烯醯氧基丙基甲基二甲氧基矽烷-四甲氧基矽烷共聚物、3-甲基丙烯醯氧基丙基甲基二甲氧基矽烷-四乙氧基矽烷共聚物、3-甲基丙烯醯氧基丙基甲基二乙氧基矽烷-四甲氧基矽烷共聚物及3-甲基丙烯醯氧基丙基甲基二乙氧基矽烷-四乙氧基矽烷共聚物之類之含甲基丙烯醯氧基丙基之共聚物;3-丙烯醯氧基丙基三甲氧基矽烷-四甲氧基矽烷共聚物、3-丙烯醯氧基丙基三甲氧基矽烷-四乙氧基矽烷共聚物、3-丙烯醯氧基丙基三乙氧基矽烷-四甲氧基矽烷共聚物、3-丙烯醯氧基丙基三乙氧基矽烷-四乙氧基矽烷共聚物、3-丙烯醯氧基丙基甲基二甲氧基矽烷-四甲氧基矽烷共聚物、3-丙烯醯氧基丙基甲基二甲氧基矽烷-四乙氧基矽烷共聚物、3-丙烯醯氧基丙基甲基二乙氧基矽烷-四甲氧基矽烷共聚物及3-丙烯醯氧基丙基甲基二乙氧基矽烷-四乙氧基矽烷共聚物之類之含丙烯醯氧基丙基之共聚物;乙烯基三甲氧基矽烷-四甲氧基矽烷共聚物、乙烯基三甲氧基矽烷-四乙氧基矽烷共聚物、乙烯基三乙氧基矽烷-四甲氧基矽烷共聚物、乙烯基三乙氧基矽烷-四乙氧基矽烷共聚物、乙烯基甲基二甲氧基矽烷-四甲氧基矽烷共聚物、乙烯基甲基二甲氧基矽烷-四乙氧基矽烷共聚物、乙烯基甲基二乙氧基矽烷-四甲氧基矽烷共聚物及乙烯基甲基二乙氧基矽烷-四乙氧基矽烷共聚物之類之含乙烯基之共聚物;3-胺基丙基三甲氧基矽烷-四甲氧基矽烷共聚物、3-胺基丙基三甲氧基矽烷-四乙氧基矽烷共聚物、3-胺基丙基三乙氧基矽烷-四甲氧基矽烷共聚物、3-胺基丙基三乙氧基矽烷-四乙氧基矽烷共聚物、3-胺基丙基甲基二甲氧基矽烷-四甲氧基矽烷共聚物、3-胺基丙基甲基二甲氧基矽烷-四乙氧基矽烷共聚物、3-胺基丙基甲基二乙氧基矽烷-四甲氧基矽烷共聚物及3-胺基丙基甲基二乙氧基矽烷-四乙氧基矽烷共聚物之類之含胺基之共聚物等。The nonionic silane compound can be polysiloxane monomer type or polysiloxane oligomer (polymer) type. If polysiloxane oligomers are expressed in the form of (monomer)-(monomer) copolymers, examples include: 3-mercaptopropyltrimethoxysilane-tetramethoxysilane copolymer, 3-mercaptopropyltrimethoxysilane-tetraethoxysilane copolymer, 3-mercaptopropyltriethoxysilane-tetramethoxysilane copolymer, and 3-mercaptopropyltriethoxysilane-tetraethoxysilane copolymer containing mercaptopropyl groups; Silane copolymer, mercaptomethyltrimethoxysilane-tetraethoxysilane copolymer, mercaptomethyltriethoxysilane-tetramethoxysilane copolymer and mercaptomethyltriethoxysilane-tetraethoxysilane copolymer, such as mercaptomethyl-containing copolymers; 3-methacryloxypropyl trimethoxysilane-tetramethoxysilane copolymer, 3-methacryloxypropyl trimethoxysilane-tetraethoxysilane copolymer, Tetramethoxysilane copolymer, 3-methacryloxypropyltriethoxysilane-tetraethoxysilane copolymer, 3-methacryloxypropylmethyldimethoxysilane-tetramethoxysilane copolymer, 3-methacryloxypropylmethyldimethoxysilane-tetraethoxysilane copolymer, 3-methacryloxypropylmethyldiethoxysilane-tetramethoxysilane copolymer and 3-methacryloxypropylmethyldiethoxysilane-tetraethoxysilane copolymer Copolymers containing methacryloxypropyl groups such as alkane copolymers; 3-acryloxypropyltrimethoxysilane-tetramethoxysilane copolymer, 3-acryloxypropyltrimethoxysilane-tetraethoxysilane copolymer, 3-acryloxypropyltriethoxysilane-tetramethoxysilane copolymer, 3-acryloxypropyltriethoxysilane-tetraethoxysilane copolymer, 3-acryloxypropylmethyldimethoxysilane-tetramethoxysilane copolymer Oxysilane copolymer, 3-acryloxypropylmethyldimethoxysilane-tetraethoxysilane copolymer, 3-acryloxypropylmethyldiethoxysilane-tetramethoxysilane copolymer and 3-acryloxypropylmethyldiethoxysilane-tetraethoxysilane copolymer containing acryloxypropyl group; vinyltrimethoxysilane-tetramethoxysilane copolymer, vinyltrimethoxysilane-tetraethoxysilane copolymer, vinyltriethoxysilane Alkane-tetramethoxysilane copolymer, vinyltriethoxysilane-tetraethoxysilane copolymer, vinylmethyldimethoxysilane-tetramethoxysilane copolymer, vinylmethyldimethoxysilane-tetraethoxysilane copolymer, vinylmethyldiethoxysilane-tetramethoxysilane copolymer and vinylmethyldiethoxysilane-tetraethoxysilane copolymer; 3-aminopropyltrimethoxysilane-tetramethoxysilane copolymer, 3-aminopropyltrimethyl Oxysilane-tetraethoxysilane copolymer, 3-aminopropyltriethoxysilane-tetramethoxysilane copolymer, 3-aminopropyltriethoxysilane-tetraethoxysilane copolymer, 3-aminopropylmethyldimethoxysilane-tetramethoxysilane copolymer, 3-aminopropylmethyldimethoxysilane-tetraethoxysilane copolymer, 3-aminopropylmethyldiethoxysilane-tetramethoxysilane copolymer and 3-aminopropylmethyldiethoxysilane-tetramethoxysilane copolymer Amino group-containing copolymers such as ethoxysilane copolymers, etc.

矽烷偶合劑係於末端具有選自由乙烯基、環氧基、苯乙烯基、甲基丙烯基、丙烯基、胺基、異氰尿酸基、脲基、巰基、異氰酸基、羧基、及羥基所組成之群中之至少1種之類之官能基、及至少1個烷氧基矽烷基或矽烷醇基之包含Si元素之化合物。藉由適當選定該等官能基,能夠賦予垂直配向液晶硬化膜之機械強度之提高、垂直配向液晶硬化膜之表面改質、與鄰接於垂直配向液晶硬化膜之層之密接性提高等特殊之效果。就密接性之觀點而言,矽烷偶合劑較佳為具有烷氧基矽烷基與另一個不同之反應基(例如,上述官能基)之矽烷偶合劑。進而,矽烷偶合劑較佳為具有烷氧基矽烷基與極性基之矽烷偶合劑。若矽烷偶合劑於其分子內具有至少1個烷氧基矽烷基、及至少1個極性基,則有聚合性液晶化合物之垂直配向性更容易提高,而顯著地獲得垂直配向促進效果之傾向。作為極性基,例如可列舉:環氧基、胺基、異氰尿酸基、巰基、羧基及羥基。再者,極性基亦可為了控制矽烷偶合劑之反應性而具有適宜取代基或保護基。The silane coupling agent is a compound containing Si element having at least one functional group selected from the group consisting of vinyl group, epoxy group, styryl group, methacryl group, acryl group, amine group, isocyanurate group, urea group, mercapto group, isocyanate group, carboxyl group, and hydroxyl group at the end, and at least one alkoxysilyl group or silanol group. By properly selecting these functional groups, it is possible to provide special effects such as improving the mechanical strength of the vertically aligned cured liquid crystal film, modifying the surface of the vertically aligned liquid crystal cured film, and improving the adhesion to the layer adjacent to the vertically aligned cured liquid crystal film. From the viewpoint of adhesion, the silane coupling agent is preferably a silane coupling agent having an alkoxysilyl group and another different reactive group (for example, the above-mentioned functional group). Furthermore, the silane coupling agent is preferably a silane coupling agent having an alkoxysilyl group and a polar group. If the silane coupling agent has at least one alkoxysilyl group and at least one polar group in its molecule, the vertical alignment of the polymerizable liquid crystal compound is more likely to be improved, and the vertical alignment promotion effect tends to be significantly obtained. As a polar group, an epoxy group, an amino group, an isocyanuric acid group, a mercapto group, a carboxyl group, and a hydroxyl group are mentioned, for example. Furthermore, the polar group may have an appropriate substituent or protecting group in order to control the reactivity of the silane coupling agent.

作為矽烷偶合劑,例如可列舉:乙烯基三甲氧基矽烷、乙烯基三乙氧基矽烷、乙烯基三(2-甲氧基乙氧基)矽烷、N-(2-胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、N-(2-胺基乙基)-3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、3-三乙氧基矽烷基-N-(1,3-二甲基-亞丁基)丙基胺、3-縮水甘油氧基丙基三甲氧基矽烷、3-縮水甘油氧基丙基甲基二甲氧基矽烷、2-(3,4-環氧環己基)乙基三甲氧基矽烷、3-氯丙基甲基二甲氧基矽烷、3-氯丙基三甲氧基矽烷、3-甲基丙烯醯氧基丙基三甲氧基矽烷、3-巰基丙基三甲氧基矽烷、3-縮水甘油氧基丙基三甲氧基矽烷、3-縮水甘油氧基丙基三乙氧基矽烷、3-縮水甘油氧基丙基二甲氧基甲基矽烷、及3-縮水甘油氧基丙基乙氧基二甲基矽烷。Examples of silane coupling agents include: vinyltrimethoxysilane, vinyltriethoxysilane, vinyltris(2-methoxyethoxy)silane, N-(2-aminoethyl)-3-aminopropylmethyldimethoxysilane, N-(2-aminoethyl)-3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 3-triethoxysilyl-N-(1,3-dimethyl-butylene) Propylamine, 3-glycidoxypropyltrimethoxysilane, 3-glycidoxypropylmethyldimethoxysilane, 2-(3,4-epoxycyclohexyl)ethyltrimethoxysilane, 3-chloropropylmethyldimethoxysilane, 3-chloropropyltrimethoxysilane, 3-methacryloxypropyltrimethoxysilane, 3-mercaptopropyltrimethoxysilane, 3-glycidoxypropyltrimethoxysilane, 3-glycidyl Oxypropyltriethoxysilane, 3-glycidoxypropyldimethoxymethylsilane, and 3-glycidoxypropylethoxydimethylsilane.

又,作為市售之矽烷偶合劑,例如可列舉KP321、KP323、KP324、KP326、KP340、KP341、X22-161A、KF6001、KBM-1003、KBE-1003、KBM-303、KBM-402、KBM-403、KBE-402、KBE-403、KBM-1403、KBM-502、KBM-503、KBE-502、KBE-503、KBM-5103、KBM-602、KBM-603、KBM-903、KBE-903、KBE-9103、KBM-573、KBM-575、KBM-9659、KBE-585、KBM-802、KBM-803、KBE-846、及KBE-9007之類之信越化學工業(股)製造之矽烷偶合劑。In addition, examples of commercially available silane coupling agents include KP321, KP323, KP324, KP326, KP340, KP341, X22-161A, KF6001, KBM-1003, KBE-1003, KBM-303, KBM-402, KBM-403, KBE-402, KBE-403, KBM- 1403, KBM-502, KBM-503, KBE-502, KBE-503, KBM-5103, KBM-602, KBM-603, KBM-903, KBE-903, KBE-9103, KBM-573, KBM-575, KBM-9659, KBE-585, KBM-802, KBM-803, KBE- Silane coupling agents manufactured by Shin-Etsu Chemical Co., Ltd. such as 846 and KBE-9007.

於形成垂直配向液晶硬化膜之聚合性液晶組合物含有非離子性矽烷化合物之情形時,其含量通常相對於聚合性液晶組合物所含有之聚合性液晶化合物100質量份,較佳為0.01~5質量份,更佳為0.05~4質量份,進而較佳為0.1~3質量份。若非離子性矽烷化合物之含量為上述範圍內,則可一面維持聚合性液晶組合物之良好之塗佈性,一面有效地促進聚合性液晶化合物之垂直配向性。When the polymerizable liquid crystal composition for forming a vertically aligned liquid crystal cured film contains a nonionic silane compound, its content is usually preferably 0.01 to 5 parts by mass, more preferably 0.05 to 4 parts by mass, and still more preferably 0.1 to 3 parts by mass relative to 100 parts by mass of the polymerizable liquid crystal compound contained in the polymerizable liquid crystal composition. When the content of the nonionic silane compound is within the above range, the vertical alignment of the polymerizable liquid crystal compound can be effectively promoted while maintaining good coating properties of the polymerizable liquid crystal composition.

若形成垂直配向液晶硬化膜之聚合性液晶組合物含有包含非金屬原子之離子性化合物,則有於由該聚合性液晶組合物形成之乾燥塗膜中,藉由靜電相互作用而對於聚合性液晶化合物之垂直配向限制力表現,而於乾燥塗膜內聚合性液晶化合物在與膜平面垂直之方向上配向之傾向。藉此,可保持聚合性液晶化合物垂直配向之狀態而形成液晶硬化膜。If the polymerizable liquid crystal composition forming the vertically aligned liquid crystal cured film contains an ionic compound containing non-metal atoms, then in the dry coating film formed by the polymerizable liquid crystal composition, the vertical alignment restriction force for the polymerizable liquid crystal compound is expressed by electrostatic interaction, and the polymerizable liquid crystal compound tends to align in the direction perpendicular to the film plane in the dry coating film. Thereby, the state of vertical alignment of the polymerizable liquid crystal compound can be maintained to form a liquid crystal cured film.

作為包含非金屬原子之離子性化合物,例如可列舉:鎓鹽(更具體而言為氮原子具有正電荷之四級銨鹽、三級鋶鹽、及磷原子具有正電荷之四級鏻鹽等)。該等鎓鹽中,就可更為提高聚合性液晶化合物之垂直配向性之觀點而言,較佳為四級鎓鹽,就提高獲取性及量產性之觀點而言,更佳為四級鏻鹽或四級銨鹽。鎓鹽可於分子內具有2個以上之四級鎓鹽部位,亦可為低聚物或聚合物。Examples of ionic compounds containing nonmetal atoms include onium salts (more specifically, quaternary ammonium salts having a positive charge on a nitrogen atom, tertiary permeic acid salts, and quaternary phosphonium salts having a positive charge on a phosphorus atom). Among these onium salts, quaternary onium salts are preferable from the viewpoint of improving the vertical alignment of the polymerizable liquid crystal compound, and quaternary phosphonium salts or quaternary ammonium salts are more preferable from the viewpoint of improving availability and mass production. The onium salt may have two or more quaternary onium salt sites in the molecule, and may also be an oligomer or a polymer.

包含非金屬原子之離子性化合物之分子量較佳為100以上10,000以下。若分子量為上述範圍內,則容易在確保聚合性液晶組合物之塗佈性之狀態下提高聚合性液晶化合物之垂直配向性。包含非金屬原子之離子性化合物之分子量更佳為5000以下,進而較佳為3000以下。The molecular weight of the ionic compound containing nonmetal atoms is preferably from 100 to 10,000. When the molecular weight is within the above range, it is easy to improve the vertical alignment of the polymerizable liquid crystal compound while ensuring the applicability of the polymerizable liquid crystal composition. The molecular weight of the ionic compound containing a nonmetal atom is more preferably 5,000 or less, further preferably 3,000 or less.

作為包含非金屬原子之離子性化合物之陽離子成分,例如可列舉:無機之陽離子及有機之陽離子。其中,就不易產生聚合性液晶化合物之配向缺陷之方面而言,較佳為有機之陽離子。作為有機之陽離子,例如可列舉:咪唑鎓陽離子、吡啶鎓陽離子、銨陽離子、鋶陽離子及鏻陽離子等。As a cation component of the ionic compound containing a nonmetal atom, an inorganic cation and an organic cation are mentioned, for example. Among them, organic cations are preferred in terms of less likely to cause alignment defects of the polymerizable liquid crystal compound. Examples of organic cations include imidazolium cations, pyridinium cations, ammonium cations, percite cations, and phosphonium cations.

包含非金屬原子之離子性化合物一般具有抗衡陰離子。作為成為上述陽離子成分之抗衡離子之陰離子成分,例如可列舉:無機之陰離子及有機之陰離子。其中,就不易產生聚合性液晶化合物之配向缺陷之方面而言,較佳為有機之陰離子。再者,陽離子與陰離子並非必須成為一對一之對應。Ionic compounds comprising non-metal atoms generally have a counteranion. As an anion component used as a counter ion of the said cation component, an inorganic anion and an organic anion are mentioned, for example. Among these, organic anions are preferred in terms of the difficulty in generating alignment defects of the polymerizable liquid crystal compound. Furthermore, cations and anions do not have to be in one-to-one correspondence.

作為陰離子成分,具體而言,例如可列舉如以下者。 氯陰離子[Cl- ]、 溴陰離子[Br- ]、 碘陰離子[I- ]、 四氯鋁酸根陰離子[AlCl4 - ]、 七氯二鋁酸根陰離子[Al2 Cl7 - ]、 四氟硼酸根陰離子[BF4 - ]、 六氟磷酸根陰離子[PF6 - ]、 過氯酸根陰離子[ClO4 - ]、 硝酸根陰離子[NO3 - ]、 乙酸根陰離子[CH3 COO- ]、 三氟乙酸根陰離子[CF3 COO- ]、 氟磺酸根陰離子[FSO3 - ]、 甲磺酸根陰離子[CH3 SO3 - ]、 三氟甲磺酸根陰離子[CF3 SO3 - ]、 對甲苯磺酸根陰離子[p-CH3 C6 H4 SO3 - ]、 雙(氟磺醯)亞胺陰離子[(FSO2 )2 N- ]、 雙(三氟甲磺醯)亞胺陰離子[(CF3 SO2 )2 N- ]、 三(三氟甲磺醯)甲烷陰離子[(CF3 SO2 )3 C- ]、 六氟砷酸根陰離子[AsF6 - ]、 六氟銻酸根陰離子[SbF6 - ]、 六氟鈮酸根陰離子[NbF6 - ]、 六氟鉭酸根陰離子[TaF6 - ]、 二甲基次膦酸根陰離子[(CH3 )2 POO- ]、 (聚)氫氟氟化物陰離子[F(HF)n - ](例如,n表示1~3之整數)、 二氰亞胺陰離子[(CN)2 N- ]、 硫氰化物陰離子[SCN- ]、 全氟丁磺酸根陰離子[C4 F9 SO3 - ]、 雙(五氟乙磺醯)亞胺陰離子[(C2 F5 SO2 )2 N- ]、 全氟丁酸根陰離子[C3 F7 COO- ]、及 (三氟甲磺醯基)(三氟甲烷羰基)醯亞胺陰離子[(CF3 SO2 )(CF3 CO)N- ]。As an anion component, specifically, the following are mentioned, for example.氯陰離子[Cl - ]、 溴陰離子[Br - ]、 碘陰離子[I - ]、 四氯鋁酸根陰離子[AlCl 4 - ]、 七氯二鋁酸根陰離子[Al 2 Cl 7 - ]、 四氟硼酸根陰離子[BF 4 - ]、 六氟磷酸根陰離子[PF 6 - ]、 過氯酸根陰離子[ClO 4 - ]、 硝酸根陰離子[NO 3 - ]、 乙酸根陰離子[CH 3 COO - ]、 三氟乙酸根陰離子[CF 3 COO - ]、 氟磺酸根陰離子[FSO 3 - ]、 甲磺酸根陰離子[CH 3 SO 3 - ]、 三氟甲磺酸根陰離子[CF 3 SO 3 - ]、 對甲苯磺酸根陰離子[p-CH 3 C 6 H 4 SO 3 - ]、 雙(氟磺醯)亞胺陰離子[(FSO 2 ) 2 N - ]、 雙(三氟甲磺醯)亞胺陰離子[(CF 3 SO 2 ) 2 N - ]、 三(三氟甲磺醯)甲烷陰離子[(CF 3 SO 2 ) 3 C - ]、 六氟砷酸根陰離子[AsF 6 - ]、 六氟銻酸根陰離子[SbF 6 - ]、 六氟鈮酸根陰離子[NbF 6 - ]、 六氟鉭酸根陰離子[TaF 6 - ]、 二甲基次膦酸根陰離子[(CH 3 ) 2 POO - ]、 (聚)氫氟氟化物陰離子[F(HF) n - ](例如,n表示1~3之整數)、 二氰亞胺陰離子[(CN) 2 N - ]、 硫氰化物陰離子[SCN - ]、 全氟丁磺酸根陰離子[C 4 F 9 SO 3 - ]、 雙(五氟乙磺醯)亞胺陰離子[(C 2 F 5 SO 2 ) 2 N - ]、 全氟丁酸根陰離子[C 3 F 7 COO - ]、及(三氟甲磺醯基)(三氟甲烷羰基)醯亞胺陰離子[(CF 3 SO 2 )(CF 3 CO)N - ]。

包含非金屬原子之離子性化合物之具體例可自上述陽離子成分與陰離子成分之組合適當選擇。關於作為具體之陽離子成分與陰離子成分之組合之化合物,例如可列舉如下者。Specific examples of the ionic compound containing a nonmetal atom can be appropriately selected from combinations of the aforementioned cationic components and anionic components. About the compound which is a combination of a specific cationic component and an anionic component, the following are mentioned, for example.

(吡啶鎓鹽) 六氟磷酸N-己基吡啶鎓、 六氟磷酸N-辛基吡啶鎓、 六氟磷酸N-甲基-4-己基吡啶鎓、 六氟磷酸N-丁基-4-甲基吡啶鎓、 六氟磷酸N-辛基-4-甲基吡啶鎓、 雙(氟磺醯)亞胺N-己基吡啶鎓、 雙(氟磺醯)亞胺N-辛基吡啶鎓、 雙(氟磺醯)亞胺N-甲基-4-己基吡啶鎓、 雙(氟磺醯)亞胺N-丁基-4-甲基吡啶鎓、 雙(氟磺醯)亞胺N-辛基-4-甲基吡啶鎓、 雙(三氟甲磺醯)亞胺N-己基吡啶鎓、 雙(三氟甲磺醯)亞胺N-辛基吡啶鎓、 雙(三氟甲磺醯)亞胺N-甲基-4-己基吡啶鎓、 雙(三氟甲磺醯)亞胺N-丁基-4-甲基吡啶鎓、 雙(三氟甲磺醯)亞胺N-辛基-4-甲基吡啶鎓、 對甲苯磺酸N-己基吡啶鎓、 對甲苯磺酸N-辛基吡啶鎓、 對甲苯磺酸N-甲基-4-己基吡啶鎓、 對甲苯磺酸N-丁基-4-甲基吡啶鎓、及 對甲苯磺酸N-辛基-4-甲基吡啶鎓。(pyridinium salt) N-hexylpyridinium hexafluorophosphate, N-octylpyridinium hexafluorophosphate, N-methyl-4-hexylpyridinium hexafluorophosphate, N-butyl-4-methylpyridinium hexafluorophosphate, N-octyl-4-methylpyridinium hexafluorophosphate, Bis(fluorosulfonyl)imide N-hexylpyridinium, Bis(fluorosulfonyl)imide N-octylpyridinium, Bis(fluorosulfonyl)imide N-methyl-4-hexylpyridinium, Bis(fluorosulfonyl)imide N-butyl-4-methylpyridinium, Bis(fluorosulfonyl)imide N-octyl-4-methylpyridinium, Bis(trifluoromethanesulfonyl)imide N-hexylpyridinium, Bis(trifluoromethanesulfonyl)imide N-octylpyridinium, Bis(trifluoromethanesulfonyl)imide N-methyl-4-hexylpyridinium, Bis(trifluoromethanesulfonyl)imide N-butyl-4-methylpyridinium, Bis(trifluoromethanesulfonyl)imide N-octyl-4-methylpyridinium, N-hexylpyridinium p-toluenesulfonate, N-octylpyridinium p-toluenesulfonate, N-methyl-4-hexylpyridinium p-toluenesulfonate, N-butyl-4-methylpyridinium p-toluenesulfonate, and N-octyl-4-methylpyridinium p-toluenesulfonate.

(咪唑鎓鹽) 六氟磷酸1-乙基-3-甲基咪唑鎓、 雙(氟磺醯)亞胺1-乙基-3-甲基咪唑鎓、 雙(三氟甲磺醯)亞胺1-乙基-3-甲基咪唑鎓、 對甲苯磺酸1-乙基-3-甲基咪唑鎓、 甲磺酸1-丁基-3-甲基咪唑鎓等。(imidazolium salt) 1-ethyl-3-methylimidazolium hexafluorophosphate, Bis(fluorosulfonyl)imide 1-ethyl-3-methylimidazolium, Bis(trifluoromethanesulfonyl)imide 1-ethyl-3-methylimidazolium, 1-ethyl-3-methylimidazolium p-toluenesulfonate, 1-butyl-3-methylimidazolium methanesulfonate, etc.

(吡咯啶鎓鹽) 六氟磷酸N-丁基-N-甲基吡咯啶鎓、 雙(氟磺醯)亞胺N-丁基-N-甲基吡咯啶鎓、 雙(三氟甲磺醯)亞胺N-丁基-N-甲基吡咯啶鎓、 對甲苯磺酸N-丁基-N-甲基吡咯啶鎓等。(pyrrolidinium salt) N-butyl-N-methylpyrrolidinium hexafluorophosphate, Bis(fluorosulfonyl)imide N-butyl-N-methylpyrrolidinium, Bis(trifluoromethanesulfonyl)imide N-butyl-N-methylpyrrolidinium, N-butyl-N-methylpyrrolidinium p-toluenesulfonate, etc.

(銨鹽) 六氟磷酸四丁基銨、 雙(氟磺醯)亞胺四丁基銨、 雙(氟磺醯)亞胺四己基銨、 雙(氟磺醯)亞胺三辛基甲基銨、 雙(氟磺醯)亞胺(2-羥基乙基)三甲基銨、 雙(三氟甲磺醯)亞胺四丁基銨、 雙(三氟甲磺醯)亞胺四己基銨、 雙(三氟甲磺醯)亞胺三辛基甲基銨、 雙(三氟甲磺醯)亞胺(2-羥基乙基)三甲基銨、 對甲苯磺酸四丁基銨、 對甲苯磺酸四己基銨、 對甲苯磺酸三辛基甲基銨、 對甲苯磺酸(2-羥基乙基)三甲基銨、 二甲基亞膦酸(2-羥基乙基)三甲基銨、 雙(三氟甲磺醯)亞胺1-(3-三甲氧基矽烷基丙基)-1,1,1-三丁基銨、 雙(三氟甲磺醯)亞胺1-(3-三甲氧基矽烷基丙基)-1,1,1-三甲基銨、 雙(三氟甲磺醯)亞胺1-(3-三甲氧基矽烷基丁基)-1,1,1-三丁基銨、 雙(三氟甲磺醯)亞胺1-(3-三甲氧基矽烷基丁基)-1,1,1-三甲基銨、 雙(三氟甲磺醯)亞胺N-{(3-三乙氧基矽烷基丙基)胺甲醯氧基乙基)}-N,N,N-三甲基銨、及 雙(三氟甲磺醯)亞胺N-[2-{3-(3-三甲氧基矽烷基丙基胺基)-1-側氧基丙氧基}乙基]-N,N,N-三甲基銨。(ammonium salt) Tetrabutylammonium hexafluorophosphate, Tetrabutylammonium bis(fluorosulfonyl)imide, Bis(fluorosulfonyl)imide tetrahexylammonium, bis(fluorosulfonyl)imide trioctylmethylammonium, Bis(fluorosulfonyl)imide (2-hydroxyethyl)trimethylammonium, Tetrabutylammonium bis(trifluoromethanesulfonyl)imide, Tetrahexylammonium bis(trifluoromethanesulfonyl)imide, bis(trifluoromethanesulfonyl)imide trioctylmethylammonium, bis(trifluoromethanesulfonyl)imide(2-hydroxyethyl)trimethylammonium, Tetrabutylammonium p-toluenesulfonate, Tetrahexylammonium p-toluenesulfonate, Trioctylmethylammonium p-toluenesulfonate, (2-Hydroxyethyl)trimethylammonium p-toluenesulfonate, (2-Hydroxyethyl)trimethylammonium dimethylphosphonous acid, Bis(trifluoromethanesulfonyl)imide 1-(3-trimethoxysilylpropyl)-1,1,1-tributylammonium, Bis(trifluoromethanesulfonyl)imide 1-(3-trimethoxysilylpropyl)-1,1,1-trimethylammonium, Bis(trifluoromethanesulfonyl)imide 1-(3-trimethoxysilylbutyl)-1,1,1-tributylammonium, Bis(trifluoromethanesulfonyl)imide 1-(3-trimethoxysilylbutyl)-1,1,1-trimethylammonium, Bis(trifluoromethanesulfonyl)imide N-{(3-triethoxysilylpropyl)aminoformyloxyethyl)}-N,N,N-trimethylammonium, and Bis(trifluoromethanesulfonyl)imide N-[2-{3-(3-trimethoxysilylpropylamino)-1-oxopropoxy}ethyl]-N,N,N-trimethylammonium.

(鏻鹽) 雙(三氟甲磺醯)亞胺三丁基(2-甲氧基乙基)鏻、 雙(三氟甲磺醯)亞胺三丁基甲基鏻、 雙(三氟甲磺醯)亞胺1,1,1-三甲基-1-[(三甲氧基矽烷基)甲基]鏻、 雙(三氟甲磺醯)亞胺1,1,1-三甲基-1-[2-(三甲氧基矽烷基)乙基]鏻、 雙(三氟甲磺醯)亞胺1,1,1-三甲基-1-[3-(三甲氧基矽烷基)丙基]鏻、 雙(三氟甲磺醯)亞胺1,1,1-三甲基-1-[4-(三甲氧基矽烷基)丁基]鏻、 雙(三氟甲磺醯)亞胺1,1,1-三丁基-1-[(三甲氧基矽烷基)甲基]鏻、 雙(三氟甲磺醯)亞胺1,1,1-三丁基-1-[2-(三甲氧基矽烷基)乙基]鏻、及 雙(三氟甲磺醯)亞胺1,1,1-三丁基-1-[3-(三甲氧基矽烷基)丙基]鏻。 該等離子性化合物可分別單獨使用,或者亦可組合2種以上使用。其中,較佳為包含鏻鹽、吡啶鎓鹽、銨鹽之離子性化合物。(phosphonium salt) Bis(trifluoromethanesulfonyl)imide tributyl(2-methoxyethyl)phosphonium, Bis(trifluoromethanesulfonyl)imide tributylmethylphosphonium, Bis(trifluoromethanesulfonyl)imide 1,1,1-trimethyl-1-[(trimethoxysilyl)methyl]phosphonium, Bis(trifluoromethanesulfonyl)imide 1,1,1-trimethyl-1-[2-(trimethoxysilyl)ethyl]phosphonium, Bis(trifluoromethanesulfonyl)imide 1,1,1-trimethyl-1-[3-(trimethoxysilyl)propyl]phosphonium, Bis(trifluoromethanesulfonyl)imide 1,1,1-trimethyl-1-[4-(trimethoxysilyl)butyl]phosphonium, Bis(trifluoromethanesulfonyl)imide 1,1,1-tributyl-1-[(trimethoxysilyl)methyl]phosphonium, 1,1,1-tributyl-1-[2-(trimethoxysilyl)ethyl]phosphonium bis(trifluoromethanesulfonyl)imide, and Bis(trifluoromethanesulfonyl)imide 1,1,1-tributyl-1-[3-(trimethoxysilyl)propyl]phosphonium. These ionic compounds may be used alone, respectively, or may be used in combination of two or more. Among them, ionic compounds containing phosphonium salts, pyridinium salts, and ammonium salts are preferred.

就可更為提高聚合性液晶化合物之垂直配向性之觀點而言,包含非金屬原子之離子性化合物較佳為於陽離子部位之分子結構中具有Si元素及/或F元素。若包含非金屬原子之離子性化合物於陽離子部位之分子結構中具有Si元素及/或F元素,則容易使離子性化合物偏析至垂直配向液晶硬化膜之表面。其中,作為構成之元素全部為非金屬元素之離子性化合物,較佳為下述離子性化合物(i)~(iii)等。The ionic compound containing nonmetal atoms preferably has Si element and/or F element in the molecular structure of the cation site from the viewpoint of further improving the vertical alignment of the polymerizable liquid crystal compound. If the ionic compound containing non-metal atoms has Si element and/or F element in the molecular structure of the cationic part, the ionic compound is easily segregated to the surface of the vertically aligned liquid crystal cured film. Among these, the ionic compounds in which all the constituent elements are nonmetallic elements are preferably the following ionic compounds (i) to (iii) and the like.

(離子性化合物(i)) [化1] (離子性化合物(ii)) [化2] (離子性化合物(iii)) [化3] (ionic compound (i)) [Chem. 1] (ionic compound (ii)) [Chem. 2] (ionic compound (iii)) [Chem. 3]

例如,可應用使用具有鏈長一定程度較長之烷基之界面活性劑對基材表面進行處理而使液晶之配向性提高之方法(例如參照「液晶便覽」之第2章 液晶之配向與物性(丸善股份有限公司發行)等),進一步提高聚合性液晶化合物之垂直配向性。即,藉由使用具有鏈長一定程度較長之烷基之離子性化合物對基材表面進行處理,可有效地提高聚合性液晶化合物之垂直配向性。For example, it is possible to apply a method of treating the surface of the substrate with a surfactant having an alkyl group with a certain length of chain to improve the alignment of the liquid crystal (for example, refer to Chapter 2 "Alignment and Physical Properties of Liquid Crystals" in "Liquid Crystal Handbook" (issued by Maruzen Co., Ltd.), etc.), to further improve the vertical alignment of the polymerizable liquid crystal compound. That is, the vertical alignment of the polymerizable liquid crystal compound can be effectively improved by treating the surface of the substrate with an ionic compound having an alkyl group having a certain length of chain.

具體而言,包含非金屬原子之離子性化合物較佳為滿足下述式(3)。 5<M<16 (3) 式(3)中,M由下述式(4)表示。 M=(直接鍵結於具有正電荷之原子上之取代基中,至分子鏈末端之共價鍵數最多之取代基的自具有正電荷之原子至分子鏈末端之共價鍵數)÷(具有正電荷之原子之數) (4) 藉由使包含非金屬原子之離子性化合物滿足上述(3),可有效地提高聚合性液晶化合物之垂直配向性。Specifically, the ionic compound containing a nonmetal atom preferably satisfies the following formula (3). 5<M<16 (3) In formula (3), M is represented by the following formula (4). M=(among substituents directly bonded to atoms with positive charge, the number of covalent bonds from the atom with positive charge to the end of the molecular chain of the substituent with the largest number of covalent bonds to the end of the molecular chain)÷(number of atoms with positive charge) (4) By making the ionic compound containing a nonmetal atom satisfy the above (3), the vertical alignment of the polymerizable liquid crystal compound can be effectively improved.

再者,於在包含非金屬原子之離子性化合物之分子中存在2個以上具有正電荷之原子的情形時,關於具有2個以上具有正電荷之原子之取代基,將自視作基點之具有正電荷之原子開始算起,至最近之另一具有正電荷之原子的共價鍵數作為上述M之定義中所記載之「自具有正電荷之原子起至分子鏈末端之共價鍵數」。又,於包含非金屬原子之離子性化合物為具有2個以上重複單元之低聚物或聚合物之情形時,將結構單元視作一分子,算出上述M。於具有正電荷之原子組入至環結構之情形時,將經由環結構至該具有正電荷之原子之共價鍵數、或至環結構上鍵結之取代基之末端之共價鍵數中共價鍵數較多者作為上述M之定義中所記載之「自具有正電荷之原子起至分子鏈末端之共價鍵數」。Furthermore, when there are two or more positively charged atoms in the molecule of an ionic compound containing nonmetal atoms, regarding a substituent having two or more positively charged atoms, the number of covalent bonds from the positively charged atom regarded as the base point to the nearest other positively charged atom is taken as the "number of covalent bonds from the positively charged atom to the end of the molecular chain" described in the definition of M above. Moreover, when the ionic compound containing a nonmetal atom is an oligomer or a polymer having 2 or more repeating units, the structural unit is regarded as one molecule, and the above-mentioned M is calculated. When an atom with a positive charge is incorporated into a ring structure, the number of covalent bonds to the atom with a positive charge via the ring structure, or the number of covalent bonds to the end of a substituent bonded to the ring structure, whichever has the greater number of covalent bonds, is taken as the "number of covalent bonds from the atom with a positive charge to the end of the molecular chain" described in the definition of M above.

於形成垂直配向液晶硬化膜之聚合性液晶組合物含有包含非金屬原子之離子性化合物之情形時,其含量通常相對於聚合性液晶組合物中所含之聚合性液晶化合物100質量份,較佳為0.01~5質量份,更佳為0.05~4質量份,進而較佳為0.1~3質量份。若包含非金屬原子之離子性化合物之含量為上述範圍內,則可維持聚合性液晶組合物之良好之塗佈性,並且有效地促進聚合性液晶化合物之垂直配向性。When the polymerizable liquid crystal composition forming a vertically aligned liquid crystal cured film contains an ionic compound containing a non-metal atom, the content thereof is usually preferably 0.01 to 5 parts by mass, more preferably 0.05 to 4 parts by mass, and still more preferably 0.1 to 3 parts by mass relative to 100 parts by mass of the polymerizable liquid crystal compound contained in the polymerizable liquid crystal composition. If the content of the ionic compound containing non-metal atoms is within the above range, the good coatability of the polymerizable liquid crystal composition can be maintained, and the vertical alignment of the polymerizable liquid crystal compound can be effectively promoted.

藉由使形成垂直配向液晶硬化膜之聚合性液晶組合物含有非離子性矽烷化合物及包含非金屬原子之離子性化合物兩者,而於由垂直配向液晶硬化膜形成用聚合性液晶組合物所形成之乾燥塗膜中,藉由來自包含非金屬原子之離子性化合物之靜電相互作用與來自非離子性矽烷化合物之表面張力降低效果,變得容易進一步促進聚合性液晶化合物之垂直配向。藉此,可保持聚合性液晶化合物更高精度地垂直配向之狀態而形成液晶硬化膜。By making the polymerizable liquid crystal composition for forming a vertically aligned liquid crystal cured film contain both a nonionic silane compound and an ionic compound containing a non-metal atom, in a dry coating film formed from a polymerizable liquid crystal composition for forming a vertically aligned liquid crystal cured film, the vertical alignment of the polymerizable liquid crystal compound can be further facilitated by the electrostatic interaction from the ionic compound containing a nonmetal atom and the surface tension reduction effect from the nonionic silane compound. Thereby, it is possible to form a cured liquid crystal film while maintaining a state where the polymerizable liquid crystal compound is vertically aligned with higher precision.

垂直配向液晶硬化膜係含有上述垂直配向促進劑及至少1種聚合性液晶化合物之聚合性液晶組合物的硬化物,較佳為具有至少1個自由基聚合性基之聚合性液晶化合物於相對於該液晶硬化膜之面內方向垂直地配向之狀態下硬化而成的液晶硬化膜。本發明中,形成垂直配向液晶硬化膜之聚合性液晶組合物中所含之聚合性液晶化合物意指具有聚合性基之液晶化合物,尤佳為具有至少1個自由基聚合性基之液晶化合物。聚合性液晶化合物並無特別限定,例如可使用相位差膜之領域中先前公知之聚合性液晶化合物。The vertically aligned liquid crystal cured film is a cured product of a polymerizable liquid crystal composition containing the above-mentioned vertical alignment promoter and at least one polymerizable liquid crystal compound, preferably a cured liquid crystal film formed by curing a polymerizable liquid crystal compound having at least one radically polymerizable group in a state of vertical alignment relative to the in-plane direction of the liquid crystal cured film. In the present invention, the polymerizable liquid crystal compound contained in the polymerizable liquid crystal composition for forming a vertically aligned liquid crystal cured film means a liquid crystal compound having a polymerizable group, especially a liquid crystal compound having at least one radically polymerizable group. The polymerizable liquid crystal compound is not particularly limited, and for example, previously known polymerizable liquid crystal compounds in the field of retardation films can be used.

聚合性基係指自聚合起始劑產生之活性自由基或可藉由酸等而參與聚合反應之基。作為聚合性基,例如可列舉:乙烯基、乙烯基氧基、1-氯乙烯基、異丙烯基、4-乙烯基苯基、丙烯醯氧基、甲基丙烯醯氧基、環氧乙烷基、氧雜環丁基等。其中,較佳為自由基聚合性基,更佳為丙烯醯氧基、甲基丙烯醯氧基、乙烯基、乙烯基氧基,進而較佳為丙烯醯氧基、甲基丙烯醯氧基。於垂直配向液晶硬化膜與水平配向液晶硬化膜經由水平配向膜積層之情形時,在垂直配向液晶硬化膜與水平配向液晶硬化膜均為具有至少1個自由基聚合性基之聚合性液晶化合物的硬化物時,經由自具有(甲基)丙烯醯基之聚合物形成而成之水平光配向膜,連續形成之垂直配向液晶硬化膜與水平配向液晶硬化膜之密接性容易提高。The polymerizable group refers to an active radical generated from a polymerization initiator or a group that can participate in a polymerization reaction by an acid or the like. Examples of the polymerizable group include vinyl, vinyloxy, 1-chlorovinyl, isopropenyl, 4-vinylphenyl, acryloxy, methacryloxy, oxiranyl, oxetanyl and the like. Among them, a radical polymerizable group is preferable, an acryloxy group, a methacryloxy group, a vinyl group, and a vinyloxy group are more preferable, and an acryloxy group and a methacryloxy group are still more preferable. When the vertical alignment cured liquid crystal film and the horizontal alignment cured liquid crystal film are laminated via the horizontal alignment film, when both the vertical alignment liquid crystal cured film and the horizontal alignment liquid crystal cured film are cured products of a polymerizable liquid crystal compound having at least one radical polymerizable group, the adhesion between the vertical alignment liquid crystal cured film and the horizontal alignment cured liquid crystal film formed continuously through the horizontal photo-alignment film formed from a polymer having a (meth)acryl group is easy to improve.

聚合性液晶化合物所顯示之液晶性可為向熱性液晶,亦可為向液性液晶,就能夠控制精細之膜厚之方面而言,較佳為向熱性液晶。又,作為向熱性液晶中之相秩序構造,可為向列型液晶,亦可為層列型液晶。聚合性液晶化合物可單獨或組合兩種以上而使用。The liquid crystallinity exhibited by the polymerizable liquid crystal compound may be a thermotropic liquid crystal or a lyotropic liquid crystal, and a thermotropic liquid crystal is preferable in terms of being able to control fine film thickness. In addition, as the phase order structure in the thermotropic liquid crystal, it may be a nematic liquid crystal or a smectic liquid crystal. A polymeric liquid crystal compound can be used individually or in combination of 2 or more types.

作為聚合性液晶化合物,一般可列舉:顯示正波長分散性之聚合性液晶化合物與顯示逆波長分散性之聚合性液晶化合物,可僅使用其中一種聚合性液晶化合物,亦可將兩種聚合性液晶化合物混合使用。就將垂直配向液晶硬化膜應用於顯示裝置時之黑顯示時之斜向反射色相之抑制效果較大的觀點而言,較佳為含有顯示逆波長分散性之聚合性液晶化合物。The polymerizable liquid crystal compound generally includes: a polymerizable liquid crystal compound exhibiting positive wavelength dispersion and a polymerizable liquid crystal compound exhibiting reverse wavelength dispersion. Only one of the polymerizable liquid crystal compounds may be used, or two polymerizable liquid crystal compounds may be used in combination. It is preferable to contain a polymerizable liquid crystal compound exhibiting reverse wavelength dispersion from the viewpoint that the suppressing effect of oblique reflection hue at the time of black display when the vertically aligned liquid crystal cured film is applied to a display device is large.

作為顯示逆波長分散性之聚合性液晶化合物,較佳為具有下述(A)~(D)之特徵之化合物。 (A)可形成向列相或層列相之化合物。 (B)於該聚合性液晶化合物之長軸方向(a)上具有π電子。 (C)在與長軸方向(a)交叉之方向[交叉方向(b)]上具有π電子。 (D)將存在於長軸方向(a)上之π電子之合計設為N(πa),將存在於長軸方向上之分子量之合計設為N(Aa),下述式(i)所定義之聚合性液晶化合物之長軸方向(a)之π電子密度: D(πa)=N(πa)/N(Aa) (i); 與將存在於交叉方向(b)之π電子之合計設為N(πb),將存在於交叉方向(b)之分子量之合計設為N(Ab),下述式(ii)所定義之聚合性液晶化合物之交叉方向(b)之π電子密度: D(πb)=N(πb)/N(Ab) (ii) 處於式(iii) 0≦[D(πa)/D(πb)]<1 (iii) 之關係[即,交叉方向(b)之π電子密度大於長軸方向(a)之π電子密度]。又,如上述記載般,於長軸及與其交叉之方向上具有π電子之聚合性液晶化合物例如成為T字結構。As the polymerizable liquid crystal compound showing reverse wavelength dispersibility, compounds having the characteristics of the following (A) to (D) are preferred. (A) A compound capable of forming a nematic phase or a smectic phase. (B) It has π electrons in the long-axis direction (a) of the polymerizable liquid crystal compound. (C) There are π-electrons in a direction intersecting with the major axis direction (a) [intersecting direction (b)]. (D) Assuming that the total of π electrons present in the major axis direction (a) is N(πa), and the total of molecular weights present in the major axis direction is N(Aa), the π electron density of the polymerizable liquid crystal compound in the major axis direction (a) defined by the following formula (i): D(πa)=N(πa)/N(Aa) (i); Assuming that the total of π electrons present in the crossing direction (b) is N(πb), and the sum of the molecular weights present in the crossing direction (b) is N(Ab), the π electron density in the crossing direction (b) of the polymerizable liquid crystal compound defined by the following formula (ii): D(πb)=N(πb)/N(Ab) (ii) in formula (iii) 0≦[D(πa)/D(πb)]<1 (iii) The relationship [that is, the π-electron density in the cross direction (b) is greater than the π-electron density in the long-axis direction (a)]. Also, as described above, the polymerizable liquid crystal compound having π electrons in the long axis and the direction intersecting it has, for example, a T-shaped structure.

於上述(A)~(D)之特徵中,長軸方向(a)及π電子數N係以下述方式定義。 ・關於長軸方向(a),若例如為具有棒狀結構之化合物,則為其棒狀之長軸方向。 ・存在於長軸方向(a)上之π電子數N(πa)不包括藉由聚合反應而消失之π電子。 ・關於存在於長軸方向(a)上之π電子數N(πa),係長軸上之π電子及與其共軛之π電子之合計數,例如包括存在於長軸方向(a)上且滿足休克爾定律之環上所存在之π電子的數。 ・存在於交叉方向(b)上之π電子數N(πb)不包括藉由聚合反應而消失之π電子。 滿足上述之聚合性液晶化合物於長軸方向上具有液晶原基結構。藉由該液晶原基結構,表現液晶相(向列相、層列相)。Among the features (A) to (D) above, the major axis direction (a) and the number N of π electrons are defined as follows. ・As for the major axis direction (a), for example, in the case of a compound having a rod-like structure, it is the rod-like major axis direction. ・Number of π electrons N(πa) present in the major axis direction (a) does not include π electrons that disappear by polymerization reaction. ・The number N(πa) of π electrons present in the major axis direction (a) is the total number of π electrons on the major axis and their conjugated π electrons, including, for example, the number of π electrons present on rings that exist in the major axis direction (a) and satisfy Huckel's law. ・Number of π electrons N(πb) present in the crossing direction (b) does not include π electrons that disappear by polymerization reaction. The polymerizable liquid crystal compound satisfying the above has a mesogenic structure in the long axis direction. With this mesogen structure, a liquid crystal phase (nematic phase, smectic phase) is expressed.

將滿足上述(A)~(D)之聚合性液晶化合物塗佈於形成液晶硬化膜之膜(層)上,加熱至相轉移溫度以上,藉此能夠形成向列相或層列相。於該聚合性液晶化合物配向所形成之向列相或層列相中,通常以聚合性液晶化合物之長軸方向變得相互平行之方式配向,該長軸方向成為向列相之配向方向。若將此種聚合性液晶化合物製成膜狀,使之於向列相或層列相之狀態下進行聚合,則可形成包含於在長軸方向(a)上配向之狀態下聚合而成之聚合物之聚合物膜。該聚合物膜藉由長軸方向(a)上之π電子與交叉方向(b)上之π電子而吸收紫外線。此處,將藉由交叉方向(b)上之π電子所吸收之紫外線之吸收極大波長設為λbmax。λbmax通常為300 nm~400 nm。由於π電子之密度滿足上述式(iii),且交叉方向(b)之π電子密度大於長軸方向(a)之π電子密度,故而成為交叉方向(b)上具有振動面之直線偏光紫外線(波長為λbmax)之吸收大於長軸方向(a)上具有振動面之直線偏光紫外線(波長為λbmax)之吸收的聚合物膜。其比(直線偏光紫外線之交叉方向(b)之吸光度/長軸方向(a)之吸光度之比)例如超過1.0、較佳為1.2以上,且通常為30以下、例如為10以下。Apply the polymerizable liquid crystal compound satisfying the above (A) to (D) on the film (layer) forming the liquid crystal cured film, and heat it above the phase transition temperature to form a nematic phase or a smectic phase. In the nematic phase or smectic phase formed by the alignment of the polymerizable liquid crystal compound, the polymerizable liquid crystal compound is usually aligned so that the long-axis directions of the polymerizable liquid crystal compound become parallel to each other, and the long-axis direction becomes the alignment direction of the nematic phase. When such a polymerizable liquid crystal compound is formed into a film and polymerized in a state of a nematic phase or a smectic phase, a polymer film containing a polymer polymerized in a state aligned in the major axis direction (a) can be formed. The polymer film absorbs ultraviolet rays through π electrons in the long axis direction (a) and π electrons in the cross direction (b). Here, let the absorption maximum wavelength of the ultraviolet rays absorbed by the π electrons in the intersecting direction (b) be λbmax. λbmax is usually 300 nm to 400 nm. Since the density of π electrons satisfies the above formula (iii), and the π electron density in the crossing direction (b) is greater than the π electron density in the major axis direction (a), the absorption of linearly polarized ultraviolet light (wavelength λbmax) with a vibrating plane in the crossing direction (b) is greater than the absorption of linearly polarized ultraviolet light (wavelength λbmax) with a vibrating plane in the major axis direction (a). The ratio (absorbance in the cross direction (b) of linearly polarized ultraviolet light/absorbance in the major axis direction (a)) is, for example, more than 1.0, preferably 1.2 or more, and usually 30 or less, for example, 10 or less.

具有上述特性之聚合性液晶化合物一般大多顯示逆波長分散性。具體而言,例如可列舉:下述式(X)所表示之化合物。 [化4] Polymerizable liquid crystal compounds having the above characteristics generally exhibit reverse wavelength dispersion in many cases. Specifically, for example, a compound represented by the following formula (X) is exemplified. [chemical 4]

式(X)中,Ar表示可具有取代基之具有芳香族基之二價基。此處所謂芳香族基,係指該環結構所具有之π電子數依據休克爾定律為[4n+2]個者,例如亦可經由二價之連結基而具有2個以上之如下述(Ar-1)~(Ar-23)所例示之Ar基。此處n表示整數。於包含-N=或-S-等雜原子而形成環結構之情形時,亦包括包含該等雜原子上之非共價鍵電子對在內滿足休克爾定律,具有芳香族性之情形。於該芳香族基中,較佳為含有氮原子、氧原子、硫原子中之至少1個以上。二價基Ar所包含之芳香族基可為1個,亦可為2個以上。於芳香族基為1個之情形時,二價基Ar亦可為可具有取代基之二價之芳香族基。於二價基Ar所包含之芳香族基為2個以上之情形時,2個以上之芳香族基亦可相互以單鍵、-CO-O-、-O-等二價鍵結基進行鍵結。 G1 及G2 分別獨立地表示二價之芳香族基或二價之脂環式烴基。此處,該二價之芳香族基或二價之脂環式烴基所包含之氫原子亦可被取代為鹵素原子、碳數1~4之烷基、碳數1~4之氟烷基、碳數1~4之烷氧基、氰基或硝基,亦可將構成該二價之芳香族基或二價之脂環式烴基之碳原子取代為氧原子、硫原子或氮原子。 L1 、L2 、B1 及B2 分別獨立地為單鍵或二價之連結基。 k、l分別獨立地表示0~3之整數,滿足1≦k+l之關係。此處,於2≦k+l之情形時,B1 及B2 、G1 及G2 分別相互相同,亦可互不相同。 E1 及E2 分別獨立地表示碳數1~17之烷二基,此處,更佳為碳數4~12之烷二基。又,烷二基所包含之氫原子亦可被取代為鹵素原子,該烷二基所包含之-CH2 -亦可被取代為-O-、-S-、-SiH2 -、-C(=O)-。 P1 及P2 相互獨立地表示聚合性基或氫原子,至少1個為聚合性基。In formula (X), Ar represents a divalent group having an aromatic group which may have a substituent. The term "aromatic group" here means that the number of π electrons in the ring structure is [4n+2] according to Huckel's law. For example, it may have two or more Ar groups as exemplified in (Ar-1) to (Ar-23) below via a divalent linking group. Here n represents an integer. In the case of forming a ring structure including heteroatoms such as -N= or -S-, it also includes the non-covalent bond electron pairs on these heteroatoms that satisfy Huckel's law and have aromaticity. In this aromatic group, it is preferable to contain at least one or more of a nitrogen atom, an oxygen atom, and a sulfur atom. The aromatic group included in the divalent group Ar may be one, or two or more. When there is one aromatic group, the divalent group Ar may be a divalent aromatic group which may have a substituent. When the divalent group Ar contains two or more aromatic groups, the two or more aromatic groups may be bonded to each other by a single bond, -CO-O-, -O-, or other divalent bonding groups. G 1 and G 2 each independently represent a divalent aromatic group or a divalent alicyclic hydrocarbon group. Here, the hydrogen atom contained in the divalent aromatic group or the divalent alicyclic hydrocarbon group may also be substituted by a halogen atom, an alkyl group having 1 to 4 carbons, a fluoroalkyl group having 1 to 4 carbons, an alkoxy group having 1 to 4 carbons, a cyano group or a nitro group, and the carbon atoms constituting the divalent aromatic group or alicyclic hydrocarbon group may be replaced by an oxygen atom, a sulfur atom or a nitrogen atom. L 1 , L 2 , B 1 and B 2 are each independently a single bond or a divalent linking group. k and l each independently represent an integer of 0 to 3, and satisfy the relationship of 1≦k+l. Here, in the case of 2≦k+l, B 1 and B 2 , G 1 and G 2 are the same as or different from each other. E 1 and E 2 each independently represent an alkanediyl group having 1 to 17 carbon atoms, and here, more preferably an alkanediyl group having 4 to 12 carbon atoms. Also, the hydrogen atom contained in the alkanediyl group may be substituted with a halogen atom, and the -CH 2 - contained in the alkanediyl group may be substituted with -O-, -S-, -SiH 2 -, -C(=O)-. P1 and P2 independently represent a polymerizable group or a hydrogen atom, and at least one of them is a polymerizable group.

G1 及G2 分別獨立,較佳為可經選自由鹵素原子及碳數1~4之烷基所組成之群中之至少1個取代基取代的1,4-伸苯二基、可經選自由鹵素原子及碳數1~4之烷基所組成之群中之至少1個取代基取代的1,4-環己二基,更佳為經甲基取代之1,4-伸苯二基、未經取代之1,4-伸苯二基、或未經取代之1,4-反式環己二基,尤佳為未經取代之1,4-伸苯二基、或未經取代之1,4-反式環己二基。 又,較佳為存在複數個之G1 及G2 中之至少1個為二價脂環式烴基,又,更佳為鍵結於L1 或L2 之G1 及G2 中之至少1個為二價脂環式烴基。 G1 and G2 are independent, preferably 1,4-phenylenediyl which may be substituted by at least one substituent selected from the group consisting of halogen atoms and alkyl groups having 1 to 4 carbons, 1,4-cyclohexanediyl which may be substituted by at least one substituent selected from the group consisting of halogen atoms and alkyls having 1 to 4 carbons, more preferably methyl-substituted 1,4-phenylenediyl, unsubstituted 1,4-phenylenediyl, or unsubstituted 1,4 - trans-cyclohexanediyl, especially unsubstituted 1,4-phenylenediyl or unsubstituted 1,4-trans-cyclohexanediyl. Also, it is preferable that at least one of the plural G 1 and G 2 is a divalent alicyclic hydrocarbon group, and more preferably at least one of the G 1 and G 2 bonded to L 1 or L 2 is a divalent alicyclic hydrocarbon group.

L1 及L2 分別獨立,較佳為單鍵、碳數1~4之伸烷基、-O-、-S-、-Ra1 ORa2 -、-Ra3 COORa4 -、-Ra5 OCORa6 -、Ra7 OC=OORa8 -、-N=N-、-CRc =CRd -、或-C≡C-。此處,Ra1 ~Ra8 分別獨立地表示單鍵、或碳數1~4之伸烷基,Rc 及Rd 表示碳數1~4之烷基或氫原子。L1 及L2 分別獨立,更佳為單鍵、-ORa2-1 -、-CH2 -、-CH2 CH2 -、-COORa4-1 -、或者-OCORa6-1 -。此處,Ra2-1 、Ra4-1 、Ra6-1 分別獨立地表示單鍵、-CH2 -、-CH2 CH2 -之任一者。L1 及L2 分別獨立,進而較佳為單鍵、-O-、-CH2 CH2 -、-COO-、-COOCH2 CH2 -、或-OCO-。L 1 and L 2 are each independently, preferably a single bond, an alkylene group having 1 to 4 carbon atoms, -O-, -S-, -R a1 OR a2 -, -R a3 COOR a4 -, -R a5 OCOR a6 -, R a7 OC=OOR a8 -, -N=N-, -CR c =CR d -, or -C≡C-. Here, R a1 to R a8 each independently represent a single bond or an alkylene group having 1 to 4 carbons, and R c and R d represent an alkyl group having 1 to 4 carbons or a hydrogen atom. L 1 and L 2 are each independently, more preferably a single bond, -OR a2-1 -, -CH 2 -, -CH 2 CH 2 -, -COOR a4-1 -, or -OCOR a6-1 -. Here, R a2-1 , R a4-1 , and R a6-1 each independently represent any of a single bond, -CH 2 -, and -CH 2 CH 2 -. L 1 and L 2 are each independently, and are further preferably a single bond, -O-, -CH 2 CH 2 -, -COO-, -COOCH 2 CH 2 -, or -OCO-.

B1 及B2 分別獨立,較佳為單鍵、碳數1~4之伸烷基、-O-、-S-、-Ra9 ORa10 -、-Ra11 COORa12 -、-Ra13 OCORa14 -、或Ra15 OC=OORa16 -。此處,Ra9 ~Ra16 分別獨立地表示單鍵、或碳數1~4之伸烷基。B1 及B2 分別獨立,更佳為單鍵、-ORa10-1 -、-CH2 -、-CH2 CH2 -、-COORa12-1 -、或OCORa14-1 -。此處,Ra10-1 、Ra12-1 、Ra14-1 分別獨立地表示單鍵、-CH2 -、-CH2 CH2 -之任一者。B1 及B2 分別獨立,進而較佳為單鍵、-O-、-CH2 CH2 -、-COO-、-COOCH2 CH2 -、-OCO-、或-OCOCH2 CH2 -。B 1 and B 2 are each independently, preferably a single bond, an alkylene group having 1 to 4 carbon atoms, -O-, -S-, -R a9 OR a10 -, -R a11 COOR a12 -, -R a13 OCOR a14 -, or R a15 OC=OOR a16 -. Here, R a9 to R a16 each independently represent a single bond or an alkylene group having 1 to 4 carbon atoms. B 1 and B 2 are each independently, more preferably a single bond, -OR a10-1 -, -CH 2 -, -CH 2 CH 2 -, -COOR a12-1 -, or OCOR a14-1 -. Here, R a10-1 , R a12-1 , and R a14-1 each independently represent any of a single bond, -CH 2 -, and -CH 2 CH 2 -. B 1 and B 2 are each independently, and are further preferably a single bond, -O-, -CH 2 CH 2 -, -COO-, -COOCH 2 CH 2 -, -OCO-, or -OCOCH 2 CH 2 -.

k及l就表現逆波長分散性之觀點而言,較佳為2≦k+l≦6之範圍,且較佳為k+l=4,更佳為k=2且l=2。若k=2且l=2,則成為對稱結構,故而較佳。From the viewpoint of expressing inverse wavelength dispersion, k and l are preferably in the range of 2≦k+l≦6, preferably k+l=4, more preferably k=2 and l=2. If k=2 and l=2, since it becomes a symmetrical structure, it is preferable.

作為P1 或P2 所表示之聚合性基,可列舉:環氧基、乙烯基、乙烯基氧基、1-氯乙烯基、異丙烯基、4-乙烯基苯基、丙烯醯氧基、甲基丙烯醯氧基、環氧乙烷基、及氧雜環丁基等。其中,較佳為丙烯醯氧基、甲基丙烯醯氧基、乙烯基及乙烯基氧基,更佳為丙烯醯氧基、甲基丙烯醯氧基。Examples of the polymerizable group represented by P1 or P2 include epoxy group, vinyl group, vinyloxy group, 1-chlorovinyl group, isopropenyl group, 4-vinylphenyl group, acryloxy group, methacryloxy group, oxiranyl group, and oxetanyl group. Among them, acryloxy, methacryloxy, vinyl and vinyloxy are preferred, and acryloxy and methacryloxy are more preferred.

Ar較佳為具有選自可具有取代基之芳香族烴環、可具有取代基之芳香族雜環、及拉電子性基中之至少一個。作為該芳香族烴環,例如可列舉苯環、萘環、蒽環等,較佳為苯環、萘環。作為該芳香族雜環,可列舉:呋喃環、苯并呋喃環、吡咯環、吲哚環、噻吩環、苯并噻吩環、吡啶環、吡𠯤環、嘧啶環、三唑環、三𠯤環、吡咯啉環、咪唑環、吡唑環、噻唑環、苯并噻唑環、噻吩并噻唑環、㗁唑環、苯并㗁唑環、及啡啉環等。其中,較佳為具有噻唑環、苯并噻唑環、或苯并呋喃環,進而較佳為具有苯并噻唑基。又,於Ar包含氮原子之情形時,該氮原子較佳為具有π電子。Ar preferably has at least one selected from an aromatic hydrocarbon ring which may have a substituent, an aromatic heterocyclic ring which may have a substituent, and an electron-withdrawing group. Examples of the aromatic hydrocarbon ring include a benzene ring, a naphthalene ring, an anthracene ring, and the like, preferably a benzene ring and a naphthalene ring. Examples of the aromatic heterocycle include a furan ring, a benzofuran ring, a pyrrole ring, an indole ring, a thiophene ring, a benzothiophene ring, a pyridine ring, a pyridine ring, a pyrimidine ring, a triazole ring, a triazole ring, a pyrroline ring, an imidazole ring, a pyrazole ring, a thiazole ring, a benzothiazole ring, a thienothiazole ring, a oxazole ring, a benzoxazole ring, and a morpholine ring. Among them, it is preferable to have a thiazole ring, a benzothiazole ring, or a benzofuran ring, and it is more preferable to have a benzothiazolyl group. Also, when Ar contains a nitrogen atom, the nitrogen atom preferably has π electrons.

式(X)中,Ar所表示之2價之芳香族基所包含之π電子之合計數Nπ 較佳為8以上,更佳為10以上,進而較佳為14以上,尤佳為16以上。又,較佳為30以下,更佳為26以下,進而較佳為24以下。In the formula (X), the total number N π of π electrons contained in the divalent aromatic group represented by Ar is preferably 8 or more, more preferably 10 or more, further preferably 14 or more, particularly preferably 16 or more. Moreover, it is preferably 30 or less, more preferably 26 or less, and still more preferably 24 or less.

作為Ar所表示之芳香族基,例如可列舉以下之基。As an aromatic group represented by Ar, the following groups are mentioned, for example.

[化5] [chemical 5]

式(Ar-1)~式(Ar-23)中,*印表示連結部,Z0 、Z1 及Z2 分別獨立地表示氫原子、鹵素原子、碳數1~12之烷基、氰基、硝基、碳數1~12之烷基亞磺醯基、碳數1~12之烷基磺醯基、羧基、碳數1~12之氟烷基、碳數1~12之烷氧基、碳數1~12之烷硫基、碳數1~12之N-烷基胺基、碳數2~12之N,N-二烷基胺基、碳數1~12之N-烷基胺磺醯基或碳數2~12之N,N-二烷基胺磺醯基。又,Z0 、Z1 及Z2 亦可含有聚合性基。式(Ar-1)~式(Ar-23)中,*印表示連結部,Z 0 、Z 1及Z 2分別獨立地表示氫原子、鹵素原子、碳數1~12之烷基、氰基、硝基、碳數1~12之烷基亞磺醯基、碳數1~12之烷基磺醯基、羧基、碳數1~12之氟烷基、碳數1~12之烷氧基、碳數1~12之烷硫基、碳數1~12之N-烷基胺基、碳數2~12之N,N-二烷基胺基、碳數1~12之N-烷基胺磺醯基或碳數2~12之N,N-二烷基胺磺醯基。 In addition, Z 0 , Z 1 and Z 2 may contain a polymerizable group.

Q1 及Q2 分別獨立地表示-CR2' R3' -、-S-、-NH-、-NR2' -、-CO-或-O-,R2' 及R3' 分別獨立地表示氫原子或碳數1~4之烷基。Q 1 and Q 2 each independently represent -CR 2' R 3' -, -S-, -NH-, -NR 2' -, -CO- or -O-, R 2' and R 3' each independently represent a hydrogen atom or an alkyl group having 1 to 4 carbons.

J1 、及J2 分別獨立地表示碳原子、或氮原子。J 1 and J 2 each independently represent a carbon atom or a nitrogen atom.

Y1 、Y2 及Y3 分別獨立地表示可經取代之芳香族烴基或芳香族雜環基。Y 1 , Y 2 and Y 3 each independently represent an aromatic hydrocarbon group or an aromatic heterocyclic group which may be substituted.

W1 及W2 分別獨立地表示氫原子、氰基、甲基或鹵素原子,m表示0~6之整數。W 1 and W 2 each independently represent a hydrogen atom, a cyano group, a methyl group or a halogen atom, and m represents an integer of 0-6.

作為Y1 、Y2 及Y3 中之芳香族烴基,可列舉:苯基、萘基、蒽基、菲基、聯苯基等碳數6~20之芳香族烴基,較佳為苯基、萘基,更佳為苯基。作為芳香族雜環基,可列舉:呋喃基、吡咯基、噻吩基、吡啶基、噻唑基、苯并噻唑基等含有至少1個氮原子、氧原子、硫原子等雜原子之碳數4~20之芳香族雜環基,較佳為呋喃基、噻吩基、吡啶基、噻唑基、苯并噻唑基。The aromatic hydrocarbon groups in Y 1 , Y 2 and Y 3 include aromatic hydrocarbon groups having 6 to 20 carbon atoms such as phenyl, naphthyl, anthracenyl, phenanthrenyl, and biphenyl, preferably phenyl and naphthyl, more preferably phenyl. Examples of the aromatic heterocyclic group include: furyl, pyrrolyl, thienyl, pyridyl, thiazolyl, benzothiazolyl and other aromatic heterocyclic groups with 4 to 20 carbon atoms containing at least one heteroatom such as nitrogen atom, oxygen atom, sulfur atom, etc., preferably furyl, thienyl, pyridyl, thiazolyl, and benzothiazolyl.

Y1 、Y2 及Y3 亦可分別獨立地為可經取代之多環系芳香族烴基或多環系芳香族雜環基。多環系芳香族烴基係指縮合多環系芳香族烴基、或源自芳香集合環之基。多環系芳香族雜環基係指縮合多環系芳香族雜環基、或源自芳香集合環之基。Y 1 , Y 2 and Y 3 may each independently be an optionally substituted polycyclic aromatic hydrocarbon group or a polycyclic aromatic heterocyclic group. The polycyclic aromatic hydrocarbon group refers to a condensed polycyclic aromatic hydrocarbon group, or a group derived from aromatic aggregate rings. The polycyclic aromatic heterocyclic group refers to a condensed polycyclic aromatic heterocyclic group or a group derived from an aromatic aggregate ring.

Z0 、Z1 及Z2 較佳為分別獨立地為氫原子、鹵素原子、碳數1~12之烷基、氰基、硝基、碳數1~12之烷氧基,Z0 進而較佳為氫原子、碳數1~12之烷基、氰基,Z1 及Z2 進而較佳為氫原子、氟原子、氯原子、甲基、氰基。又,Z0 、Z1 及Z2 亦可含有聚合性基。Z 0 , Z 1 and Z 2 are preferably each independently a hydrogen atom, a halogen atom, an alkyl group having 1 to 12 carbons, a cyano group, a nitro group, an alkoxy group having 1 to 12 carbons, Z 0 is further preferably a hydrogen atom, an alkyl group having 1 to 12 carbons, or a cyano group, Z 1 and Z 2 are further preferably a hydrogen atom, a fluorine atom, a chlorine atom, a methyl group, or a cyano group. In addition, Z 0 , Z 1 and Z 2 may contain a polymerizable group.

Q1 及Q2 較佳為-NH-、-S-、-NR2' -、-O-,R2' 較佳為氫原子。其中,尤佳為-S-、-O-、-NH-。Q 1 and Q 2 are preferably -NH-, -S-, -NR 2' -, -O-, and R 2' is preferably a hydrogen atom. Among them, -S-, -O-, and -NH- are particularly preferable.

式(Ar-1)~(Ar-23)之中,式(Ar-6)及式(Ar-7)就分子之穩定性之觀點而言較佳。Among formulas (Ar-1) to (Ar-23), formula (Ar-6) and formula (Ar-7) are preferable from the viewpoint of molecular stability.

式(Ar-16)~(Ar-23)中,Y1 亦可與其所鍵結之氮原子及Z0 一起形成芳香族雜環基。作為芳香族雜環基,可列舉:作為Ar亦可具有之芳香族雜環於上文所述者,例如可列舉:吡咯環、咪唑環、吡咯啉環、吡啶環、吡𠯤環、嘧啶環、吲哚環、喹啉環、異喹啉環、嘌呤環、吡咯啶環等。該芳香族雜環基亦可具有取代基。又,Y1 亦可與其所鍵結之氮原子及Z0 一起為上述可經取代之多環系芳香族烴基或多環系芳香族雜環基。例如可列舉:苯并呋喃環、苯并噻唑環、苯并㗁唑環等。In the formulas (Ar-16) to (Ar-23), Y 1 may form an aromatic heterocyclic group together with the nitrogen atom to which it is bonded and Z 0 . Examples of the aromatic heterocyclic group include those described above as the aromatic heterocycle that Ar may have, for example, a pyrrole ring, an imidazole ring, a pyrroline ring, a pyridine ring, a pyrroline ring, a pyrimidine ring, an indole ring, a quinoline ring, an isoquinoline ring, a purine ring, and a pyrrolidine ring. This aromatic heterocyclic group may have a substituent. In addition, Y 1 may be the above-mentioned optionally substituted polycyclic aromatic hydrocarbon group or polycyclic aromatic heterocyclic group together with the nitrogen atom to which it is bonded and Z 0 . For example, a benzofuran ring, a benzothiazole ring, a benzoxazole ring, etc. are mentioned.

又,本發明中作為形成垂直配向液晶硬化膜之聚合性液晶化合物,例如亦可使用含有下述式(Y)所表示之基之化合物(以下,亦稱為「聚合性液晶化合物(Y)」)。聚合性液晶化合物(Y)一般有顯示正波長分散性之傾向。聚合性液晶化合物可單獨使用或組合2種以上使用。In addition, in the present invention, as the polymerizable liquid crystal compound forming the vertically aligned liquid crystal cured film, for example, a compound containing a group represented by the following formula (Y) (hereinafter also referred to as "polymerizable liquid crystal compound (Y)") can also be used. The polymerizable liquid crystal compound (Y) generally has a tendency to exhibit positive wavelength dispersion. A polymeric liquid crystal compound can be used individually or in combination of 2 or more types.

P11-B11-E11-B12-A11-B13- (Y) [式(Y)中,P11表示聚合性基; A11表示2價脂環式烴基或2價芳香族烴基;該2價脂環式烴基及2價芳香族烴基所含有之氫原子可被取代為鹵素原子、碳數1~6之烷基、碳數1~6之烷氧基、氰基或硝基,該碳數1~6之烷基及該碳數1~6之烷氧基所含有之氫原子可被取代為氟原子; B11表示-O-、-S-、-CO-O-、-O-CO-、-O-CO-O-、-CO-NR16 -、-NR16 -CO-、-CO-、-CS-或單鍵。R16 表示氫原子或碳數1~6之烷基。 B12及B13分別獨立地表示-C≡C-、-CH=CH-、-CH2 -CH2 -、-O-、-S-、-C(=O)-、-C(=O)-O-、-O-C(=O)-、-O-C(=O)-O-、-CH=N-、-N=CH-、-N=N-、-C(=O)-NR16 -、-NR16 -C(=O)-、-OCH2 -、-OCF2 -、-CH2 O-、-CF2 O-、-CH=CH-C(=O)-O-、-O-C(=O)-CH=CH-或單鍵; E11表示碳數1~12之烷二基,該烷二基所含有之氫原子亦可被取代為碳數1~5之烷氧基,該烷氧基所含有之氫原子亦可被取代為鹵素原子;又,構成該烷二基之-CH2 -亦可被取代為-O-或-CO-]。P11-B11-E11-B12-A11-B13- (Y) [式(Y)中,P11表示聚合性基; A11表示2價脂環式烴基或2價芳香族烴基;該2價脂環式烴基及2價芳香族烴基所含有之氫原子可被取代為鹵素原子、碳數1~6之烷基、碳數1~6之烷氧基、氰基或硝基,該碳數1~6之烷基及該碳數1~6之烷氧基所含有之氫原子可被取代為氟原子; B11表示-O-、-S-、-CO-O-、-O-CO-、-O-CO-O-、-CO-NR 16 -、-NR 16 -CO-、-CO-、-CS-或單鍵。 R 16 represents a hydrogen atom or an alkyl group having 1 to 6 carbons. B12及B13分別獨立地表示-C≡C-、-CH=CH-、-CH 2 -CH 2 -、-O-、-S-、-C(=O)-、-C(=O)-O-、-OC(=O)-、-OC(=O)-O-、-CH=N-、-N=CH-、-N=N-、-C(=O)-NR 16 -、-NR 16 -C(=O)-、-OCH 2 -、-OCF 2 -、-CH 2 O-、-CF 2 O-、-CH=CH-C(=O)-O-、-OC(=O)-CH=CH-或單鍵; E11表示碳數1~12之烷二基,該烷二基所含有之氫原子亦可被取代為碳數1~5之烷氧基,該烷氧基所含有之氫原子亦可被取代為鹵素原子;又,構成該烷二基之-CH 2 -亦可被取代為-O-或-CO-]。

A11之芳香族烴基及脂環式烴基之碳數較佳為3~18之範圍,更佳為5~12之範圍,尤佳為5或6。作為A11,較佳為環己烷-1,4-二基、1,4-伸苯基。The carbon number of the aromatic hydrocarbon group and alicyclic hydrocarbon group of A11 is preferably in the range of 3-18, more preferably in the range of 5-12, especially preferably 5 or 6. A11 is preferably cyclohexane-1,4-diyl or 1,4-phenylene.

作為E11,較佳為直鏈狀之碳數1~12之烷二基。構成該烷二基之-CH2 -亦可被取代為-O-。 具體而言,可列舉:亞甲基、伸乙基、丙烷-1,3-二基、丁烷-1,4-二基、戊烷-1,5-二基、己烷-1,6-二基、庚烷-1,7-二基、辛烷-1,8-二基、壬烷-1,9-二基、癸烷-1,10-二基、十一烷-1,11-二基及十二烷-1,12-二基等碳數1~12之直鏈狀烷二基;-CH2 -CH2 -O-CH2 -CH2 -、-CH2 -CH2 -O-CH2 -CH2 -O-CH2 -CH2 -及-CH2 -CH2 -O-CH2 -CH2 -O-CH2 -CH2 -O-CH2 -CH2 -等。 作為B11,較佳為-O-、-S-、-CO-O-、-O-CO-,其中更佳為-CO-O-。 作為B12及B13,較佳為分別獨立為-O-、-S-、-C(=O)-、-C(=O)-O-、-O-C(=O)-、-O-C(=O)-O-,其中,更佳為-O-或-O-C(=O)-O-。E11 is preferably a linear C 1-12 alkanediyl group. -CH 2 - constituting the alkanediyl group may be substituted with -O-.具體而言,可列舉:亞甲基、伸乙基、丙烷-1,3-二基、丁烷-1,4-二基、戊烷-1,5-二基、己烷-1,6-二基、庚烷-1,7-二基、辛烷-1,8-二基、壬烷-1,9-二基、癸烷-1,10-二基、十一烷-1,11-二基及十二烷-1,12-二基等碳數1~12之直鏈狀烷二基;-CH 2 -CH 2 -O-CH 2 -CH 2 -、-CH 2 -CH 2 -O-CH 2 -CH 2 -O-CH 2 -CH 2 -及-CH 2 -CH 2 -O-CH 2 -CH 2 -O-CH 2 -CH 2 -O-CH 2 -CH 2 -等。 As B11, -O-, -S-, -CO-O-, -O-CO- are preferable, and -CO-O- is more preferable among them. B12 and B13 are preferably independently -O-, -S-, -C(=O)-, -C(=O)-O-, -OC(=O)-, -OC(=O)-O-, and among them, -O- or -OC(=O)-O- are more preferable.

作為P11所示之聚合性基,就聚合反應性、尤其是光聚合反應性較高之方面而言,較佳為自由基聚合性基或陽離子聚合性基,就操作容易而且液晶化合物之製造本身亦容易之方面而言,聚合性基較佳為下述式(P-11)~式(P-15)所表示之基。 [化6] [式(P-11)~(P-15)中, R17 ~R21 分別獨立地表示碳數1~6之烷基或氫原子]。The polymerizable group represented by P11 is preferably a radically polymerizable group or a cationic polymerizable group in terms of high polymerization reactivity, especially photopolymerization reactivity, and is preferably a group represented by the following formulas (P-11) to formula (P-15) in terms of ease of handling and easy production of liquid crystal compounds. [chemical 6] [In the formulas (P-11) to (P-15), R 17 to R 21 each independently represent an alkyl group having 1 to 6 carbon atoms or a hydrogen atom].

作為式(P-11)~式(P-15)所表示之基之具體例,可列舉:下述式(P-16)~式(P-20)所表示之基。 [化7] Specific examples of the groups represented by the formulas (P-11) to (P-15) include groups represented by the following formulas (P-16) to (P-20). [chemical 7]

P11較佳為式(P-14)~式(P-20)所表示之基,更佳為乙烯基、對茋基、環氧基或氧雜環丁基。 進而較佳為P11-B11-所表示之基為丙烯醯氧基或甲基丙烯醯氧基。P11 is preferably a group represented by formula (P-14) to formula (P-20), more preferably vinyl group, p-stilbene group, epoxy group or oxetanyl group. Further preferably, the group represented by P11-B11- is acryloxy or methacryloxy.

作為聚合性液晶化合物(Y),可列舉:式(I)、式(II)、式(III)、式(IV)、式(V)或式(VI)所表示之化合物。 P11-B11-E11-B12-A11-B13-A12-B14-A13-B15-A14-B16-E12-B17-P12 (I) P11-B11-E11-B12-A11-B13-A12-B14-A13-B15-A14-F11 (II) P11-B11-E11-B12-A11-B13-A12-B14-A13-B15-E12-B17-P12 (III) P11-B11-E11-B12-A11-B13-A12-B14-A13-F11 (IV) P11-B11-E11-B12-A11-B13-A12-B14-E12-B17-P12 (V) P11-B11-E11-B12-A11-B13-A12-F11 (VI) (式中, A12~A14分別獨立地與與A11含義相同,B14~B16分別獨立地與B12含義相同,B17與B11含義相同,E12與E11含義相同; F11表示氫原子、碳數1~13之烷基、碳數1~13之烷氧基、氰基、硝基、三氟甲基、二甲胺基、羥基、羥甲基、甲醯基、磺基(-SO3 H)、羧基、碳數1~10之烷氧基羰基或鹵素原子,構成該烷基及烷氧基之-CH2 -亦可被取代為-O-)。Examples of the polymerizable liquid crystal compound (Y) include compounds represented by formula (I), formula (II), formula (III), formula (IV), formula (V) or formula (VI). P11-B11-E11-B12-A11-B13-A12-B14-A13-B15-A14-B16-E12-B17-P12 (I) P11-B11-E11-B12-A11-B13-A12-B14-A13-B15-A14-F11 (II) P11-B11-E11-B12-A11-B13-A12-B14-A13-B15-E12-B17-P12 (III) P11-B11-E11-B12-A11-B13-A12-B14-A13-F11 (IV) P11-B11-E11-B12-A11-B13-A12-B14-E12-B17-P12 (V) P11-B11-E11-B12-A11-B13-A12-F11 (VI) (式中, A12~A14分別獨立地與與A11含義相同,B14~B16分別獨立地與B12含義相同,B17與B11含義相同,E12與E11含義相同; F11表示氫原子、碳數1~13之烷基、碳數1~13之烷氧基、氰基、硝基、三氟甲基、二甲胺基、羥基、羥甲基、甲醯基、磺基(-SO 3 H)、羧基、碳數1~10之烷氧基羰基或鹵素原子,構成該烷基及烷氧基之-CH 2 -亦可被取代為-O-)。

作為聚合性液晶化合物(Y)之具體例,可列舉:液晶便覽(液晶便覽編集委員會編,丸善(股)2000年10月30日發行)之「3.8.6 網狀(完全交聯型)」、「6.5.1 液晶材料 b.聚合性向列型液晶材料」所記載之化合物中具有聚合性基之化合物、日本專利特開2010-31223號公報、日本專利特開2010-270108號公報、日本專利特開2011-6360號公報及日本專利特開2011-207765號公報記載之聚合性液晶。Specific examples of the polymerizable liquid crystal compound (Y) include compounds having a polymerizable group among the compounds described in "3.8.6 Network (Completely Crosslinked Type)" in Liquid Crystal Handbook (edited by the Liquid Crystal Handbook Editorial Committee, published by Maruzen Co., Ltd. on October 30, 2000), "6.5.1 Liquid Crystal Material b. Polymerizable liquid crystals described in Gazette No. 70108, JP-A-2011-6360 and JP-A-2011-207765.

作為聚合性液晶化合物(Y)之具體例,可列舉:下述式(I-1)~式(I-4)、式(II-1)~式(II-4)、式(III-1)~式(III-26)、式(IV-1)~式(IV-26)、式(V-1)~式(V-2)及式(VI-1)~式(VI-6)所表示之化合物。再者,下述式中,k1及k2分別獨立地表示2~12之整數。該等聚合性液晶化合物(Y)就其合成之容易性、或獲取之容易性之方面而言較佳。Specific examples of the polymerizable liquid crystal compound (Y) include compounds represented by the following formula (I-1) to formula (I-4), formula (II-1) to formula (II-4), formula (III-1) to formula (III-26), formula (IV-1) to formula (IV-26), formula (V-1) to formula (V-2), and formula (VI-1) to formula (VI-6). In addition, in the following formula, k1 and k2 each independently represent the integer of 2-12. These polymerizable liquid crystal compounds (Y) are preferred in terms of ease of synthesis or ease of acquisition.

[化8] [chemical 8]

[化9] [chemical 9]

[化10] [chemical 10]

[化11] [chemical 11]

[化12] [chemical 12]

[化13] [chemical 13]

[化14] [chemical 14]

[化15] [chemical 15]

[化16] [chemical 16]

藉由使用顯示層列型液晶性之聚合性液晶化合物,可形成配向秩序度較高之垂直配向液晶硬化膜。作為本發明中形成垂直配向液晶硬化膜之聚合性液晶化合物,於使用顯示層列型液晶性之聚合性液晶化合物之情形時,就可實現更高之配向秩序度之觀點而言,該聚合性液晶化合物更佳為高次層列相(高次層列型液晶狀態)。此處,所謂高次層列相,意味著層列型B相、層列型D相、層列型E相、層列型F相、層列型G相、層列型H相、層列型I相、層列型J相、層列型K相及層列型L相,該等之中,更佳為層列型B相、層列型F相及層列型I相。液晶性可為向熱性液晶,亦可為向液性液晶,就能夠控制精細之膜厚之方面而言,較佳為向熱性液晶。又,顯示層列型液晶性之聚合性液晶化合物可為單體,亦可為聚合性基聚合而成之低聚物,亦可為聚合物。By using a polymerizable liquid crystal compound exhibiting smectic liquid crystallinity, a vertically aligned liquid crystal cured film with a high degree of alignment order can be formed. In the case of using a polymerizable liquid crystal compound exhibiting smectic liquid crystallinity as the polymerizable liquid crystal compound forming a vertically aligned liquid crystal cured film in the present invention, the polymerizable liquid crystal compound is more preferably a higher order smectic phase (higher order smectic liquid crystal state) from the viewpoint of realizing a higher degree of alignment order. Here, the so-called high-order smectic phase means smectic B phase, smectic D phase, smectic E phase, smectic F phase, smectic G phase, smectic H phase, smectic I phase, smectic J phase, smectic K phase, and smectic L phase, and among them, smectic B phase, smectic F phase, and smectic I phase are more preferable. The liquid crystallinity may be a thermotropic liquid crystal or a lyotropic liquid crystal, and a thermotropic liquid crystal is preferable at the point that a fine film thickness can be controlled. In addition, the polymerizable liquid crystal compound exhibiting smectic liquid crystallinity may be a monomer, an oligomer obtained by polymerizing a polymerizable group, or a polymer.

顯示層列型液晶性之聚合性液晶化合物係具有至少1個聚合性基之液晶化合物,就提高垂直配向液晶硬化膜之耐熱性之觀點而言,較佳為具有2個以上之聚合性基之液晶化合物。作為聚合性基,例如可列舉:(甲基)丙烯醯氧基、乙烯基、乙烯基氧基、1-氯乙烯基、異丙烯基、4-乙烯基苯基、環氧乙烷基、氧雜環丁基等,其中,就製造容易;垂直配向液晶硬化膜之耐熱性容易提高;及容易調整、提高垂直配向液晶硬化膜與由具有(甲基)丙烯醯基之聚合物形成之水平配向膜之密接性、進而經由該水平配向膜與水平配向液晶硬化膜之密接性之方面而言,較佳為含有(甲基)丙烯醯氧基。The polymerizable liquid crystal compound exhibiting smectic liquid crystallinity is a liquid crystal compound having at least one polymerizable group, and is preferably a liquid crystal compound having two or more polymerizable groups from the viewpoint of improving the heat resistance of a vertically aligned liquid crystal cured film. Examples of polymerizable groups include: (meth)acryloxy, vinyl, vinyloxy, 1-chlorovinyl, isopropenyl, 4-vinylphenyl, oxiranyl, oxetanyl, and the like. Among them, it is easy to manufacture; the heat resistance of the vertical alignment cured liquid crystal film is easy to improve; In terms of binding properties, it is preferable to contain a (meth)acryloyloxy group.

作為顯示層列型液晶性之聚合性液晶化合物,例如可列舉:下述式(Z)所表示之化合物(以下,有時稱為「聚合性液晶化合物(Z)」)。 U1z -V1z -W1z -(X1z -Y1z -)nz -X2z -W2z -V2z -U2z (Z) [式(Z)中,X1z 及X2z 相互獨立地表示2價芳香族基或2價脂環式烴基,此處,該2價芳香族基或2價脂環式烴基所含有之氫原子可被取代為鹵素原子、碳數1~4之烷基、碳數1~4之氟烷基、碳數1~4之烷氧基、氰基或硝基,構成該2價芳香族基或2價脂環式烴基之碳原子亦可被取代為氧原子或硫原子或氮原子;其中,X1z 及X2z 中之至少1個為可具有取代基之1,4-伸苯基或可具有取代基之環己烷-1,4-二基; Y1z 為單鍵或二價連結基; nz為1~3,於nz為2以上之情形時,複數個X1z 相互可相同亦可不同。X2z 可與複數個X1z 中之任一者或全部相同,亦可不同;又,於nz為2以上之情形時,複數個Y1z 可相互相同亦可不同;就液晶性之觀點而言,nz較佳為2以上。 U1z 表示氫原子或(甲基)丙烯醯氧基; U2z 表示聚合性基; W1z 及W2z 相互獨立地為單鍵或二價連結基; V1z 及V2z 相互獨立地表示可具有取代基之碳數1~20之烷二基,構成該烷二基之-CH2 -亦可被取代為-O-、-CO-、-S-或NH-]。Examples of the polymerizable liquid crystal compound exhibiting smectic liquid crystallinity include compounds represented by the following formula (Z) (hereinafter, sometimes referred to as "polymerizable liquid crystal compound (Z)"). U 1z -V 1z -W 1z -(X 1z -Y 1z -) nz -X 2z -W 2z -V 2z -U 2z (Z) [式(Z)中,X 1z及X 2z相互獨立地表示2價芳香族基或2價脂環式烴基,此處,該2價芳香族基或2價脂環式烴基所含有之氫原子可被取代為鹵素原子、碳數1~4之烷基、碳數1~4之氟烷基、碳數1~4之烷氧基、氰基或硝基,構成該2價芳香族基或2價脂環式烴基之碳原子亦可被取代為氧原子或硫原子或氮原子;其中,X 1z及X 2z中之至少1個為可具有取代基之1,4-伸苯基或可具有取代基之環己烷-1,4-二基; Y 1z為單鍵或二價連結基; nz為1~3,於nz為2以上之情形時,複數個X 1z相互可相同亦可不同。 X 2z may be the same as any or all of the plurality of X 1z , or may be different; and when nz is 2 or more, the plurality of Y 1z may be the same or different from each other; from the viewpoint of liquid crystallinity, nz is preferably 2 or more. U 1z represents a hydrogen atom or a (meth)acryloyloxy group; U 2z represents a polymerizable group; W 1z and W 2z are independently a single bond or a divalent linking group; V 1z and V 2z independently represent an alkanediyl group having 1 to 20 carbon atoms that may have a substituent, and the -CH 2 - constituting the alkanediyl group may also be substituted with -O-, -CO-, -S- or NH-].

於聚合性液晶化合物(Z)中,X1z 及X2z 較佳為相互獨立為可具有取代基之1,4-伸苯基、或可具有取代基之環己烷-1,4-二基,X1z 及X2z 中之至少1個為可具有取代基之1,4-伸苯基、或可具有取代基之環己烷-1,4-二基,較佳為反式-環己烷-1,4-二基。作為可具有取代基之1,4-伸苯基、或可具有取代基之環己烷-1,4-二基所任意具有之取代基,可列舉:甲基、乙基及丁基等碳數1~4之烷基、氰基及氯原子、氟原子等鹵素原子。較佳為未經取代。In the polymerizable liquid crystal compound (Z), X 1z and X 2z are preferably independently substituted 1,4-phenylene or substituted cyclohexane-1,4-diyl, and at least one of X 1z and X 2z is substituted 1,4-phenylene or substituted cyclohexane-1,4-diyl, preferably trans-cyclohexane-1,4-diyl. Examples of substituents that optionally substituted 1,4-phenylene groups or optionally substituted cyclohexane-1,4-diyl groups include alkyl groups having 1 to 4 carbon atoms such as methyl groups, ethyl groups, and butyl groups, cyano groups, and halogen atoms such as chlorine atoms and fluorine atoms. Preferably it is unsubstituted.

又,聚合性液晶化合物(Z)係式(Z)中,式(Z1): -(X1z -Y1z -)nz -X2z - (Z1) [式中,X1z 、Y1z 、X2z 及nz分別表示與上述相同之含義] 所示之部分[以下,稱為部分結構(Z1)]為非對稱結構,就容易表現層列型液晶性之方面而言較佳。 作為部分結構(Z1)為非對稱結構之聚合性液晶化合物(Z),例如可列舉:nz為1,1個X1z 與X2z 為互不相同之結構之聚合性液晶化合物(Z)。又,亦可列舉:nz為2,2個Y1z 為相互相同之結構,且2個X1z 為相互相同之結構,1個X2z 與該等2個X1z 為不同結構之聚合性液晶化合物(Z);2個X1z 中鍵結於W1z 之X1z 為與另一個X1z 及X2z 不同之結構,另一個X1z 與X2z 為相互相同之結構之聚合性液晶化合物(Z)。進而,可列舉:nz為3,3個Y1z 為相互相同之結構,且3個X1z 及1個X2z 中之任一個為與其他3個均不同之結構的聚合性液晶化合物(Z)。In addition, in the polymerizable liquid crystal compound (Z)-based formula (Z), the formula (Z1): -(X 1z -Y 1z -) nz -X 2z - (Z1) [wherein X 1z , Y 1z , X 2z and nz have the same meanings as above] [hereinafter referred to as partial structure (Z1)] is an asymmetric structure, which is preferable in terms of easily expressing smectic liquid crystallinity. The polymerizable liquid crystal compound (Z) whose partial structure (Z1) is an asymmetric structure includes, for example, a polymerizable liquid crystal compound (Z) in which nz is 1 and one X 1z and X 2z are mutually different structures. In addition, polymerizable liquid crystal compounds (Z) in which nz is 2, two Y 1z have the same structure, and two X 1z have the same structure, one X 2z and the two X 1z have different structures; X 1z bonded to W 1z among the two X 1z have a different structure from the other X 1z and X 2z , and the other X 1z and X 2z have the same structure. . Furthermore, a polymerizable liquid crystal compound (Z) in which nz is 3, three Y 1z have the same structure as each other, and any one of three X 1z and one X 2z is a structure different from the other three is exemplified.

Y1z 較佳為-CH2 CH2 -、-CH2 O-、-CH2 CH2 O-、-COO-、-OCOO-、單鍵、-N=N-、-CRaz =CRbz -、-C≡C-、-CRaz =N-或-CO-NRaz -。Raz 及Rbz 相互獨立地表示氫原子或碳數1~4之烷基。Y1z 更佳為-CH2 CH2 -、-COO-或單鍵,於存在複數個Y1z 之情形時,與X2z 鍵結之Y1z 更佳為-CH2 CH2 -或CH2 O-。於X1z 及X2z 全部為相同結構之情形時,較佳為存在為互不相同之鍵結方式之2個以上之Y1z 。於存在為互不相同之鍵結方式之複數個Y1z 之情形時,由於成為非對稱結構,故而有容易表現層列型液晶性之傾向。Y 1z is preferably -CH 2 CH 2 -, -CH 2 O-, -CH 2 CH 2 O-, -COO-, -OCOO-, a single bond, -N=N-, -CR az =CR bz -, -C≡C-, -CR az =N- or -CO-NR az -. R az and R bz independently represent a hydrogen atom or an alkyl group having 1 to 4 carbon atoms. Y 1z is more preferably -CH 2 CH 2 -, -COO- or a single bond, and when there are multiple Y 1z , Y 1z bonded to X 2z is more preferably -CH 2 CH 2 - or CH 2 O-. When all of X 1z and X 2z have the same structure, it is preferable that two or more Y 1z exist in mutually different bonding modes. When there are a plurality of Y 1z having mutually different bonding methods, since it becomes an asymmetric structure, smectic liquid crystallinity tends to be easily expressed.

U2z 係上述聚合性基。U1z 係氫原子或聚合性基。就製造容易;垂直配向液晶硬化膜之耐熱性容易提高;及容易調整、提高垂直配向液晶硬化膜與水平配向液晶硬化膜之密接性之方面而言,聚合性基較佳為(甲基)丙烯醯氧基。聚合性基可為已聚合之狀態,亦可為未聚合之狀態,較佳為未聚合之狀態。U 2z is the aforementioned polymerizable group. U 1z is a hydrogen atom or a polymerizable group. The polymerizable group is preferably a (meth)acryloxyl group in terms of ease of manufacture; easy improvement of heat resistance of the vertically aligned liquid crystal cured film; and easy adjustment and improvement of the adhesion between the vertically aligned liquid crystal cured film and the horizontally aligned liquid crystal cured film. The polymerizable group may be in a polymerized state or an unpolymerized state, preferably an unpolymerized state.

作為V1z 及V2z 所表示之烷二基,可列舉:亞甲基、伸乙基、丙烷-1,3-二基、丁烷-1,3-二基、丁烷-1,4-二基、戊烷-1,5-二基、己烷-1,6-二基、庚烷-1,7-二基、辛烷-1,8-二基、癸烷-1,10-二基、十四烷-1,14-二基及二十烷-1,20-二基等。V1z 及V2z 較佳為碳數2~12之烷二基,更佳為碳數6~12之烷二基。As the alkanediyl group represented by V1z and V2z , methylene, ethylidene, propane-1,3-diyl, butane-1,3-diyl, butane-1,4-diyl, pentane-1,5-diyl, hexane-1,6-diyl, heptane-1,7-diyl, octane-1,8-diyl, decane-1,10-diyl, tetradecane-1,14-diyl and eicosane- 1,20-Dibase etc. V 1z and V 2z are preferably an alkanediyl group having 2 to 12 carbons, more preferably an alkanediyl group having 6 to 12 carbons.

作為該烷二基所任意具有之取代基,可列舉氰基及鹵素原子等,該烷二基較佳為未經取代,更佳為未經取代之直鏈狀烷二基。A cyano group, a halogen atom, etc. are mentioned as a substituent which this alkanediyl group arbitrarily has, and this alkanediyl group is preferably an unsubstituted, more preferably an unsubstituted linear alkanediyl group.

W1z 及W2z 相互獨立,較佳為單鍵、-O-、-S-、-COO-或OCOO-,更佳為單鍵或-O-。W 1z and W 2z are independent of each other, and are preferably a single bond, -O-, -S-, -COO- or OCOO-, more preferably a single bond or -O-.

聚合性液晶化合物(Z)較佳為於分子結構中具有非對稱性之分子結構,具體而言,更佳為具有以下(A-a)~(A-i)之部分結構之聚合性液晶化合物。就容易表現高次層列型液晶性之觀點而言,更佳為具有(A-a)、(A-b)或(A-c)之部分結構。再者,於下述(A-a)~(A-i)中,*表示鍵結鍵(單鍵)。The polymerizable liquid crystal compound (Z) is preferably a molecular structure having an asymmetric molecular structure, specifically, a polymerizable liquid crystal compound having the following partial structures (A-a) to (A-i). It is more preferable to have a partial structure of (A-a), (A-b) or (A-c) from the viewpoint of easily expressing higher-order smectic liquid crystallinity. In addition, in following (A-a)-(A-i), * represents a bond (single bond).

[化17] [chemical 17]

作為聚合性液晶化合物(Z),具體而言,例如可列舉式(A-1)~式(A-25)所表示之化合物。於聚合性液晶化合物(Z)具有環己烷-1,4-二基之情形時,該環己烷-1,4-二基較佳為反式體。As a polymeric liquid crystal compound (Z), specifically, the compound represented by a formula (A-1) - a formula (A-25) is mentioned, for example. When the polymerizable liquid crystal compound (Z) has a cyclohexane-1,4-diyl group, the cyclohexane-1,4-diyl group is preferably a trans form.

[化18] [chemical 18]

[化19] [chemical 19]

[化20] [chemical 20]

[化21] [chem 21]

[化22] [chem 22]

該等之中,較佳為選自由式(A-2)、式(A-3)、式(A-4)、式(A-5)、式(A-6)、式(A-7)、式(A-8)、式(A-13)、式(A-14)、式(A-15)、式(A-16)及式(A-17)所表示之化合物所組成之群中之至少1種。作為聚合性液晶化合物(Z),可單獨使用1種,亦可組合2種以上使用。Among these, at least one selected from the group consisting of compounds represented by formula (A-2), formula (A-3), formula (A-4), formula (A-5), formula (A-6), formula (A-7), formula (A-8), formula (A-13), formula (A-14), formula (A-15), formula (A-16) and formula (A-17) is preferred. As the polymerizable liquid crystal compound (Z), one type may be used alone, or two or more types may be used in combination.

聚合性液晶化合物(Z)例如可藉由Lub等、Recl. Trav. Chim. Pays-Bas, 115, 321-328 (1996)、或日本專利第4719156號等所記載之公知方法進行製造。The polymerizable liquid crystal compound (Z) can be produced, for example, by a known method described in Lub et al., Recl. Trav. Chim. Pays-Bas, 115, 321-328 (1996), or Japanese Patent No. 4719156.

於本發明中,垂直配向液晶硬化膜較佳為於波長300~400 nm之間具有至少1個極大吸收,形成垂直配向液晶硬化膜之聚合性液晶化合物較佳為於波長300~400 nm之間具有極大吸收波長之聚合性液晶化合物。於聚合性液晶組合物中含有光聚合起始劑之情形時,有於長期保管時聚合性液晶化合物之聚合反應及凝膠化進行之虞。然而,若聚合性液晶化合物之極大吸收波長為300~400 nm,則即便於保管中暴露於紫外光,亦可有效地抑制自光聚合起始劑產生反應活性種及由該反應活性種引起之聚合性液晶化合物之聚合反應及凝膠化之進行。因此,於聚合性液晶組合物之長期穩定性之方面上變得有利,可提高所獲得之液晶硬化膜之配向性及膜厚之均一性。再者,聚合性液晶化合物之極大吸收波長可於溶劑中使用紫外可見分光光度計進行測定。該溶劑為可使聚合性液晶化合物溶解之溶劑,例如可列舉氯仿等。In the present invention, the vertically aligned liquid crystal cured film preferably has at least one maximum absorption between wavelengths of 300-400 nm, and the polymerizable liquid crystal compound forming the vertically aligned liquid crystal cured film is preferably a polymerizable liquid crystal compound having a maximum absorption wavelength between 300-400 nm. When the photopolymerization initiator is contained in the polymerizable liquid crystal composition, the polymerization reaction and gelation of the polymerizable liquid crystal compound may progress during long-term storage. However, if the maximum absorption wavelength of the polymerizable liquid crystal compound is 300 to 400 nm, even if it is exposed to ultraviolet light during storage, it can effectively inhibit the generation of reactive species from the photopolymerization initiator and the progress of polymerization and gelation of the polymerizable liquid crystal compound caused by the reactive species. Therefore, it becomes advantageous at the point of the long-term stability of a polymeric liquid crystal composition, and the orientation of the obtained liquid crystal cured film and the uniformity of film thickness can be improved. Furthermore, the maximum absorption wavelength of the polymerizable liquid crystal compound can be measured in a solvent using an ultraviolet-visible spectrophotometer. The solvent is a solvent capable of dissolving a polymerizable liquid crystal compound, and examples thereof include chloroform and the like.

於利用黏接著劑層將垂直配向液晶硬化膜與水平配向液晶硬化膜貼合而成之積層體中,就積層體之薄型化或彎曲性之提高等觀點而言,認為與感壓式黏接著劑相比,能量線硬化型之黏接著劑有利。然而,於垂直配向液晶硬化膜由含有在波長300~400 nm之間具有極大吸收波長之聚合性液晶化合物的聚合性液晶組合物形成之情形時,於包含該垂直配向液晶硬化膜之積層體之形成時,由於垂直配向液晶硬化膜於上述波長區域顯示吸收,故而難以利用藉由上述波長區域之光(紫外光)而硬化之紫外線硬化型接著劑將垂直配向液晶硬化膜與水平配向液晶硬化膜等其他層以較高之密接性積層。本發明由於可不經由黏接著劑層而連續地形成垂直配向液晶硬化膜與水平配向液晶硬化膜,故而於積層體之薄型化方面有利,不僅如此,由於亦可不產生與密接性相關之上述問題地將大多於300~400 nm之波長區域具有極大吸收的所謂顯示逆波長分散性之聚合性液晶化合物用於積層體之構成,故而於可獲得具有較高之光學特性之薄型積層體之方面亦有利。In a laminate formed by laminating a vertically aligned liquid crystal cured film and a horizontally aligned liquid crystal cured film using an adhesive layer, energy ray-curable adhesives are considered to be more advantageous than pressure-sensitive adhesives in terms of thinning the laminated body or improving flexibility. However, when the vertically aligned liquid crystal cured film is formed of a polymerizable liquid crystal composition containing a polymerizable liquid crystal compound having a maximum absorption wavelength between 300 and 400 nm, when forming a laminate including the vertically aligned liquid crystal cured film, since the vertically aligned liquid crystal cured film exhibits absorption in the above-mentioned wavelength region, it is difficult to use a UV-curable adhesive that is cured by light (ultraviolet light) in the above-mentioned wavelength region. layers. The present invention is advantageous in thinning the layered body because the vertically aligned liquid crystal cured film and the horizontally aligned liquid crystal cured film can be formed continuously without an adhesive layer. Not only that, it is also advantageous in that a thin layered layer with high optical characteristics can be obtained because a so-called polymeric liquid crystal compound exhibiting a large absorption in the wavelength region of 300 to 400 nm, which has a large absorption in the wavelength region of 300 to 400 nm, can be used for the composition of the layered body.

形成垂直配向液晶硬化膜之聚合性液晶組合物中之聚合性液晶化合物之含量相對於聚合性液晶組合物之固形物成分100質量份,例如為70~99.5質量份,較佳為80~99質量份,更佳為85~98質量份,進而較佳為90~95質量份。若聚合性液晶化合物之含量為上述範圍內,則就所獲得之液晶硬化膜之配向性之觀點而言有利。再者,於本發明中,聚合性液晶組合物之固形物成分意指自聚合性液晶組合物去除有機溶劑等揮發性成分後之所有成分。The content of the polymerizable liquid crystal compound in the polymerizable liquid crystal composition forming a vertically aligned liquid crystal cured film is, for example, 70-99.5 parts by mass, preferably 80-99 parts by mass, more preferably 85-98 parts by mass, and still more preferably 90-95 parts by mass, relative to 100 parts by mass of the solid content of the polymerizable liquid crystal composition. It is favorable from the viewpoint of the orientation of the obtained liquid crystal cured film that content of a polymeric liquid crystal compound exists in the said range. In addition, in this invention, the solid content of a polymeric liquid crystal composition means all components after removing the volatile components, such as an organic solvent, from a polymeric liquid crystal composition.

用於形成垂直配向液晶硬化膜之聚合性液晶組合物除垂直配向促進劑及聚合性液晶化合物以外,亦可進而含有溶劑、聚合起始劑、調平劑、抗氧化劑、光增感劑等添加劑。該等成分可分別僅使用1種,亦可組合2種以上使用。The polymerizable liquid crystal composition for forming a vertically aligned liquid crystal cured film may further contain additives such as solvents, polymerization initiators, leveling agents, antioxidants, and photosensitizers, in addition to vertical alignment promoters and polymerizable liquid crystal compounds. These components may use only 1 type, respectively, and may use it in combination of 2 or more types.

垂直配向液晶硬化膜形成用聚合性液晶組合物由於通常以溶解於溶劑中之狀態塗佈於基材等,故而較佳為包含溶劑。作為溶劑,較佳為可溶解聚合性液晶化合物之溶劑,又,較佳為對於聚合性液晶化合物之聚合反應為惰性之溶劑。作為溶劑,例如可列舉:水、甲醇、乙醇、乙二醇、異丙醇、丙二醇、乙二醇甲醚、乙二醇丁醚、1-甲氧基-2-丙醇、2-丁氧基乙醇及丙二醇單甲醚等醇溶劑;乙酸乙酯、乙酸丁酯、乙二醇甲醚乙酸酯、γ-丁內酯、丙二醇甲醚乙酸酯及乳酸乙酯等酯溶劑;丙酮、甲基乙基酮、環戊酮、環己酮、2-庚酮及甲基異丁基酮等酮溶劑;戊烷、己烷及庚烷等脂肪族烴溶劑;乙基環己烷等脂環式烴溶劑;甲苯及二甲苯等芳香族烴溶劑;乙腈等腈溶劑;四氫呋喃及二甲氧基乙烷等醚溶劑;氯仿及氯苯等含氯溶劑;二甲基乙醯胺、二甲基甲醯胺、N-甲基-2-吡咯啶酮(NMP)、1,3-二甲基-2-咪唑啶酮等醯胺系溶劑等。該等溶劑可單獨使用或組合兩種以上使用。該等中,較佳為醇溶劑、酯溶劑、酮溶劑、含氯溶劑、醯胺系溶劑、及芳香族烴溶劑。Since the polymerizable liquid crystal composition for vertical alignment liquid crystal cured film formation is applied to a base material etc. normally in the state dissolved in the solvent, it is preferable to contain a solvent. The solvent is preferably a solvent that can dissolve the polymerizable liquid crystal compound, and is preferably a solvent that is inert to the polymerization reaction of the polymerizable liquid crystal compound. Examples of solvents include alcohol solvents such as water, methanol, ethanol, ethylene glycol, isopropanol, propylene glycol, ethylene glycol methyl ether, ethylene glycol butyl ether, 1-methoxy-2-propanol, 2-butoxyethanol, and propylene glycol monomethyl ether; ester solvents such as ethyl acetate, butyl acetate, ethylene glycol methyl ether acetate, γ-butyrolactone, propylene glycol methyl ether acetate, and ethyl lactate; acetone, methyl ethyl ketone, cyclopentanone, cyclohexanone, and 2-heptanone Ketone solvents such as ketone and methyl isobutyl ketone; aliphatic hydrocarbon solvents such as pentane, hexane and heptane; alicyclic hydrocarbon solvents such as ethylcyclohexane; aromatic hydrocarbon solvents such as toluene and xylene; nitrile solvents such as acetonitrile; ether solvents such as tetrahydrofuran and dimethoxyethane; Isoamide-based solvents, etc. These solvents can be used alone or in combination of two or more. Among these, alcohol solvents, ester solvents, ketone solvents, chlorine-containing solvents, amide-based solvents, and aromatic hydrocarbon solvents are preferable.

聚合性液晶組合物中之溶劑之含量相對於聚合性液晶組合物100質量份,較佳為50~98質量份,更佳為70~95質量份。因此,聚合性液晶組合物100質量份中之固形物成分較佳為2~50質量份。若固形物成分為50質量份以下,則聚合性液晶組合物之黏度變低,因此有膜之厚度大致變均一,不易產生不均之傾向。上述固形物成分可考慮欲製造之液晶硬化膜之厚度而適當決定。The content of the solvent in the polymerizable liquid crystal composition is preferably from 50 to 98 parts by mass, more preferably from 70 to 95 parts by mass, relative to 100 parts by mass of the polymerizable liquid crystal composition. Therefore, it is preferable that the solid content in 100 mass parts of polymerizable liquid crystal compositions is 2-50 mass parts. When the solid content is 50 parts by mass or less, the viscosity of the polymerizable liquid crystal composition becomes low, so the thickness of the film tends to become substantially uniform and unevenness is less likely to occur. The above-mentioned solid content can be appropriately determined in consideration of the thickness of the liquid crystal cured film to be produced.

聚合起始劑係可藉由熱或光之幫助而生成反應活性種,使聚合性液晶化合物等之聚合反應開始之化合物。作為反應活性種,可列舉自由基或陽離子或陰離子等活性種。其中,就容易進行反應控制之觀點而言,較佳為藉由光照射而產生自由基之光聚合起始劑。The polymerization initiator is a compound that can generate a reactive species with the help of heat or light, and start the polymerization reaction of a polymerizable liquid crystal compound or the like. Examples of the reactive species include active species such as radicals and cations or anions. Among them, a photopolymerization initiator that generates radicals by light irradiation is preferable from the viewpoint of easy reaction control.

作為光聚合起始劑,例如可列舉:安息香化合物、二苯甲酮化合物、苯偶醯縮酮化合物、α-羥基酮化合物、α-胺基酮化合物、肟化合物、三𠯤化合物、錪鹽及鋶鹽。具體而言,可列舉:Irgacure(註冊商標)907、Irgacure 184、Irgacure 651、Irgacure 819、Irgacure 250、Irgacure 369、Irgacure 379、Irgacure 127、Irgacure 2959、Irgacure 754、Irgacure 379EG(以上為BASF Japan股份有限公司製造)、SEIKUOL BZ、SEIKUOL Z、SEIKUOL BEE(以上為精工化學股份有限公司製造)、Kayacure BP100(日本化藥股份有限公司製造)、Kayacure UVI-6992(Dow公司製造)、Adeka Optomer SP-152、Adeka Optomer SP-170、Adeka Optomer N-1717、Adeka Optomer N-1919、Adeka Arkls NCI-831、Adeka Arkls NCI-930(以上為ADEKA股份有限公司製造)、TAZ-A、TAZ-PP(以上為Nihon Siber Hegner公司製造)及TAZ-104(Sanwa Chemical公司製造)。Examples of photopolymerization initiators include benzoin compounds, benzophenone compounds, benzoyl ketal compounds, α-hydroxy ketone compounds, α-amino ketone compounds, oxime compounds, trioxane compounds, iodonium salts, and phosphonium salts. Specifically, Irgacure (registered trademark) 907, Irgacure 184, Irgacure 651, Irgacure 819, Irgacure 250, Irgacure 369, Irgacure 379, Irgacure 127, Irgacure 2959, Irgacure 754, Irgacure 379EG (above manufactured by BASF Japan Co., Ltd.), SEIKUOL BZ, SEIKUOL Z, SEIKUOL BEE (manufactured by Seiko Chemical Co., Ltd. above), Kayacure BP100 (manufactured by Nippon Kayaku Co., Ltd.), Kayacure UVI-6992 (manufactured by Dow Corporation), Adeka Optomer SP-152, Adeka Optomer SP-170, Adeka Optomer N-1717, Adeka Optomer Optomer N-1919, Adeka Arkls NCI-831, Adeka Arkls NCI-930 (manufactured by ADEKA Co., Ltd. above), TAZ-A, TAZ-PP (manufactured by Nihon Siber Hegner Co., Ltd. above), and TAZ-104 (manufactured by Sanwa Chemical Co., Ltd.).

光聚合起始劑就能夠充分地利用自光源發出之能量而生產性優異而言,極大吸收波長較佳為300 nm~400 nm,更佳為300 nm~380 nm,其中,較佳為α-苯乙酮系聚合起始劑、肟系光聚合起始劑。The photopolymerization initiator can fully utilize the energy emitted from the light source and is excellent in productivity. The maximum absorption wavelength is preferably 300 nm to 400 nm, and more preferably 300 nm to 380 nm. Among them, α-acetophenone-based polymerization initiators and oxime-based photopolymerization initiators are preferred.

作為α-苯乙酮化合物,可列舉:2-甲基-2-𠰌啉基-1-(4-甲基硫基苯基)丙烷-1-酮、2-二甲基胺基-1-(4-𠰌啉基苯基)-2-苄基丁烷-1-酮及2-二甲基胺基-1-(4-𠰌啉基苯基)-2-(4-甲基苯基甲基)丁烷-1-酮等,更佳為可列舉:2-甲基-2-𠰌啉基-1-(4-甲基硫基苯基)丙烷-1-酮及2-二甲基胺基-1-(4-𠰌啉基苯基)-2-苄基丁烷-1-酮。作為α-苯乙酮化合物之市售品,可列舉:Irgacure 369、379EG、907(以上,BASF Japan(股)製造)及SEIKUOL BEE(精工化學公司製造)等。Examples of the α-acetophenone compound include 2-methyl-2-metholinyl-1-(4-methylthiophenyl)propan-1-one, 2-dimethylamino-1-(4-metholinylphenyl)-2-benzylbutane-1-one, and 2-dimethylamino-1-(4-metholinylphenyl)-2-(4-methylphenylmethyl)butane-1-one, and more preferably 2-methyl-2 - 𠰌linyl-1-(4-methylthiophenyl)propan-1-one and 2-dimethylamino-1-(4-𠰌linylphenyl)-2-benzylbutan-1-one. Examples of commercially available α-acetophenone compounds include Irgacure 369, 379EG, and 907 (the above, manufactured by BASF Japan Co., Ltd.), SEIKUOL BEE (manufactured by Seiko Chemical Co., Ltd.), and the like.

肟系光聚合起始劑可藉由照射光而生成苯基自由基或甲基自由基等自由基。藉由該自由基,聚合性液晶化合物之聚合適宜地進行,其中,使甲基自由基產生之肟系光聚合起始劑於聚合反應之起始效率較高之方面上較佳。又,就使聚合反應更有效率地進行之觀點而言,較佳為使用能夠有效地利用波長350 nm以上之紫外線之光聚合起始劑。作為能夠有效地利用波長350 nm以上之紫外線之光聚合起始劑,較佳為包含肟結構之三𠯤化合物或咔唑化合物,就感度之觀點而言,更佳為包含肟酯結構之咔唑化合物。作為包含肟結構之咔唑化合物,可列舉:1,2-辛二酮、1-[4-(苯硫基)-2-(O-苯甲醯基肟)]、1-[9-乙基-6-(2-甲基苯甲醯基)-9H-咔唑-3-基]乙酮-1-(O-乙醯基肟)等。作為肟酯系光聚合起始劑之市售品,可列舉:Irgacure OXE-01、Irgacure OXE-02、Irgacure OXE-03(以上,BASF Japan股份有限公司製造)、Adeka Optomer N-1919、Adeka Arkls NCI-831(以上,ADEKA股份有限公司製造)等。The oxime-based photopolymerization initiator can generate radicals such as phenyl radicals and methyl radicals by irradiating light. Polymerization of the polymerizable liquid crystal compound proceeds favorably by the radicals, and among them, an oxime-based photopolymerization initiator that generates methyl radicals is preferable in that the initiation efficiency of the polymerization reaction is high. Moreover, it is preferable to use the photoinitiator which can utilize the ultraviolet-ray of wavelength 350 nm or more effectively from a viewpoint of advancing a polymerization reaction more efficiently. As a photopolymerization initiator capable of effectively utilizing ultraviolet light with a wavelength of 350 nm or more, a trioxane compound or a carbazole compound containing an oxime structure is preferable, and a carbazole compound containing an oxime ester structure is more preferable from the viewpoint of sensitivity. Examples of the carbazole compound containing an oxime structure include 1,2-octanedione, 1-[4-(phenylthio)-2-(O-benzoyl oxime)], 1-[9-ethyl-6-(2-methylbenzoyl)-9H-carbazol-3-yl]ethanone-1-(O-acetyl oxime), and the like. Examples of commercially available oxime ester-based photopolymerization initiators include Irgacure OXE-01, Irgacure OXE-02, and Irgacure OXE-03 (the above, manufactured by BASF Japan Co., Ltd.), Adeka Optomer N-1919, and Adeka Arkls NCI-831 (the above, manufactured by ADEKA Co., Ltd.).

光聚合起始劑之含量相對於聚合性液晶化合物100質量份,通常為0.1~30質量份,較佳為1~20質量份,更佳為1~15質量份。若為上述範圍內,則聚合性基之反應充分地進行,且不易使聚合性液晶化合物之配向混亂。Content of a photoinitiator is 0.1-30 mass parts normally with respect to 100 mass parts of polymerizable liquid crystal compounds, Preferably it is 1-20 mass parts, More preferably, it is 1-15 mass parts. When it is in the said range, the reaction of a polymeric group will fully progress, and it will become difficult to disturb the alignment of a polymeric liquid crystal compound.

所謂調平劑,係具有調整聚合性液晶組合物之流動性而使塗佈組合物所獲得之塗膜更平坦之功能的添加劑,例如可列舉:聚矽氧系、聚丙烯酸酯系及全氟烷基系之調平劑。作為調平劑,亦可使用市售品,具體而言,可列舉:DC3PA、SH7PA、DC11PA、SH28PA、SH29PA、SH30PA、ST80PA、ST86PA、SH8400、SH8700、FZ2123(以上,全部為東麗道康寧(股)製造);KP321、KP323、KP324、KP326、KP340、KP341、X22-161A、KF6001(以上,全部為信越化學工業(股)製造);TSF400、TSF401、TSF410、TSF4300、TSF4440、TSF4445、TSF-4446、TSF4452、TSF4460(以上,全部為Momentive Performance Materials Japan有限責任公司製造);Fluorinert(註冊商標)FC-72、Fluorinert FC-40、Fluorinert FC-43、Fluorinert FC-3283(以上,全部為住友3M(股)製造);MEGAFAC(註冊商標)R-08、MEGAFAC R-30、MEGAFAC R-90、MEGAFAC F-410、MEGAFAC F-411、MEGAFAC F-443、MEGAFAC F-445、MEGAFAC F-470、MEGAFAC F-477、MEGAFAC F-479、MEGAFAC F-482、MEGAFAC F-483、MEGAFAC F-556(以上,均為DIC(股)製造);Eftop(商品名)EF301、Eftop EF303、Eftop EF351、Eftop EF352(以上,全部為Mitsubishi Materials Electronic Chemicals(股)製造);Surflon(註冊商標)S-381、Surflon S-382、Surflon S-383、Surflon S-393、Surflon SC-101、Surflon SC-105、KH-40、SA-100(以上,全部為AGC SEIMI CHEMICAL(股)製造);商品名E1830、商品名E5844(大金精密化學研究所(股)製造);BM-1000、BM-1100、BYK-352、BYK-353及BYK-361N(均為商品名:BM Chemie公司製造)等。調平劑可單獨使用,亦可組合2種以上使用。The so-called leveling agent is an additive that has the function of adjusting the fluidity of the polymerizable liquid crystal composition to make the coating film obtained by the coating composition more flat. Examples include silicone-based, polyacrylate-based and perfluoroalkyl-based leveling agents. Commercially available products can also be used as the leveling agent. Specifically, DC3PA, SH7PA, DC11PA, SH28PA, SH29PA, SH30PA, ST80PA, ST86PA, SH8400, SH8700, FZ2123 (all of the above are manufactured by Toray Dow Corning Co., Ltd.); KP321, KP323, KP324, KP326, KP340, KP 341, X22-161A, KF6001 (all of the above are manufactured by Shin-Etsu Chemical Co., Ltd.); TSF400, TSF401, TSF410, TSF4300, TSF4440, TSF4445, TSF-4446, TSF4452, TSF4460 (all of the above are manufactured by Momentive Performance Materials Japan Co., Ltd.); Fluorin ert (registered trademark) FC-72, Fluorinert FC-40, Fluorinert FC-43, Fluorinert FC-3283 (the above, all manufactured by Sumitomo 3M Co., Ltd.); MEGAFAC (registered trademark) R-08, MEGAFAC R-30, MEGAFAC R-90, MEGAFAC F-410, MEGAFAC F-411, MEGAFAC F-443, MEGAF AC F-445, MEGAFAC F-470, MEGAFAC F-477, MEGAFAC F-479, MEGAFAC F-482, MEGAFAC F-483, MEGAFAC F-556 (the above are all manufactured by DIC); Eftop (trade name) EF301, Eftop EF303, Eftop EF351, Eftop EF352 (the above are all Mi manufactured by subishi Materials Electronic Chemicals Co., Ltd.); Surflon (registered trademark) S-381, Surflon S-382, Surflon S-383, Surflon S-393, Surflon SC-101, Surflon SC-105, KH-40, SA-100 (all of the above are manufactured by AGC SEIMI CHEMICAL Co., Ltd.); trade names E1830, trade name E5844 (manufactured by Daikin Institute of Fine Chemicals Co., Ltd.); BM-1000, BM-1100, BYK-352, BYK-353, and BYK-361N (all trade names: manufactured by BM Chemie), etc. A leveling agent may be used individually or in combination of 2 or more types.

調平劑之含量相對於聚合性液晶化合物100質量份,較佳為0.01~5質量份,進而較佳為0.05~3質量份。若調平劑之含量為上述範圍內,則有容易使聚合性液晶化合物配向,且所獲得之液晶硬化膜變得更平滑之傾向,故而較佳。The content of the leveling agent is preferably from 0.01 to 5 parts by mass, more preferably from 0.05 to 3 parts by mass, relative to 100 parts by mass of the polymerizable liquid crystal compound. When the content of the leveling agent is within the above range, the polymerizable liquid crystal compound tends to be easily aligned, and the obtained liquid crystal cured film tends to be smoother, which is preferable.

藉由調配抗氧化劑,可控制聚合性液晶化合物之聚合反應。作為抗氧化劑,可為選自苯酚系抗氧化劑、胺系抗氧化劑、醌系抗氧化劑、亞硝基系抗氧化劑中之一次抗氧化劑,亦可為選自磷系抗氧化劑及硫系抗氧化劑中之二次抗氧化劑。為了不會使聚合性液晶化合物之配向混亂而使聚合性液晶化合物聚合,抗氧化劑之含量相對於聚合性液晶化合物100質量份,通常為0.01~10質量份,較佳為0.1~5質量份,進而較佳為0.1~3質量份。抗氧化劑可單獨使用或組合2種以上使用。By formulating antioxidants, the polymerization reaction of polymerizable liquid crystal compounds can be controlled. The antioxidant may be a primary antioxidant selected from phenol-based antioxidants, amine-based antioxidants, quinone-based antioxidants, and nitroso-based antioxidants, or a secondary antioxidant selected from phosphorus-based antioxidants and sulfur-based antioxidants. In order not to cause the polymerizable liquid crystal compound to be polymerized without disturbing the alignment of the polymerizable liquid crystal compound, the content of the antioxidant is usually 0.01 to 10 parts by mass, preferably 0.1 to 5 parts by mass, and more preferably 0.1 to 3 parts by mass relative to 100 parts by mass of the polymerizable liquid crystal compound. Antioxidants can be used individually or in combination of 2 or more types.

又,藉由使用光增感劑,可使光聚合起始劑高感度化。作為光增感劑,例如可列舉:𠮿酮、9-氧硫𠮿等𠮿酮類;蒽及烷基醚等具有取代基之蒽類;啡噻𠯤;紅螢烯。光增感劑可單獨使用或組合2種以上使用。光增感劑之含量相對於聚合性液晶化合物100質量份,通常為0.01~10質量份,較佳為0.05~5質量份,進而較佳為0.1~3質量份。Moreover, by using a photosensitizer, a photoinitiator can be made highly sensitive. Examples of photosensitizers include: ketone, 9-oxosulfur Such as ketones; anthracenes with substituents such as anthracene and alkyl ethers; A photosensitizer can be used individually or in combination of 2 or more types. Content of a photosensitizer is 0.01-10 mass parts normally with respect to 100 mass parts of polymeric liquid crystal compounds, Preferably it is 0.05-5 mass parts, More preferably, it is 0.1-3 mass parts.

垂直配向液晶硬化膜形成用聚合性液晶組合物可藉由將垂直配向促進劑及聚合性液晶化合物、與溶劑或光聚合起始劑等除垂直配向促進劑及聚合性液晶化合物以外之成分於特定溫度下進行攪拌等而獲得。The polymerizable liquid crystal composition for forming a vertical alignment liquid crystal cured film can be obtained by stirring a vertical alignment promoter, a polymerizable liquid crystal compound, a solvent or a photopolymerization initiator, and other components other than the vertical alignment promoter and the polymerizable liquid crystal compound at a specific temperature.

於本發明中,垂直配向液晶硬化膜較佳為滿足下述式(2)。 RthC(450)/RthC(550)≦1 (2) [式(2)中,RthC(450)表示波長450 nm下之垂直配向液晶硬化膜之膜厚方向之相位差值,RthC(550)表示波長550 nm下之垂直配向液晶硬化膜之膜厚方向之相位差值]。 藉由滿足上述式(2),可於包含該垂直配向液晶硬化膜之積層體中在短波長側抑制橢圓率之降低,而可提高將垂直配向液晶硬化膜應用於顯示裝置時之黑顯示時之斜向反射色相提高。垂直配向液晶硬化膜中之RthC(450)/RthC(550)之值更佳為0.95以下,進而較佳為0.92以下,尤佳為0.9以下,又,較佳為0.7以上,更佳為0.75以上,進而較佳為0.8以上。In the present invention, the vertical alignment liquid crystal cured film preferably satisfies the following formula (2). RthC(450)/RthC(550)≦1 (2) [In the formula (2), RthC (450) represents the retardation value in the film thickness direction of the vertically aligned liquid crystal cured film at a wavelength of 450 nm, and RthC (550) represents the retardation value in the film thickness direction of the vertically aligned liquid crystal cured film at a wavelength of 550 nm]. By satisfying the above-mentioned formula (2), the decrease in ellipticity can be suppressed on the short-wavelength side in the laminate including the vertically aligned liquid crystal cured film, and the oblique reflection hue at the time of black display when the vertically aligned liquid crystal cured film is applied to a display device can be improved. The value of RthC(450)/RthC(550) in the vertical alignment liquid crystal cured film is more preferably 0.95 or less, more preferably 0.92 or less, especially preferably 0.9 or less, and is preferably 0.7 or more, more preferably 0.75 or more, and still more preferably 0.8 or more.

垂直配向液晶硬化膜之膜厚方向之相位差值RthC(λ)可藉由垂直配向液晶硬化膜之厚度dC進行調整。面內相位差值係藉由下述式: RthC(λ)=((nxC(λ)+nyC(λ))/2-nzC(λ))×dC (此處,式中nxC(λ)表示波長λnm下之垂直配向液晶硬化膜之面內主折射率,nyC(λ)表示波長λnm下之在面內與nxC(λ)正交之方向之折射率,nzC(λ)表示波長λnm下之垂直配向液晶硬化膜之厚度方向之折射率,於nxC(λ)=nyC(λ)之情形時,nxC(λ)可設為膜面內之任意方向之折射率,dC表示垂直配向液晶硬化膜之膜厚) 而決定,因此為了獲得所需之膜厚方向之相位差值RthC(λ),只要調整3次元折射率與膜厚dC即可。再者,三維折射率係依存於上述聚合性液晶化合物之分子結構以及配向狀態。The retardation value RthC(λ) of the vertically aligned liquid crystal cured film in the film thickness direction can be adjusted by the thickness dC of the vertically aligned liquid crystal cured film. The in-plane phase difference value is given by the following formula: RthC(λ)=((nxC(λ)+nyC(λ))/2-nzC(λ))×dC (In the formula, nxC(λ) represents the in-plane principal refractive index of the vertically aligned liquid crystal cured film at a wavelength of λnm, nyC(λ) represents the refractive index in the direction perpendicular to nxC(λ) in the plane at a wavelength of λnm, and nzC(λ) represents the refractive index in the thickness direction of the vertically aligned liquid crystal cured film at a wavelength of λnm. When nxC(λ)=nyC(λ), nxC(λ) can be set as the refractive index in any direction in the film , dC represents the film thickness of vertically aligned liquid crystal cured film) Therefore, in order to obtain the desired retardation value RthC(λ) in the film thickness direction, it is only necessary to adjust the three-dimensional refractive index and the film thickness dC. Furthermore, the three-dimensional refractive index depends on the molecular structure and alignment state of the polymerizable liquid crystal compound.

又,本發明中,垂直配向液晶硬化膜較佳為朝液晶硬化膜之垂直方向以較高之秩序度進行配向。於垂直配向液晶硬化膜中,藉由使聚合性液晶化合物以較高之秩序度配向,於將包含該垂直配向液晶硬化膜之積層體組入至有機EL顯示裝置中之情形時,有黑顯示時之斜向反射色相變化之抑制效果優異之傾向。作為表示垂直配向液晶硬化膜中之聚合性液晶化合物之較高配向狀態,且表示黑顯示時之斜向光學補償效果之程度之一指標,垂直配向液晶硬化膜較佳為滿足下述式(5)。 -120 nm≦RthC(550)≦-30 nm (5) 式(5)中,RthC(550)係與上述含義相同。就可進一步提高黑顯示時之斜向反射色相之觀點而言,垂直配向液晶硬化膜之膜厚方向之相位差值RthC(550)更佳為-100 nm以上,進而較佳為-90 nm以上,尤佳為-80 nm以上,又,更佳為-40 nm以下,進而較佳為-50 nm以下。Also, in the present invention, the vertically aligned cured liquid crystal film is preferably aligned with a high degree of order in the vertical direction of the cured liquid crystal film. In the vertically aligned liquid crystal cured film, by aligning the polymerizable liquid crystal compound with a high degree of order, when a laminate including the vertically aligned liquid crystal cured film is incorporated into an organic EL display device, there is a tendency that the effect of suppressing the hue change of oblique reflection during black display is excellent. As an index indicating the higher alignment state of the polymerizable liquid crystal compound in the vertically aligned liquid crystal cured film and indicating the degree of oblique optical compensation effect during black display, the vertically aligned liquid crystal cured film preferably satisfies the following formula (5). -120nm≦RthC(550)≦-30nm (5) In formula (5), RthC(550) has the same meaning as above. From the viewpoint of further improving the oblique reflection hue during black display, the retardation value RthC(550) in the film thickness direction of the vertically aligned liquid crystal cured film is more preferably -100 nm or more, further preferably -90 nm or more, particularly preferably -80 nm or more, and more preferably -40 nm or less, and more preferably -50 nm or less.

[水平配向液晶硬化膜] 構成本發明之積層體之水平配向液晶硬化膜係聚合性液晶化合物於相對於該液晶硬化膜平面朝水平方向配向之狀態下硬化而成的聚合性液晶組合物之硬化物,較佳為具有至少1個自由基聚合性基之聚合性液晶化合物於相對於該液晶硬化膜之面內方向水平地配向之狀態下硬化而成的液晶硬化膜。本發明中,形成水平配向液晶硬化膜之聚合性液晶組合物所含有之聚合性液晶化合物意味著具有聚合性基之液晶化合物,尤佳為具有至少1個自由基聚合性基之液晶化合物。於將水平配向液晶硬化膜經由自具有(甲基)丙烯醯基之聚合物形成而成之水平光配向膜而積層於垂直配向液晶硬化膜之情形時,若垂直配向液晶硬化膜與水平配向液晶硬化膜均為具有至少1個自由基聚合性基之聚合性液晶化合物的硬化物,則容易提高經由上述水平配向膜而連續形成之垂直配向液晶硬化膜與水平配向液晶硬化膜之密接性。尤其就有水平配向液晶硬化膜與垂直配向液晶硬化膜之密接性更為提高之傾向而言,較佳為構成水平配向液晶硬化膜之聚合性液晶化合物與構成垂直配向液晶硬化膜之聚合性液晶化合物均具有與形成水平配向膜之聚合物所具有之聚合性基近似或相同之聚合性基,更佳為水平配向液晶硬化膜與垂直配向液晶硬化膜均由包含具有(甲基)丙烯醯基之聚合性液晶化合物之聚合性液晶組合物所構成。[Horizontal Alignment Liquid Crystal Curing Film] The horizontal alignment liquid crystal cured film constituting the laminate of the present invention is a cured product of a polymerizable liquid crystal composition formed by curing a polymerizable liquid crystal compound in a state aligned horizontally with respect to the plane of the liquid crystal cured film, preferably a liquid crystal cured film formed by curing a polymerizable liquid crystal compound having at least one radical polymerizable group in a state aligned horizontally with respect to the in-plane direction of the liquid crystal cured film. In the present invention, the polymerizable liquid crystal compound contained in the polymerizable liquid crystal composition for forming a horizontally aligned liquid crystal cured film means a liquid crystal compound having a polymerizable group, preferably a liquid crystal compound having at least one radically polymerizable group. When the horizontal alignment cured liquid crystal film is laminated on the vertical alignment cured liquid crystal film via the horizontal photo-alignment film formed from a polymer having (meth)acryl group, if both the vertical alignment liquid crystal cured film and the horizontal alignment liquid crystal cured film are cured products of a polymerizable liquid crystal compound having at least one radical polymerizable group, the adhesion between the vertical alignment liquid crystal cured film and the horizontal alignment liquid crystal cured film continuously formed through the horizontal alignment film can be easily improved. In particular, since the adhesion between the horizontal alignment cured liquid crystal film and the vertical alignment liquid crystal cured film tends to be more improved, it is preferable that the polymerizable liquid crystal compound constituting the horizontal alignment liquid crystal cured film and the polymerizable liquid crystal compound constituting the vertical alignment liquid crystal cured film have polymerizable groups similar to or identical to those of the polymer forming the horizontal alignment film.

構成水平配向液晶硬化膜之聚合性液晶化合物並無特別限定,例如可使用相位差膜之領域中先前公知之聚合性液晶化合物。具體而言,可使用作為可用於垂直配向液晶硬化膜之形成之聚合性液晶化合物所例示之式(X)、(Y)或(Z)所表示之化合物,其中,較佳為顯示所謂逆波長分散性之聚合性液晶化合物,例如可適宜地使用上述式(X)所表示之化合物。於垂直配向液晶硬化膜形成用聚合性液晶組合物中,聚合性液晶化合物可單獨使用或組合2種以上使用。The polymerizable liquid crystal compound constituting the horizontally aligned liquid crystal cured film is not particularly limited, and for example, previously known polymerizable liquid crystal compounds in the field of retardation films can be used. Specifically, a compound represented by formula (X), (Y) or (Z) can be used as an example of a polymerizable liquid crystal compound that can be used in the formation of a vertically aligned liquid crystal cured film. Among them, a polymerizable liquid crystal compound that exhibits so-called reverse wavelength dispersion is preferable, for example, a compound represented by the above-mentioned formula (X) can be suitably used. In the polymeric liquid crystal composition for vertical alignment liquid crystal cured film formation, a polymeric liquid crystal compound can be used individually or in combination of 2 or more types.

用於形成水平配向液晶硬化膜之聚合性液晶組合物中之聚合性液晶化合物的含量相對於聚合性液晶組合物之固形物成分100質量份,例如為70~99.5質量份,較佳為80~99質量份,更佳為85~98質量份,進而較佳為90~95質量份。若聚合性液晶化合物之含量為上述範圍內,則就所獲得之液晶硬化膜之配向性之觀點而言有利。The content of the polymerizable liquid crystal compound in the polymerizable liquid crystal composition for forming a horizontally aligned liquid crystal cured film is, for example, 70 to 99.5 parts by mass, preferably 80 to 99 parts by mass, more preferably 85 to 98 parts by mass, and still more preferably 90 to 95 parts by mass, relative to 100 parts by mass of the solid content of the polymerizable liquid crystal composition. It is favorable from the viewpoint of the orientation of the obtained liquid crystal cured film that content of a polymeric liquid crystal compound exists in the said range.

用於形成水平配向液晶硬化膜之聚合性液晶組合物除聚合性液晶化合物以外,亦可進而含有溶劑、聚合起始劑、調平劑、抗氧化劑、光增感劑等添加劑。作為該等成分,可列舉與先前作為垂直配向液晶硬化膜中可使用之成分例示者相同者,分別可僅使用1種,亦可組合2種以上使用。The polymerizable liquid crystal composition for forming a horizontally aligned liquid crystal cured film may further contain additives such as solvents, polymerization initiators, leveling agents, antioxidants, and photosensitizers in addition to polymerizable liquid crystal compounds. As these components, the same thing as what was exemplified previously as the component which can be used for a vertical alignment liquid crystal cured film is mentioned, Each may use only 1 type, and may use it in combination of 2 or more types.

水平配向液晶硬化膜形成用聚合性液晶組合物可藉由將聚合性液晶化合物、與溶劑或光聚合起始劑等除聚合性液晶化合物以外之成分在特定溫度下進行攪拌等而獲得。The polymerizable liquid crystal composition for forming a horizontally aligned liquid crystal cured film can be obtained by stirring a polymerizable liquid crystal compound, a solvent or a photopolymerization initiator, and other components other than the polymerizable liquid crystal compound at a specific temperature.

又,於本發明中,出於與垂直配向液晶硬化膜於波長300~400 nm之間具有至少1個極大吸收之情形時有利之理由相同之理由,較佳為水平配向液晶硬化膜於波長300~400 nm之間具有至少1個極大吸收。於本發明之較佳一態樣中,垂直配向液晶硬化膜及水平配向液晶硬化膜均於波長300~400 nm之間具有至少1個極大吸收。Also, in the present invention, for the same reason that it is advantageous that the vertically aligned liquid crystal cured film has at least one maximum absorption between wavelengths of 300 to 400 nm, it is preferable that the horizontally aligned liquid crystal cured film has at least one maximum absorption between wavelengths of 300 to 400 nm. In a preferred aspect of the present invention, both the vertically aligned liquid crystal cured film and the horizontally aligned liquid crystal cured film have at least one maximum absorption at a wavelength of 300-400 nm.

於本發明中,水平配向液晶硬化膜較佳為滿足下述式(1)。 ReA(450)/ReA(550)≦1 (1) [式(1)中,ReA(λ)表示波長λnm下之水平配向液晶硬化膜之面內相位差值,ReA(λ)=(nxA(λ)-nyA(λ))×dA(式中,nxA(λ)表示水平配向液晶硬化膜面內之波長λnm下之主折射率,nyA(λ)表示在與nxA同一面內與nxA之方向正交之方向之波長λnm下的折射率,dA表示水平配向液晶硬化膜之膜厚)]In the present invention, the horizontal alignment liquid crystal cured film preferably satisfies the following formula (1). ReA(450)/ReA(550)≦1 (1) [In the formula (1), ReA(λ) represents the in-plane retardation value of the horizontally aligned liquid crystal cured film at a wavelength of λnm, ReA(λ)=(nxA(λ)-nyA(λ))×dA (wherein, nxA(λ) represents the main refractive index at the wavelength λnm in the plane of the horizontally aligned liquid crystal cured film, nyA(λ) represents the refractive index at the wavelength λnm in the direction perpendicular to the direction of nxA in the same plane as nxA, and dA represents the level Alignment liquid crystal cured film thickness)]

於水平配向液晶硬化膜滿足式(1)之情形時,該水平配向液晶硬化膜顯示短波長下之面內相位差值變得小於長波長下之面內相位差值的所謂逆波長分散性。藉由將此種水平配向液晶硬化膜與上述垂直配向液晶硬化膜組合,可獲得組入至有機EL顯示裝置中之情形時之黑顯示時之正面及斜向反射色相的提高效果優異之積層體。為了可提高逆波長分散性,而更為提高水平配向液晶硬化膜之正面方向之反射色相之提高效果,ReA(450)/ReA(550)較佳為0.70以上,更佳為0.78以上,又,較佳為0.95以下,更佳為0.92以下。When the horizontally aligned liquid crystal cured film satisfies the formula (1), the horizontally aligned liquid crystal cured film exhibits so-called inverse wavelength dispersion in which the in-plane retardation value at short wavelengths becomes smaller than that at long wavelengths. By combining such a horizontally aligned liquid crystal cured film with the above-mentioned vertically aligned liquid crystal cured film, a laminate excellent in the effect of improving the front and oblique reflection hues during black display when incorporated into an organic EL display device can be obtained. In order to improve the reverse wavelength dispersibility, and further increase the effect of improving the reflection hue in the front direction of the horizontally aligned liquid crystal cured film, ReA(450)/ReA(550) is preferably at least 0.70, more preferably at least 0.78, and is preferably at most 0.95, more preferably at most 0.92.

上述面內相位差值可藉由水平配向液晶硬化膜之厚度dA進行調整。面內相位差值係藉由上述式ReA(λ)=(nxA(λ)-nyA(λ))×dA而決定,因此為了獲得所需之面內相位差值(ReA(λ):波長λ(nm)下之水平配向液晶硬化膜之面內相位差值),只要調整三維折射率與膜厚dA即可。The above-mentioned in-plane retardation value can be adjusted by the thickness dA of the horizontal alignment liquid crystal cured film. The in-plane retardation value is determined by the above formula ReA(λ)=(nxA(λ)-nyA(λ))×dA, so in order to obtain the required in-plane retardation value (ReA(λ): the in-plane retardation value of the horizontally aligned liquid crystal cured film at the wavelength λ(nm)), it is only necessary to adjust the three-dimensional refractive index and film thickness dA.

又,水平配向液晶硬化膜較佳為滿足下述式(6)。 120 nm≦ReA(550)≦170 nm (6) [式(6)中,ReA(λ)係與上述含義相同] 若水平配向液晶硬化膜之面內相位差ReA(550)為式(6)之範圍內,則將包含該水平配向液晶硬化膜之積層體(橢圓偏光板)應用至有機EL顯示裝置之情形時使黑顯示時之正面反射色相提高之效果變得顯著。面內相位差值進一步較佳之範圍係130 nm≦ReA(550)≦150 nm。Moreover, it is preferable that a horizontal alignment liquid crystal cured film satisfies the following formula (6). 120 nm≦ReA(550)≦170 nm (6) [In the formula (6), ReA(λ) has the same meaning as above] If the in-plane retardation ReA(550) of the horizontally aligned liquid crystal cured film is within the range of formula (6), the effect of improving the front reflection hue during black display becomes remarkable when the laminate (ellipsoidal polarizer) including the horizontally aligned liquid crystal cured film is applied to an organic EL display device. A further preferable range of in-plane phase difference is 130 nm≦ReA(550)≦150 nm.

[水平配向膜] 構成本發明之積層體之水平配向膜係由具有(甲基)丙烯醯基之聚合物形成而成之光配向膜。水平配向膜係具有使聚合性液晶化合物於相對於塗膜平面為水平方向上配向之水平配向限制力者。配向限制力可藉由配向膜之種類、表面狀態或摩擦條件等而任意地調整,若為由光配向性聚合物形成之光配向膜,則能夠藉由偏光照射條件等而任意地調整。本發明中,於基材上形成垂直配向液晶硬化膜,進而於其上形成水平配向膜,於其上形成水平配向液晶硬化膜,但該情形時有水平配向液晶硬化膜之配向性容易變差之傾向。理由並未確定,但推測:由於垂直配向液晶硬化膜所含有之調平劑等添加劑而表面能量降低,而於上層形成水平配向液晶硬化膜時液晶化合物之配向性容易受損。尤其是於無垂直配向膜而形成垂直配向液晶硬化膜之情形時進而含有配向促進劑,因此其影響變得更為顯著。因此,垂直配向液晶硬化膜形成時之液晶配向性容易受到水平配向膜之種類或厚度等之影響。[Horizontal Alignment Film] The horizontal alignment film constituting the laminate of the present invention is a photo-alignment film formed of a polymer having a (meth)acryl group. The horizontal alignment film is one that has a horizontal alignment restriction force that aligns the polymerizable liquid crystal compound in a horizontal direction with respect to the plane of the coating film. The alignment restriction force can be arbitrarily adjusted by the type of alignment film, surface state, rubbing conditions, etc. If it is a photo-alignment film formed of a photo-alignment polymer, it can be arbitrarily adjusted by polarized light irradiation conditions, etc. In the present invention, a vertically aligned liquid crystal cured film is formed on a substrate, a horizontally aligned liquid crystal film is formed thereon, and a horizontally aligned liquid crystal cured film is formed thereon, but in this case, the orientation of the horizontally aligned liquid crystal cured film tends to deteriorate. The reason has not been determined, but it is speculated that the surface energy decreases due to additives such as leveling agents contained in the vertically aligned liquid crystal cured film, and the alignment of the liquid crystal compound is easily damaged when the horizontally aligned liquid crystal cured film is formed on the upper layer. Especially in the case of forming a vertically aligned liquid crystal cured film without a vertically aligned film, since an alignment promoter is further included, its influence becomes more remarkable. Therefore, the liquid crystal alignment at the time of forming the vertically aligned liquid crystal cured film is easily affected by the type and thickness of the horizontally aligned film.

於水平配向膜具有與構成垂直配向液晶硬化膜及水平配向液晶硬化膜之聚合性液晶化合物近似或相同之聚合性基之情形時,有經由該水平配向膜而垂直配向液晶硬化膜與水平配向液晶硬化膜之密接性更為提高之傾向,因此較佳為水平配向膜由具有(甲基)丙烯醯基之聚合物形成,垂直配向液晶硬化膜及水平配向液晶硬化膜均由含有具有(甲基)丙烯醯基之聚合性液晶化合物之聚合性液晶組合物形成而成。When the horizontal alignment film has a polymeric group similar to or identical to the polymerizable liquid crystal compound constituting the vertical alignment liquid crystal cured film and the horizontal alignment liquid crystal cured film, the adhesion between the vertical alignment liquid crystal cured film and the horizontal alignment liquid crystal cured film tends to be improved through the horizontal alignment film. Therefore, it is preferable that the horizontal alignment film is formed of a polymer having a (meth)acryl group. Formed from a liquid crystal composition.

光配向膜通常可藉由將包含具有光反應性基之聚合物或單體及溶劑之組合物(以下,亦稱為「光配向膜形成用組合物」)塗佈於基材,去除溶劑後照射偏光(較佳為偏光UV)而獲得。光配向膜於可藉由選擇照射之偏光之偏光方向而任意地控制配向限制力之方向的方面上亦有利。A photoalignment film can usually be obtained by applying a composition containing a polymer or monomer with a photoreactive group and a solvent (hereinafter, also referred to as "photoalignment film forming composition") to a substrate, removing the solvent, and then irradiating polarized light (preferably polarized UV). The photo-alignment film is also advantageous in that the direction of the alignment-regulating force can be arbitrarily controlled by selecting the polarization direction of the irradiated polarized light.

光反應性基係指藉由光照射而產生配向能力之基。具體而言,可列舉參與藉由光照射而產生之分子之配向誘發或異構化反應、二聚反應、光交聯反應或光分解反應等成為液晶配向能力之起源之光反應的基。其中,參與二聚反應或光交聯反應之基就配向性優異之方面而言較佳。作為光反應性基,較佳為具有不飽和鍵、尤其是雙鍵之基,尤佳為具有選自由碳-碳雙鍵(C=C鍵)、碳-氮雙鍵(C=N鍵)、氮-氮雙鍵(N=N鍵)、及碳-氧雙鍵(C=O鍵結)所組成之群中之至少一個的基。The photoreactive group refers to a group that produces alignment ability by light irradiation. Specifically, groups that participate in photoreactions that are the origin of liquid crystal alignment ability, such as induction of molecular alignment by light irradiation, isomerization reaction, dimerization reaction, photocrosslinking reaction, or photodecomposition reaction, can be mentioned. Among them, a group that participates in a dimerization reaction or a photocrosslinking reaction is preferable in terms of being excellent in alignment. As the photoreactive group, it is preferably a group having an unsaturated bond, especially a double bond, and is especially preferably a group having at least one selected from the group consisting of a carbon-carbon double bond (C=C bond), a carbon-nitrogen double bond (C=N bond), a nitrogen-nitrogen double bond (N=N bond), and a carbon-oxygen double bond (C=O bond).

作為具有C=C鍵之光反應性基,例如可列舉乙烯基、多烯基、茋基、茋唑基、茋唑鎓基、查耳酮基、及桂皮醯基。作為具有C=N鍵之光反應性基,例如可列舉具有芳香族希夫鹼、芳香族腙等結構之基。作為具有N=N鍵之光反應性基,例如可列舉偶氮苯基、偶氮萘基、芳香族雜環偶氮基、雙偶氮基、甲臢基、及具有氧偶氮苯結構之基。作為具有C=O鍵結之光反應性基,例如可列舉二苯甲酮基、香豆素基、蒽醌基、及馬來醯亞胺基。該等基可具有烷基、烷氧基、芳基、烯丙氧基、氰基、烷氧基羰基、羥基、磺酸基、及鹵化烷基之類之取代基。Examples of the photoreactive group having a C=C bond include a vinyl group, a polyalkenyl group, a stilbene group, a stilazolyl group, a stilazolium group, a chalcone group, and a cinnamoyl group. As a photoreactive group which has a C=N bond, the group which has structures, such as an aromatic Schiff base and an aromatic hydrazone, is mentioned, for example. As the photoreactive group having an N=N bond, for example, an azophenyl group, an azonaphthyl group, an aromatic heterocyclic azo group, a disazo group, a formazan group, and a group having an oxyazobenzene structure are exemplified. Examples of photoreactive groups having a C=O bond include benzophenone groups, coumarin groups, anthraquinone groups, and maleimide groups. These groups may have substituents such as alkyl, alkoxy, aryl, allyloxy, cyano, alkoxycarbonyl, hydroxyl, sulfonic acid, and halogenated alkyl.

其中,較佳為參與光二聚反應之光反應性基,就光配向所需之偏光照射量相對較少,且容易獲得熱穩定性或經時穩定性優異之光配向膜之方面而言,較佳為偶氮基、桂皮醯基及查耳酮基。作為具有光反應性基之聚合物,較佳為具有偶氮基或桂皮醯基之聚合物,就水平配向膜與垂直配向液晶硬化膜及水平配向液晶硬化膜之密接性提高之觀點而言,尤佳為如該聚合物側鏈之末端部成為桂皮酸結構之具有桂皮醯基者。Among them, photoreactive groups that participate in photodimerization reactions are preferred, and azo groups, cinnamonyl groups, and chalcone groups are preferred in terms of the relatively small amount of polarized light irradiation required for photoalignment and the ease of obtaining a photoalignment film with excellent thermal stability or stability over time. As a polymer having a photoreactive group, a polymer having an azo group or a cinnamic acid group is preferable, and a polymer having a cinnamic acid group in which the end of the side chain of the polymer becomes a cinnamic acid structure is particularly preferable from the viewpoint of improving the adhesion between the horizontal alignment film, the vertical alignment liquid crystal cured film, and the horizontal alignment liquid crystal cured film.

作為光配向膜形成用組合物中可含有之溶劑,可列舉:與先前作為聚合性液晶組合物可使用之溶劑例示之溶劑同樣者,可視具有光反應性基之聚合物或單體之溶解性而適當選擇。Examples of solvents that can be contained in the composition for forming a photoalignment film include the same solvents as those exemplified above as solvents that can be used in the polymerizable liquid crystal composition, and can be appropriately selected depending on the solubility of the polymer or monomer having a photoreactive group.

光配向膜形成用組合物中之具有光反應性基之聚合物或單體之含量可根據聚合物或單體之種類或目標之光配向膜之厚度而適當調節,相對於光配向膜形成用組合物之質量,較佳為設為至少0.2質量%,更佳為0.3~10質量%之範圍。於不會顯著損害光配向膜之特性之範圍內,光配向膜形成用組合物亦可含有聚乙烯醇或聚醯亞胺等高分子材料或光增感劑。The content of the polymer or monomer having a photoreactive group in the composition for forming a photoalignment film can be appropriately adjusted according to the type of polymer or monomer or the thickness of the target photoalignment film. It is preferably at least 0.2% by mass, more preferably in the range of 0.3 to 10% by mass, relative to the mass of the composition for forming a photoalignment film. The composition for forming a photoalignment film may also contain a polymer material such as polyvinyl alcohol or polyimide, or a photosensitizer within a range that does not significantly impair the properties of the photoalignment film.

水平配向膜(光配向膜)之厚度通常為10~5000 nm,較佳為100~1000 nm,更佳為100~500 nm,進而較佳為100~300 nm,尤佳為100~250 nm。若配向膜之厚度為上述範圍內,則充分地具有水平配向限制力,又,積層體中之該配向膜不易產生凝集破壞。The thickness of the horizontal alignment film (photo-alignment film) is usually 10-5000 nm, preferably 100-1000 nm, more preferably 100-500 nm, further preferably 100-300 nm, especially 100-250 nm. When the thickness of the alignment film is within the above-mentioned range, the horizontal alignment restraint force is sufficiently provided, and the alignment film in the laminate is less prone to coagulation failure.

[基材] 作為構成本發明之積層體之基材,例如可列舉:玻璃基材或膜基材等,就加工性之觀點而言,較佳為樹脂膜基材。作為構成膜基材之樹脂,例如可列舉:聚乙烯、聚丙烯、及降𦯉烯系聚合物之類之聚烯烴;環狀烯烴系樹脂;聚乙烯醇;聚對苯二甲酸乙二酯;聚甲基丙烯酸酯;聚丙烯酸酯;三乙醯纖維素、二乙醯纖維素、及乙酸丙酸纖維素之類之纖維素酯;聚萘二甲酸乙二酯;聚碳酸酯;聚碸;聚醚碸;聚醚酮;聚苯硫醚及聚苯醚之類之塑膠。可藉由溶劑流延法、熔融擠出法等公知之方法將此種樹脂進行製膜而作為基材。亦可對於基材表面實施聚矽氧處理之類之脫模處理、電暈處理、電漿處理等表面處理。[substrate] As a base material which comprises the laminated body of this invention, a glass base material, a film base material, etc. are mentioned, for example, A resin film base material is preferable from a processability viewpoint. As the resin constituting the film substrate, for example, polyolefins such as polyethylene, polypropylene, and northylene-based polymers; cyclic olefin-based resins; polyvinyl alcohol; polyethylene terephthalate; polymethacrylate; polyacrylate; cellulose esters such as triacetyl cellulose, diacetyl cellulose, and cellulose acetate propionate; Plastics such as ether. Such a resin can be formed into a film by a known method such as a solvent casting method and a melt extrusion method, and can be used as a base material. Surface treatments such as polysiloxane treatment, corona treatment, and plasma treatment can also be performed on the surface of the substrate.

作為基材,亦可使用市售之製品。作為市售之纖維素酯基材,例如可列舉:FUJITAC FILM之類之富士軟片股份有限公司製造之纖維素酯基材;「KC8UX2M」、「KC8UY」、及「KC4UY」之類之Konica Minolta股份有限公司製造之纖維素酯基材等。作為市售之環狀烯烴系樹脂,例如可列舉:「Topas(註冊商標)」之類之Ticona公司(德國)製造之環狀烯烴系樹脂;「ARTON(註冊商標)」之類之JSR股份有限公司製造之環狀烯烴系樹脂;「ZEONOR(註冊商標)」、及「ZEONEX(註冊商標)」之類之日本ZEON股份有限公司製造之環狀烯烴系樹脂;「APEL」(註冊商標)之類之三井化學股份有限公司製造之環狀烯烴系樹脂。亦可使用市售之環狀烯烴系樹脂基材。作為市售之環狀烯烴系樹脂基材,可列舉:「S-SINA(註冊商標)」及「SCA40(註冊商標)」之類之積水化學工業股份有限公司製造之環狀烯烴系樹脂基材;「ZEONOR FILM(註冊商標)」之類之Optronics股份有限公司製造之環狀烯烴系樹脂基材;「ARTON FILM(註冊商標)」之類之JSR股份有限公司製造之環狀烯烴系樹脂基材。A commercially available product can also be used as a base material. Examples of commercially available cellulose ester substrates include cellulose ester substrates manufactured by Fuji Film Co., Ltd. such as FUJITAC FILM; cellulose ester substrates manufactured by Konica Minolta Co., Ltd. such as “KC8UX2M”, “KC8UY” and “KC4UY”. Examples of commercially available cyclic olefin-based resins include: Cyclic olefin-based resins manufactured by Ticona (Germany) such as "Topas (registered trademark)"; Cyclic olefin-based resins manufactured by JSR Co., Ltd. such as "ARTON (registered trademark)"; Cyclic olefin-based resins manufactured by Japan Zeon Co., Ltd. such as "ZEONOR (registered trademark)" and "ZEONEX (registered trademark)"; Cyclic olefin resin. Commercially available cyclic olefin-based resin substrates can also be used. Examples of commercially available cyclic olefin resin substrates include Sekisui Chemical Co., Ltd. cyclic olefin resin substrates such as "S-SINA (registered trademark)" and "SCA40 (registered trademark)", cyclic olefin resin substrates manufactured by Optronics Co., Ltd. such as "ZEONOR FILM (registered trademark)", and cyclic olefin resin substrates manufactured by JSR Co., Ltd. such as "ARTON FILM (registered trademark)".

於本發明中,基材較佳為最終能夠自本發明之積層體剝離者,例如,藉由將剝離基材後之積層體之垂直配向液晶硬化膜經由黏接著劑層與偏光膜進行貼合,可獲得橢圓偏光板。In the present invention, the substrate is preferably one that can finally be peeled off from the laminate of the present invention. For example, an elliptically polarizing plate can be obtained by laminating the vertically aligned liquid crystal cured film of the laminate after peeling off the substrate to a polarizing film via an adhesive layer.

就積層體之薄型化、基材之剝離容易性、基材之處理性等觀點而言,基材之厚度通常為5~300 μm,較佳為10~150 μm。The thickness of the substrate is usually 5 to 300 μm, preferably 10 to 150 μm, from the viewpoints of thinning the laminate, ease of peeling of the substrate, and rationality of the substrate.

本發明之積層體於不會對本發明之效果造成影響之範圍內,亦可包含除基材、垂直配向液晶硬化膜、水平配向膜及水平配向液晶硬化膜以外之層。作為此種其他層,例如可列舉:以提高基材之耐溶劑性,或提高液晶硬化膜之機械強度,或進行補強為目的之硬化樹脂層、硬塗層、底塗層等。例如,可將基材與垂直配向液晶硬化膜經由不具有垂直配向限制力之層進行積層,亦可將垂直配向液晶硬化膜與水平配向膜經由不具有垂直配向限制力之層(除黏接著劑層以外)進行積層。The laminate of the present invention may also include layers other than the base material, vertical alignment liquid crystal cured film, horizontal alignment film, and horizontal alignment liquid crystal cured film within the range that does not affect the effect of the present invention. Examples of such another layer include a cured resin layer, a hard coat layer, and a primer layer for the purpose of improving the solvent resistance of the substrate, improving the mechanical strength of the liquid crystal cured film, or reinforcing. For example, the base material and vertically aligned liquid crystal cured film can be laminated through a layer that does not have vertical alignment restrictive force, and the vertically aligned liquid crystal cured film and horizontal alignment film can also be laminated through a layer that does not have vertical alignment restrictive force (except the adhesive layer).

上述硬化樹脂層例如可由丙烯酸系樹脂、甲基丙烯酸系樹脂、環氧樹脂、氧雜環丁烷樹脂、胺基甲酸酯樹脂、三聚氰胺樹脂等形成。藉由設置硬化樹脂層,可使基材之耐溶劑性提高,或者即便與硬化樹脂層鄰接形成之垂直配向液晶硬化膜為薄膜,硬化樹脂層亦作為保護層或補強層充分地彌補垂直配向液晶硬化膜之強度。The cured resin layer can be formed of, for example, acrylic resin, methacrylic resin, epoxy resin, oxetane resin, urethane resin, melamine resin, or the like. By providing the cured resin layer, the solvent resistance of the substrate can be improved, or even if the vertically aligned liquid crystal cured film formed adjacent to the cured resin layer is a thin film, the cured resin layer can also be used as a protective layer or a reinforcing layer to fully compensate for the strength of the vertically aligned liquid crystal cured film.

於本發明之積層體包含如上述硬化樹脂層之其他層之情形時,該其他層之厚度只要根據所設置之層之目的或種類而適當決定即可,較佳為0.1~10.0 μm,更佳為0.3~5.0 μm。When the laminate of the present invention includes other layers such as the above-mentioned cured resin layer, the thickness of the other layer may be appropriately determined according to the purpose or type of the layer provided, and is preferably 0.1 to 10.0 μm, more preferably 0.3 to 5.0 μm.

[積層體之製造方法] 本發明之積層體例如可藉由如下製造方法進行製造,該製造方法依序包括: 形成含有聚合性液晶化合物之垂直配向液晶硬化膜形成用聚合性液晶組合物之塗膜,自該塗膜形成垂直配向液晶硬化膜之步驟(以下,亦稱為「垂直配向液晶硬化膜形成步驟」)、 形成水平配向膜形成用組合物之塗膜,自該塗膜形成水平配向膜之步驟(以下,亦稱為「水平配向膜形成步驟」)、及 形成含有聚合性液晶化合物之水平配向液晶硬化膜形成用聚合性液晶組合物之塗膜,自該塗膜形成水平配向液晶硬化膜之步驟(以下,亦稱為「水平配向液晶硬化膜形成步驟」)。 於在本發明之積層體中垂直配向液晶硬化膜、水平配向膜及水平配向液晶硬化膜鄰接存在之情形時,較佳為將垂直配向液晶硬化膜形成步驟、水平配向膜形成步驟及垂直配向液晶硬化膜形成步驟依序連續地進行。[Manufacturing method of laminated body] The laminate of the present invention can be produced, for example, by the following production method, which sequentially includes: Forming a coating film of a polymerizable liquid crystal composition for forming a vertical alignment liquid crystal cured film containing a polymerizable liquid crystal compound, and forming a vertical alignment liquid crystal cured film from the coating film (hereinafter also referred to as "vertical alignment liquid crystal cured film forming step"), A step of forming a coating film of the composition for forming a horizontal alignment film and forming a horizontal alignment film from the coating film (hereinafter also referred to as "horizontal alignment film forming step"), and Forming a coating film of a polymerizable liquid crystal composition for forming a horizontally aligned liquid crystal cured film containing a polymerizable liquid crystal compound, and forming a horizontally aligned liquid crystal cured film from the coated film (hereinafter also referred to as "horizontally aligned liquid crystal cured film forming step"). In the case where the vertical alignment liquid crystal cured film, the horizontal alignment film, and the horizontal alignment liquid crystal cured film are adjacent to each other in the laminate of the present invention, it is preferable to perform the vertical alignment liquid crystal cured film forming step, the horizontal alignment film forming step, and the vertical alignment liquid crystal cured film forming step sequentially.

於垂直配向液晶硬化膜形成步驟中,垂直配向液晶硬化膜例如可藉由如下方法進行製造,該方法包括: 將垂直配向液晶硬化膜形成用聚合性液晶組合物塗佈於基材上而獲得塗膜之步驟; 使上述塗膜乾燥而形成乾燥塗膜之步驟;及 對乾燥塗膜照射活性能量線而形成垂直配向液晶硬化膜之步驟。In the step of forming the vertically aligned liquid crystal cured film, the vertically aligned liquid crystal cured film can be manufactured by, for example, the following method, which includes: A step of coating a polymerizable liquid crystal composition for forming a vertically aligned liquid crystal cured film on a substrate to obtain a coating film; a step of drying the above-mentioned coating film to form a dry coating film; and A step of forming a vertically aligned liquid crystal cured film by irradiating active energy rays to the dried coating film.

聚合性液晶組合物之塗膜之形成如可藉由如下方式進行:於基材上或設置基材上之不具有垂直配向限制力之硬化樹脂層等其他層上等塗佈垂直配向液晶硬化膜形成用的聚合性液晶組合物。Formation of the coating film of the polymerizable liquid crystal composition can be carried out by, for example, coating the polymerizable liquid crystal composition for forming a vertically aligned liquid crystal cured film on the substrate or on other layers such as a cured resin layer that has no vertical alignment restricting force provided on the substrate.

作為將聚合性液晶組合物塗佈於基材等之方法,可列舉:旋轉塗佈法、擠壓法、凹版塗佈法、模嘴塗佈法、棒式塗佈法、敷料器法等塗佈法、柔版法等印刷法等公知之方法。Examples of methods for applying the polymerizable liquid crystal composition to substrates include known methods such as spin coating methods, extrusion methods, gravure coating methods, die coating methods, bar coating methods, coating methods such as applicator methods, and printing methods such as flexographic methods.

繼而,藉由乾燥等將溶劑去除,藉此形成乾燥塗膜。作為乾燥方法,可列舉自然乾燥法、通風乾燥法、加熱乾燥及減壓乾燥法等。此時,藉由將自聚合性液晶組合物獲得之塗膜進行加熱,可自塗膜將溶劑乾燥去除,並且使聚合性液晶化合物在與塗膜平面垂直之方向上配向。塗膜之加熱溫度可考慮所使用之聚合性液晶化合物及形成塗膜之基材等之材質等而適當決定,為了使聚合性液晶化合物向液晶相狀態進行相轉移,通常必需為液晶相轉移溫度以上之溫度。為了將聚合性液晶組合物中所含有之溶劑去除,並且將聚合性液晶化合物設為垂直配向狀態,例如可加熱至上述聚合性液晶組合物中所含有之聚合性液晶化合物之液晶相轉移溫度(層列相轉移溫度或向列相轉移溫度)程度以上之溫度。 再者,液晶相轉移溫度例如可使用具備溫度調節台之偏光顯微鏡、或示差掃描熱量計(DSC)、熱重量-示差熱分析裝置(TG-DTA)等進行測定。又,於作為聚合性液晶化合物,組合2種以上使用之情形時,上述相轉移溫度意味著使用將構成聚合性液晶組合物之全部聚合性液晶化合物以與聚合性液晶組合物中之組成相同之比率進行混合而成之聚合性液晶化合物的混合物,並以與使用1種聚合性液晶化合物之情形相同之方式所測定之溫度。再者,已知一般上述聚合性液晶組合物中之聚合性液晶化合物之液晶相轉移溫度亦有時低於作為聚合性液晶化合物單獨成分的液晶相轉移溫度。Next, the solvent is removed by drying or the like to form a dry coating film. As a drying method, a natural drying method, a ventilating drying method, a heat drying method, and a reduced-pressure drying method etc. are mentioned. At this time, by heating the coating film obtained from the polymerizable liquid crystal composition, the solvent can be dried and removed from the coating film, and the polymerizable liquid crystal compound can be aligned in a direction perpendicular to the plane of the coating film. The heating temperature of the coating film can be appropriately determined in consideration of the polymerizable liquid crystal compound used and the material of the substrate forming the coating film, etc. In order to phase transition the polymerizable liquid crystal compound to the liquid crystal phase state, it is usually necessary to be at a temperature above the liquid crystal phase transition temperature. In order to remove the solvent contained in the polymerizable liquid crystal composition and bring the polymerizable liquid crystal compound into a homeotropic alignment state, for example, it may be heated to a temperature equal to or higher than the liquid crystal phase transition temperature (smectic phase transition temperature or nematic phase transition temperature) of the polymerizable liquid crystal compound contained in the above polymerizable liquid crystal composition. Furthermore, the liquid crystal phase transition temperature can be measured using, for example, a polarizing microscope equipped with a temperature adjustment stage, a differential scanning calorimeter (DSC), a thermogravimetric-differential thermal analyzer (TG-DTA), or the like. Also, when two or more polymerizable liquid crystal compounds are used in combination, the above-mentioned phase transition temperature means the temperature measured using a mixture of polymerizable liquid crystal compounds obtained by mixing all the polymerizable liquid crystal compounds constituting the polymerizable liquid crystal composition in the same ratio as the composition of the polymerizable liquid crystal composition in the same manner as the case of using one kind of polymerizable liquid crystal compound. Furthermore, it is generally known that the liquid crystal phase transition temperature of the polymerizable liquid crystal compound in the above polymerizable liquid crystal composition is sometimes lower than the liquid crystal phase transition temperature of the polymerizable liquid crystal compound alone.

加熱時間可視加熱溫度、所使用之聚合性液晶化合物之種類、溶劑之種類或其沸點及其量等而適當決定,通常為15秒~10分鐘,較佳為0.5~5分鐘。The heating time can be appropriately determined depending on the heating temperature, the type of polymerizable liquid crystal compound used, the type of solvent or its boiling point and its amount, and is usually 15 seconds to 10 minutes, preferably 0.5 to 5 minutes.

自塗膜去除溶劑可與將聚合性液晶化合物加熱至液晶相轉移溫度以上同時進行,亦可分開進行,就生產性提高之觀點而言,較佳為同時地進行。亦可於將聚合性液晶化合物加熱至液晶相轉移溫度以上之前,設置用以於自聚合性液晶組合物獲得之塗膜中所含有之聚合性液晶化合物未聚合之條件下將塗膜中之溶劑適度去除之預乾燥步驟。作為該預乾燥步驟中之乾燥方法,可列舉:自然乾燥法、通風乾燥法、加熱乾燥及減壓乾燥法等,該乾燥步驟中之乾燥溫度(加熱溫度)可視所使用之聚合性液晶化合物之種類、溶劑之種類或其沸點及其量等而適當決定。Removal of the solvent from the coating film may be performed simultaneously with heating the polymerizable liquid crystal compound to a liquid crystal phase transition temperature or higher, or may be performed separately, but it is preferably performed simultaneously from the viewpoint of productivity improvement. Before heating the polymerizable liquid crystal compound to the liquid crystal phase transition temperature or higher, a pre-drying step may be provided for appropriately removing the solvent in the coating film under the condition that the polymerizable liquid crystal compound contained in the coating film obtained from the polymerizable liquid crystal composition is not polymerized. As the drying method in the pre-drying step, natural drying method, ventilating drying method, heating drying and reduced-pressure drying method, etc. can be mentioned. The drying temperature (heating temperature) in the drying step can be appropriately determined depending on the type of polymerizable liquid crystal compound used, the type of solvent or its boiling point and its amount.

繼而,於所獲得之乾燥塗膜中,於保持聚合性液晶化合物之垂直配向狀態之狀態下使聚合性液晶化合物進行聚合,藉此形成垂直配向液晶硬化膜。作為聚合方法,可列舉熱聚合法或光聚合法,就容易控制聚合反應之觀點而言,較佳為光聚合法。於光聚合中,作為照射至乾燥塗膜之光,視該乾燥塗膜所含有之聚合起始劑之種類、聚合性液晶化合物之種類(尤其是該聚合性液晶化合物所具有之聚合性基之種類)及其量而適當選擇。作為其具體例,可列舉:選自由可見光、紫外光、紅外光、X射線、α射線、β射線及γ射線所組成之群中之1種以上之光或活性電子束。其中,就容易控制聚合反應之進行之方面、或可使用作為光聚合裝置之該領域中廣泛使用者之方面而言,較佳為紫外光,且較佳為以藉由紫外光而能夠進行光聚合之方式預先選擇聚合性液晶組合物所含有之聚合性液晶化合物或聚合起始劑之種類。又,亦可於聚合時藉由適當之冷卻方法而冷卻乾燥塗膜並且進行光照射,藉此亦可控制聚合溫度。藉由採用此種冷卻方法,而若於更低溫下實施聚合性液晶化合物之聚合,則即便使用耐熱性相對較低之基材,亦可適當地形成垂直配向液晶硬化膜。又,亦可藉由於不會產生由光照射時之熱引起之異常(基材之由熱引起之變形等)之範圍內使聚合溫度變高,而促進聚合反應。光聚合時,亦可藉由進行遮蔽或顯影等而獲得圖案化之硬化膜。Next, in the obtained dry coating film, the polymerizable liquid crystal compound is polymerized while maintaining the homeotropic alignment state of the polymerizable liquid crystal compound, thereby forming a homeotropically aligned liquid crystal cured film. As a polymerization method, a thermal polymerization method or a photopolymerization method is mentioned, and a photopolymerization method is preferable from a viewpoint of easy control of a polymerization reaction. In photopolymerization, the light irradiated to the dry coating film is appropriately selected depending on the type of polymerization initiator contained in the dry coating film, the type of polymerizable liquid crystal compound (especially the type of polymerizable group contained in the polymerizable liquid crystal compound) and its amount. Specific examples thereof include one or more kinds of light or active electron beams selected from the group consisting of visible light, ultraviolet light, infrared light, X-rays, α-rays, β-rays, and γ-rays. Among them, ultraviolet light is preferred because it is easy to control the progress of the polymerization reaction, or it can be used by a wide range of users in this field as a photopolymerization device, and it is preferable to select in advance the type of polymerizable liquid crystal compound or polymerization initiator contained in the polymerizable liquid crystal composition so that photopolymerization can be carried out by ultraviolet light. In addition, during polymerization, the coating film can be cooled and dried by an appropriate cooling method and then irradiated with light, thereby controlling the polymerization temperature. By adopting such a cooling method, if the polymerization of the polymerizable liquid crystal compound is performed at a lower temperature, even if a base material with relatively low heat resistance is used, a cured film of a vertically aligned liquid crystal can be appropriately formed. Also, the polymerization reaction can be accelerated by increasing the polymerization temperature within a range in which abnormalities caused by heat during light irradiation (heat-induced deformation of the substrate, etc.) do not occur. During photopolymerization, a patterned cured film can also be obtained by performing masking or development.

作為上述活性能量線之光源,例如可列舉:低壓水銀燈、中壓水銀燈、高壓水銀燈、超高壓水銀燈、氙氣燈、鹵素燈、碳弧燈、鎢絲燈、鎵燈、準分子雷射、發出波長範圍380~440 nm之光之LED光源、化學燈、黑光燈、微波激發水銀燈、金屬鹵素燈等。Examples of light sources for the active energy rays include low-pressure mercury lamps, medium-pressure mercury lamps, high-pressure mercury lamps, ultra-high-pressure mercury lamps, xenon lamps, halogen lamps, carbon arc lamps, tungsten filament lamps, gallium lamps, excimer lasers, LED light sources emitting light in the wavelength range of 380-440 nm, chemical lamps, black light lamps, microwave-excited mercury lamps, and metal halide lamps.

紫外線照射強度通常為10~3,000 mW/cm2 。紫外線照射強度較佳為對於光聚合起始劑之活化有效之波長區域中之強度。照射光之時間通常為0.1秒~10分鐘,較佳為0.1秒~5分鐘,更佳為0.1秒~3分鐘,進而較佳為0.1秒~1分鐘。若以此種紫外線照射強度照射1次或複數次,其累計光量為10~3,000 mJ/cm2 ,較佳為50~2,000 mJ/cm2 ,更佳為100~1,000 mJ/cm2The ultraviolet irradiation intensity is usually 10 to 3,000 mW/cm 2 . The intensity of ultraviolet irradiation is preferably an intensity in a wavelength region effective for activation of the photopolymerization initiator. The time for irradiating light is usually 0.1 second to 10 minutes, preferably 0.1 second to 5 minutes, more preferably 0.1 second to 3 minutes, and still more preferably 0.1 second to 1 minute. If the ultraviolet irradiation intensity is irradiated once or multiple times, the cumulative light intensity is 10-3,000 mJ/cm 2 , preferably 50-2,000 mJ/cm 2 , more preferably 100-1,000 mJ/cm 2 .

垂直配向液晶硬化膜之厚度可視所應用之顯示裝置而適當選擇,較佳為0.2~3 μm,更佳為0.2~2 μm。於垂直配向液晶硬化膜為正波長分散性之情形時,進而較佳為0.2~1 μm,於逆波長分散性之情形時,進而較佳為0.4~2 μm。The thickness of the vertically aligned liquid crystal cured film can be appropriately selected depending on the display device used, and is preferably 0.2-3 μm, more preferably 0.2-2 μm. When the vertically aligned liquid crystal cured film has positive wavelength dispersion, it is more preferably 0.2 to 1 μm, and when it has reverse wavelength dispersion, it is further preferably 0.4 to 2 μm.

於水平配向膜形成步驟中,光配向膜例如可藉由將光配向膜形成用組合物塗佈於垂直配向液晶硬化膜上,將溶劑去除後照射偏光(較佳為偏光UV)而獲得。In the step of forming the horizontal alignment film, the photo alignment film can be obtained by, for example, coating the photo alignment film forming composition on the vertical alignment liquid crystal cured film, removing the solvent, and then irradiating polarized light (preferably polarized UV).

作為將光配向膜形成用組合物塗佈於垂直配向液晶硬化膜上之方法,可列舉:與將垂直配向液晶硬化膜形成用聚合性液晶組合物塗佈於基材等之方法相同之方法。作為自塗佈之光配向膜形成用組合物去除溶劑之方法,例如可列舉:自然乾燥法、通風乾燥法、加熱乾燥及減壓乾燥法等。As a method of coating the composition for forming a photoalignment film on the cured film of vertical alignment liquid crystal, the same method as the method of coating the polymerizable liquid crystal composition for forming a cured film of vertical alignment liquid crystal on the base material and the like may be mentioned. As a method of removing a solvent from the applied composition for forming a photoalignment film, a natural drying method, an air drying method, a heat drying method, a reduced pressure drying method, etc. are mentioned, for example.

照射偏光時,可為對自光配向膜形成用組合物之塗膜去除溶劑而成者直接照射偏光UV的形式,亦可為自垂直配向液晶硬化膜側(基材側)照射偏光,使偏光透過而進行照射之形式。又,該偏光尤佳為實質上平行光。關於所照射之偏光之波長,可為具有光反應性基之聚合物或單體之光反應性基可吸收光能之波長區域者。具體而言,尤佳為波長250~400 nm之範圍之UV(紫外線)。作為該偏光照射所使用之光源,可列舉:氙氣燈、高壓水銀燈、超高壓水銀燈、金屬鹵素燈、KrF、ArF等紫外光雷射等,更佳為高壓水銀燈、超高壓水銀燈及金屬鹵素燈。該等之中,高壓水銀燈、超高壓水銀燈及金屬鹵素燈由於波長313 nm之紫外線之發光強度較大,故而較佳。藉由使來自上述光源之光通過適當偏光元件來進行照射,可照射偏光UV。作為該偏光元件,可使用偏光鏡或葛蘭-湯普生、葛蘭-泰勒等偏光稜鏡或線柵型之偏光元件。 再者,於進行偏光照射時,若進行遮蔽,則亦可形成液晶配向之方向不同之複數個區域(圖案)。When irradiating polarized light, it may be a form of directly irradiating polarized light UV to a coating film obtained by removing the solvent from the composition for forming a photoalignment film, or may be a form of irradiating polarized light from the vertically aligned liquid crystal cured film side (substrate side) to transmit the polarized light. In addition, the polarized light is preferably substantially parallel light. Regarding the wavelength of the irradiated polarized light, it may be a polymer having a photoreactive group or a wavelength region where the photoreactive group of a monomer can absorb light energy. Specifically, UV (ultraviolet rays) having a wavelength of 250 to 400 nm is particularly preferable. The light source used for the polarized light irradiation includes xenon lamp, high-pressure mercury lamp, ultra-high pressure mercury lamp, metal halide lamp, ultraviolet laser such as KrF, ArF, etc., more preferably high-pressure mercury lamp, ultra-high pressure mercury lamp and metal halide lamp. Among them, high-pressure mercury lamps, ultra-high-pressure mercury lamps, and metal halide lamps are preferable because the luminous intensity of ultraviolet rays with a wavelength of 313 nm is relatively large. Polarized light UV can be irradiated by passing light from the above-mentioned light source through an appropriate polarizing element and irradiating it. As the polarizing element, a polarizer, a polarizer such as Glenn-Thompson, Glenn-Taylor, or a wire-grid type polarizing element can be used. In addition, when irradiating polarized light, if shielding is performed, a plurality of regions (patterns) in which liquid crystal alignment directions are different can also be formed.

於水平配向液晶硬化膜形成步驟中,水平配向液晶硬化膜例如可藉由如下方法進行製作,該方法包括: 將水平配向液晶硬化膜形成用聚合性液晶組合物塗佈於水平配向膜上而獲得塗膜之步驟、 使上述塗膜乾燥而形成乾燥塗膜之步驟、及 對乾燥塗膜照射活性能量線而形成水平配向液晶硬化膜之步驟。In the step of forming the horizontally aligned liquid crystal cured film, the horizontally aligned liquid crystal cured film can be produced, for example, by the following method, which includes: A step of applying a polymerizable liquid crystal composition for forming a horizontally aligned liquid crystal cured film on a horizontally aligned film to obtain a coating film, A step of drying the above-mentioned coating film to form a dry coating film, and A step of forming a horizontally aligned liquid crystal cured film by irradiating active energy rays to the dried coating film.

聚合性液晶組合物之塗膜之形成例如可藉由於水平配向膜上塗佈水平配向液晶硬化膜形成用聚合性液晶組合物而進行。作為聚合性液晶組合物之塗佈方法,可列舉:與垂直配向液晶硬化膜之製造方法中可採用之方法相同之方法。Formation of the coating film of a polymeric liquid crystal composition can be performed by coating the polymeric liquid crystal composition for forming a cured film of a horizontal alignment liquid crystal on a horizontal alignment film, for example. As a coating method of a polymeric liquid crystal composition, the method similar to the method applicable to the manufacturing method of a vertical alignment liquid crystal cured film is mentioned.

繼而,藉由乾燥等將溶劑去除,藉此形成乾燥塗膜。作為乾燥方法,可列舉自然乾燥法、通風乾燥法、加熱乾燥及減壓乾燥法等。就生產性之方面而言,較佳為加熱乾燥,該情形時之加熱溫度較佳為可去除溶劑,且為聚合性液晶化合物之相轉移溫度以上。關於該步驟中之程序或條件,可列舉與垂直配向液晶硬化膜之製造方法中可採用之程序或條件相同者。Next, the solvent is removed by drying or the like to form a dry coating film. As a drying method, a natural drying method, a ventilating drying method, a heat drying method, and a reduced-pressure drying method etc. are mentioned. In terms of productivity, heat drying is preferred, and in this case, the heating temperature is preferably at least the phase transition temperature of the polymerizable liquid crystal compound at which the solvent can be removed. About the procedure and conditions in this process, the thing similar to the procedure or condition applicable to the manufacturing method of the vertical alignment liquid crystal cured film is mentioned.

對於所獲得之乾燥塗膜照射活性能量線(更具體而言為紫外線等),在保持聚合性液晶化合物於相對於塗膜平面為水平方向上配向之狀態之狀態下,使聚合性液晶化合物進行聚合,藉此形成水平配向液晶硬化膜。作為聚合方法,可列舉與垂直配向液晶硬化膜之製造方法中可採用之方法相同之方法。The obtained dry coating film is irradiated with active energy rays (more specifically, ultraviolet rays, etc.) to polymerize the polymerizable liquid crystal compound while maintaining the state of aligning the polymerizable liquid crystal compound in the horizontal direction with respect to the plane of the coating film, thereby forming a horizontally aligned liquid crystal cured film. As a polymerization method, the method similar to the method applicable to the manufacturing method of the vertical alignment liquid crystal cured film is mentioned.

水平配向液晶硬化膜之厚度可視所應用之顯示裝置而適當選擇,較佳為0.2~5 μm,更佳為0.2~4 μm,進而較佳為0.2~3 μm。The thickness of the horizontally aligned liquid crystal cured film can be appropriately selected depending on the display device used, and is preferably 0.2-5 μm, more preferably 0.2-4 μm, and still more preferably 0.2-3 μm.

本發明中,垂直配向液晶硬化膜由含有垂直配向促進劑之聚合性液晶組合物形成,藉此即便不使用垂直配向膜,亦可獲得無配向缺陷或配向缺陷較少之垂直配向液晶硬化膜。將此種垂直配向液晶硬化膜與水平配向液晶硬化膜組合包含之本發明之積層體有光學特性優異之傾向,尤其是於應用於有機EL顯示裝置之情形時黑顯示時之正面及斜向反射色相變化之抑制效果優異。又,由於無需形成垂直配向膜之步驟,故而於生產效率或生產成本之方面上亦有利。In the present invention, the vertical alignment liquid crystal cured film is formed of a polymerizable liquid crystal composition containing a vertical alignment promoter, thereby obtaining a vertical alignment liquid crystal cured film with no or few alignment defects even without using a vertical alignment film. The laminate of the present invention comprising such a vertically aligned liquid crystal cured film and a horizontally aligned liquid crystal cured film in combination tends to have excellent optical properties, especially when applied to an organic EL display device, it is excellent in the effect of suppressing changes in frontal and oblique reflection hues during black display. In addition, since the step of forming a vertical alignment film is unnecessary, it is also advantageous in terms of production efficiency and production cost.

[橢圓偏光板] 本發明包括包含本發明之積層體及偏光膜之橢圓偏光板。 偏光膜係具有偏光功能之膜,可列舉:包含吸附有具有吸收各向異性之色素之延伸膜或塗佈有具有吸收各向異性之色素之膜作為偏光元件的膜等。作為具有吸收各向異性之色素,例如可列舉二色性色素。[Elliptical polarizer] The present invention includes an elliptically polarizing plate including the laminate of the present invention and a polarizing film. The polarizing film is a film having a polarizing function, and examples thereof include a stretched film adsorbed with an anisotropic absorption pigment or a film coated with an anisotropic absorption pigment as a polarizing element. Examples of dyes having absorption anisotropy include dichroic dyes.

包含吸附有具有吸收各向異性之色素之延伸膜作為偏光元件之膜通常藉由如下方式進行製作:於經由將聚乙烯醇系樹脂膜進行單軸延伸之步驟、藉由利用二色性色素對聚乙烯醇系樹脂膜進行染色而吸附該二色性色素之步驟、利用硼酸水溶液對吸附有二色性色素之聚乙烯醇系樹脂膜進行處理之步驟、及於利用硼酸水溶液進行處理後進行水洗之步驟所製造之偏光元件的至少一面經由接著劑而由透明保護膜夾住。A film including a stretched film adsorbed with a dye having absorption anisotropy as a polarizing element is generally produced by uniaxially stretching the polyvinyl alcohol-based resin film, dyeing the polyvinyl alcohol-based resin film with a dichroic dye to absorb the dichroic dye, treating the polyvinyl alcohol-based resin film adsorbed with the dichroic dye with a boric acid aqueous solution, and washing the polyvinyl alcohol-based resin film with the dichroic dye after the treatment with a boric acid aqueous solution. Clamp.

聚乙烯醇系樹脂係藉由使聚乙酸乙烯酯系樹脂皂化而獲得。作為聚乙酸乙烯酯系樹脂,例如除了可使用乙酸乙烯酯之均聚物即聚乙酸乙烯酯以外,亦可使用乙酸乙烯酯與能夠與其共聚之其他單體的共聚物。作為能夠與乙酸乙烯酯共聚之其他單體,例如可列舉不飽和羧酸類、烯烴類、乙烯醚類、不飽和磺酸類、及具有銨基之丙烯醯胺類。Polyvinyl alcohol-based resins are obtained by saponifying polyvinyl acetate-based resins. As the polyvinyl acetate resin, for example, in addition to polyvinyl acetate which is a homopolymer of vinyl acetate, a copolymer of vinyl acetate and other monomers that can be copolymerized therewith can also be used. Examples of other monomers that can be copolymerized with vinyl acetate include unsaturated carboxylic acids, olefins, vinyl ethers, unsaturated sulfonic acids, and acrylamides having ammonium groups.

聚乙烯醇系樹脂之皂化度通常為85~100莫耳%左右,較佳為98莫耳%以上。聚乙烯醇系樹脂可經改性,例如亦可使用經醛類改性之聚乙烯醇縮甲醛或聚乙烯醇縮乙醛。聚乙烯醇系樹脂之聚合度通常為1,000~10,000左右,較佳為1,500~5,000之範圍。The degree of saponification of the polyvinyl alcohol-based resin is usually about 85-100 mole%, preferably more than 98 mole%. The polyvinyl alcohol-based resin may be modified, for example, polyvinyl formal or polyvinyl acetal modified with aldehydes may also be used. The degree of polymerization of the polyvinyl alcohol-based resin is usually about 1,000 to 10,000, preferably in the range of 1,500 to 5,000.

將此種聚乙烯醇系樹脂製膜而成者係用作偏光膜之坯膜。將聚乙烯醇系樹脂製膜之方法並無特別限定,可使用公知之方法製膜。聚乙烯醇系坯膜之膜厚例如可設為10~150 μm左右。Those made of such polyvinyl alcohol-based resins are used as base films for polarizing films. The method of forming a polyvinyl alcohol-based resin into a film is not particularly limited, and a known method can be used to form a film. The film thickness of a polyvinyl-alcohol-type base film can be made into about 10-150 micrometers, for example.

聚乙烯醇系樹脂膜之單軸延伸可於利用二色性色素進行染色之前、與染色同時、或於染色之後進行。於染色之後進行單軸延伸之情形時,該單軸延伸可於硼酸處理之前進行,亦可於硼酸處理中進行。又,亦可於該等複數個階段中進行單軸延伸。於進行單軸延伸時,可於周速不同之輥間單軸地進行延伸,亦可使用熱輥單軸地進行延伸。又,單軸延伸可為於大氣中進行延伸之乾式延伸,亦可為使用溶劑而於使聚乙烯醇系樹脂膜膨潤之狀態下進行延伸之濕式延伸。延伸倍率通常為3~8倍左右。The uniaxial stretching of the polyvinyl alcohol-based resin film can be performed before dyeing with a dichroic dye, simultaneously with dyeing, or after dyeing. When performing uniaxial stretching after dyeing, the uniaxial stretching may be performed before or during boric acid treatment. In addition, uniaxial stretching can also be performed in these plural stages. In the case of uniaxial stretching, it may be uniaxially stretched between rolls having different circumferential speeds, or may be uniaxially stretched using a heated roll. In addition, the uniaxial stretching may be a dry stretching in which stretching is performed in the air, or a wet stretching in which a polyvinyl alcohol-based resin film is stretched in a state in which a polyvinyl alcohol-based resin film is swollen. The elongation ratio is usually about 3 to 8 times.

聚乙烯醇系樹脂膜之利用二色性色素進行之染色例如係藉由將聚乙烯醇系樹脂膜浸漬於含有二色性色素之水溶液中之方法而進行。The dyeing of a polyvinyl-alcohol-type resin film with a dichroic dye is performed by the method of immersing a polyvinyl-alcohol-type resin film in the aqueous solution containing a dichroic dye, for example.

作為二色性色素,具體而言,可使用碘或二色性之有機染料。作為二色性之有機染料,可列舉:C.I.DIRECT RED 39等包含雙偶氮化合物之二色性直接染料、及包含三偶氮、四偶氮等化合物之二色性直接染料等。聚乙烯醇系樹脂膜較佳為預先於染色處理前實施向水中之浸漬處理。As a dichroic dye, iodine or a dichroic organic dye can be used specifically. Examples of dichroic organic dyes include dichroic direct dyes containing disazo compounds such as C.I. DIRECT RED 39, and dichroic direct dyes containing compounds such as trisazo and tetrasazo. The polyvinyl alcohol-based resin film is preferably subjected to a immersion treatment in water before the dyeing treatment.

於將碘用作二色性色素之情形時,通常採用將聚乙烯醇系樹脂膜浸漬於含有碘及碘化鉀之水溶液中進行染色之方法。該水溶液中之碘之含量相對於水100質量份,通常為0.01~1質量份左右。又,碘化鉀之含量相對於水100質量份,通常為0.5~20質量份左右。用於染色之水溶液之溫度通常為20~40℃左右。又,向該水溶液之浸漬時間(染色時間)通常為20~1,800秒左右。When iodine is used as a dichroic dye, the method of immersing and dyeing a polyvinyl alcohol-type resin film in the aqueous solution containing iodine and potassium iodide is employ|adopted normally. Content of the iodine in this aqueous solution is about 0.01-1 mass part normally with respect to 100 mass parts of water. Moreover, content of potassium iodide is about 0.5-20 mass parts normally with respect to 100 mass parts of water. The temperature of the aqueous solution used for dyeing is usually about 20-40°C. In addition, the immersion time (dyeing time) in the aqueous solution is usually about 20 to 1,800 seconds.

另一方面,於使用二色性之有機染料作為二色性色素之情形時,通常採用將聚乙烯醇系樹脂膜浸漬於包含水溶性二色性染料之水溶液進行染色之方法。該水溶液中之二色性有機染料之含量相對於水100質量份,通常為1×10-4 ~10質量份左右,較佳為1×10-3 ~1質量份,進而較佳為1×10-3 ~1×10-2 質量份。該水溶液亦可包含硫酸鈉等無機鹽作為染色助劑。用於染色之二色性染料水溶液之溫度通常為20~80℃左右。又,向該水溶液之浸漬時間(染色時間)通常為10~1,800秒左右。On the other hand, when using a dichroic organic dye as a dichroic dye, a method of immersing a polyvinyl alcohol-based resin film in an aqueous solution containing a water-soluble dichroic dye for dyeing is generally employed. The content of the dichroic organic dye in the aqueous solution is usually about 1×10 -4 to 10 parts by mass, preferably 1×10 -3 to 1 part by mass, more preferably 1×10 -3 to 1×10 -2 parts by mass relative to 100 parts by mass of water. The aqueous solution may also contain inorganic salts such as sodium sulfate as dyeing aids. The temperature of the dichroic dye aqueous solution used for dyeing is about 20-80 degreeC normally. In addition, the immersion time (dyeing time) in the aqueous solution is usually about 10 to 1,800 seconds.

利用二色性色素進行染色後之硼酸處理通常可藉由將經染色之聚乙烯醇系樹脂膜浸漬於硼酸水溶液之方法而進行。該硼酸水溶液中之硼酸之含量相對於水100質量份,通常為2~15質量份左右,較佳為5~12質量份。於使用碘作為二色性色素之情形時,該硼酸水溶液較佳為含有碘化鉀,該情形時之碘化鉀之含量相對於水100質量份,通常為0.1~15質量份左右,較佳為5~12質量份。向硼酸水溶液之浸漬時間通常為60~1,200秒左右,較佳為150~600秒,進而較佳為200~400秒。硼酸處理之溫度通常為50℃以上,較佳為50~85℃,進而較佳為60~80℃。The boric acid treatment after dyeing with a dichroic dye can be generally performed by a method of immersing a dyed polyvinyl alcohol-based resin film in a boric acid aqueous solution. Content of the boric acid in this boric-acid aqueous solution is about 2-15 mass parts normally with respect to 100 mass parts of water, Preferably it is 5-12 mass parts. When using iodine as a dichroic dye, the boric acid aqueous solution preferably contains potassium iodide, and the content of potassium iodide in this case is usually about 0.1 to 15 parts by mass, preferably 5 to 12 parts by mass, relative to 100 parts by mass of water. The immersion time in the boric acid aqueous solution is about 60 to 1,200 seconds normally, Preferably it is 150 to 600 seconds, More preferably, it is 200 to 400 seconds. The temperature of the boric acid treatment is usually above 50°C, preferably 50-85°C, more preferably 60-80°C.

硼酸處理後之聚乙烯醇系樹脂膜通常進行水洗處理。水洗處理例如可藉由將經硼酸處理之聚乙烯醇系樹脂膜浸漬於水中之方法進行。水洗處理中之水之溫度通常為5~40℃左右。又,浸漬時間通常為1~120秒左右。The polyvinyl alcohol-based resin film after the boric acid treatment is usually washed with water. The water washing treatment can be performed, for example, by a method of immersing a boric acid-treated polyvinyl alcohol-based resin film in water. The temperature of water in the washing process is usually about 5 to 40°C. Moreover, immersion time is about 1 to 120 seconds normally.

於水洗後實施乾燥處理而獲得偏光元件。乾燥處理例如可使用熱風乾燥機或遠紅外線加熱器進行。乾燥處理之溫度通常為30~100℃左右,較佳為50~80℃。乾燥處理之時間通常為60~600秒左右,較佳為120~600秒。藉由乾燥處理,偏光元件之水分率降低至實用程度。該水分率通常為5~20質量%左右,較佳為8~15重量%。若水分率低於5質量%,則有失去偏光元件之可撓性,偏光元件於其乾燥後損傷或破斷之情況。又,若水分率高於20質量%,則有偏光元件之熱穩定變差之可能性。After washing with water, drying treatment was performed to obtain a polarizing element. The drying treatment can be performed using, for example, a hot air dryer or a far-infrared heater. The temperature of the drying treatment is usually about 30-100°C, preferably 50-80°C. The drying time is usually about 60-600 seconds, preferably 120-600 seconds. By drying, the moisture content of the polarizer is reduced to a practical level. The water content is usually about 5 to 20% by mass, preferably 8 to 15% by mass. If the moisture content is less than 5% by mass, the flexibility of the polarizing element may be lost, and the polarizing element may be damaged or broken after drying. Moreover, when the moisture content exceeds 20 mass %, there exists a possibility that the thermal stability of a polarizing element may deteriorate.

如此對聚乙烯醇系樹脂膜進行單軸延伸、利用二色性色素之染色、硼酸處理、水洗及乾燥而獲得之偏光元件之厚度較佳為5~40 μm。The thickness of the polarizing element obtained by uniaxially stretching the polyvinyl alcohol-based resin film in this way, dyeing with a dichroic dye, treating with boric acid, washing with water, and drying is preferably 5 to 40 μm.

作為塗佈有具有吸收各向異性之色素之膜,可列舉:塗佈具有液晶性之含有二色性色素之組合物、或含有二色性色素及聚合性液晶之組合物所獲得之膜等。該膜較佳為於其單面或兩面具有保護膜。作為該保護膜,可列舉:與先前作為可用於垂直配向液晶硬化膜之製造之基材例示之樹脂膜相同者。Examples of the film coated with a dye having absorption anisotropy include a film obtained by coating a composition containing a liquid crystalline dichroic dye, or a composition containing a dichroic dye and a polymerizable liquid crystal. The film preferably has a protective film on one or both sides thereof. As this protective film, the thing similar to the resin film mentioned above as a base material which can be used for manufacture of a vertical alignment liquid crystal cured film is mentioned.

塗佈有具有吸收各向異性之色素之膜較佳為較薄,若過薄,則有強度降低而加工性較差之傾向。該膜之厚度通常為20 μm以下,較佳為5 μm以下,更佳為0.5~3 μm。The film coated with the pigment having anisotropic absorption is preferably thin, and if it is too thin, the strength tends to decrease and the processability tends to be poor. The thickness of the film is usually 20 μm or less, preferably 5 μm or less, more preferably 0.5-3 μm.

作為上述塗佈有具有吸收各向異性之色素之膜,具體而言,可列舉:日本專利特開2012-33249號公報等所記載之膜。Specific examples of the film coated with the dye having absorption anisotropy include films described in JP-A-2012-33249 and the like.

於如此獲得之偏光元件之至少一面例如亦可經由接著劑層而積層透明保護膜。作為透明保護膜,可使用與先前作為可用於垂直配向液晶硬化膜之製造之基材例示之樹脂膜相同之透明膜。A transparent protective film may be laminated on at least one side of the thus obtained polarizing element, for example, via an adhesive layer. As the transparent protective film, the same transparent film as the resin film exemplified above as the base material usable for the production of the vertically aligned liquid crystal cured film can be used.

本發明之橢圓偏光板係包含本發明之積層體或自本發明之積層體去除基材所得之積層體、與偏光膜者,例如可藉由將本發明之積層體與偏光膜經由接著劑層等進行積層而獲得本發明之橢圓偏光板。又,可藉由將自本發明之積層體去除基材所得之積層體與偏光膜貼合而獲得本發明之橢圓偏光板。The elliptically polarizing plate of the present invention includes the laminate of the present invention or a laminate obtained by removing the substrate from the laminate of the present invention, and a polarizing film. For example, the elliptically polarizing plate of the present invention can be obtained by laminating the laminate of the present invention and the polarizing film through an adhesive layer or the like. Moreover, the elliptically polarizing plate of this invention can be obtained by bonding the laminate obtained by removing a base material from the laminate of this invention, and a polarizing film.

於本發明之一實施態樣中,於將本發明之積層體與偏光膜積層之情形時,較佳為以構成積層體之水平配向液晶硬化膜之遲相軸(光軸)與偏光膜之吸收軸所成之角成為45±5°之方式積層。In one embodiment of the present invention, when the laminate of the present invention is laminated with a polarizing film, it is preferable to laminate in such a way that the angle formed by the retardation axis (optical axis) of the horizontal alignment liquid crystal cured film constituting the laminate and the absorption axis of the polarizing film becomes 45±5°.

本發明之橢圓偏光板亦可具有先前一般之橢圓偏光板、或偏光膜及相位差膜所具備之構成。作為此種構成,例如可列舉:用以將橢圓偏光板貼合於有機EL等顯示元件之黏著劑層(片)、以保護偏光膜或液晶硬化膜之表面免受損傷或污染為目的而使用之保護膜等。The elliptically polarizing plate of the present invention may also have the configurations of conventional elliptically polarizing plates, polarizing films, and retardation films. Such a configuration includes, for example, an adhesive layer (sheet) for bonding an elliptical polarizing plate to a display element such as an organic EL, and a protective film used for protecting the surface of a polarizing film or a cured liquid crystal film from damage or contamination.

本發明之積層體及橢圓偏光板可用於各種顯示裝置。 所謂顯示裝置係指具有顯示元件之裝置,包含發光元件或發光裝置作為發光源。作為顯示裝置,可列舉:液晶顯示裝置、有機電致發光(EL)顯示裝置、無機電致發光(EL)顯示裝置、觸控面板顯示裝置、電子發射顯示裝置(例如場發射顯示裝置(FED)、表面場發射顯示裝置(SED))、電子紙(使用電子油墨或電泳元件之顯示裝置、電漿顯示裝置、投射型顯示裝置(例如柵狀光閥(GLV)顯示裝置、具有數位微鏡裝置(DMD)之顯示裝置)及壓電陶瓷顯示器等。液晶顯示裝置包括透過型液晶顯示裝置、半透過型液晶顯示裝置、反射型液晶顯示裝置、直視型液晶顯示裝置及投影式液晶顯示裝置等之任一者。該等顯示裝置可為顯示二維圖像之顯示裝置,亦可為顯示三維圖像之立體顯示裝置。尤其是本發明之橢圓偏光板就容易顯著地發揮其效果之方面而言,可適宜地用於有機電致發光(EL)顯示裝置,本發明之積層體可適宜地用於液晶顯示裝置及觸控面板顯示裝置。藉由使用本發明之積層體或橢圓偏光板,容易實現顯示裝置之薄型化,能夠獲得光學特性優異,可表現出良好之圖像顯示特性之顯示裝置。 [實施例]The laminate and elliptically polarizing plate of the present invention can be used in various display devices. The so-called display device refers to a device having a display element, including a light-emitting element or a light-emitting device as a light-emitting source. As the display device, a liquid crystal display device, an organic electroluminescence (EL) display device, an inorganic electroluminescence (EL) display device, a touch panel display device, an electron emission display device (such as a field emission display device (FED), a surface field emission display device (SED)), an electronic paper (a display device using electronic ink or an electrophoretic element, a plasma display device, a projection display device (such as a grid light valve (GLV) display device, a display device with a digital micromirror device (DMD)), and a piezoelectric ceramic display. The device includes any one of a transmissive liquid crystal display device, a transflective liquid crystal display device, a reflective liquid crystal display device, a direct-view liquid crystal display device, and a projection type liquid crystal display device. These display devices can be display devices that display two-dimensional images, and can also be stereoscopic display devices that display three-dimensional images. Especially the elliptical polarizer of the present invention can be suitably used for organic electroluminescence (EL) display devices in terms of easily and significantly exerting its effect, and the laminate of the present invention can be suitably used for liquid crystal display devices and touch panel display devices. By using the laminate of the present invention Or an elliptically polarizing plate can easily realize thinning of the display device, and can obtain a display device with excellent optical characteristics and good image display characteristics. [Example]

以下,藉由實施例對本發明更具體地進行說明。再者,例中之「%」及「份」只要無特別記載,則分別意指質量%及質量份。Hereinafter, the present invention will be described more specifically with reference to examples. In addition, "%" and "part" in an example mean % by mass and parts by mass, respectively, unless otherwise specified.

1.實施例1 (1)水平配向膜形成用組合物之製備 藉由將下述結構之光配向性材料5質量份(重量平均分子量:30000)與環戊酮(溶劑)95質量份作為成分進行混合,並將所獲得之混合物於80℃下攪拌1小時,而獲得水平配向膜形成用組合物。 [化23] 1. Example 1 (1) Preparation of a composition for forming a horizontal alignment film A composition for forming a horizontal alignment film was obtained by mixing 5 parts by mass of a photo-alignment material (weight average molecular weight: 30,000) having the following structure and 95 parts by mass of cyclopentanone (solvent) as components, and stirring the obtained mixture at 80° C. for 1 hour. [chem 23]

(2)聚合性液晶化合物之製備 分別製備具有下述分子結構之聚合性液晶化合物(X1)及聚合性液晶化合物(X2)。聚合性液晶化合物(X1)係依據日本專利特開2010-31223號公報所記載之方法進行製造。又,聚合性液晶化合物(X2)係依據日本專利特開2009-173893號公報所記載之方法進行製造。(2) Preparation of polymerizable liquid crystal compounds A polymerizable liquid crystal compound (X1) and a polymerizable liquid crystal compound (X2) having the following molecular structures were prepared respectively. The polymerizable liquid crystal compound (X1) was produced according to the method described in JP-A-2010-31223. Moreover, the polymerizable liquid crystal compound (X2) was manufactured according to the method described in Unexamined-Japanese-Patent No. 2009-173893.

聚合性液晶化合物(X1) [化24] Polymeric Liquid Crystal Compound (X1) [Chem. 24]

聚合性液晶化合物(X2) [化25] Polymeric Liquid Crystal Compound (X2) [Chem. 25]

使聚合性液晶化合物(X1)1 mg溶解於四氫呋喃50 mL中而獲得溶液。將作為測定用試樣所獲得之溶液放入至光程長1 cm之測定用單元,將測定用試樣設置於紫外可見分光光度計(島津製作所股份有限公司製造之「UV-2450」),測定吸收光譜,自獲得之吸收光譜讀取成為極大吸收度之波長,結果波長300~400 nm之範圍內之極大吸收波長λmax 為350 nm。A solution was obtained by dissolving 1 mg of the polymerizable liquid crystal compound (X1) in 50 mL of tetrahydrofuran. The solution obtained as a measurement sample was put into a measurement cell with an optical path length of 1 cm, and the measurement sample was set in an ultraviolet-visible spectrophotometer (manufactured by Shimadzu Corporation, "UV-2450") to measure the absorption spectrum, and the wavelength of maximum absorption was read from the obtained absorption spectrum. As a result, the maximum absorption wavelength λ max in the wavelength range of 300 to 400 nm was 350 nm.

(3)水平配向液晶硬化膜形成用聚合性液晶組合物之製備 對下述式(LC242)所示之聚合性液晶化合物LC242:PaliocolorLC242(BASF公司 註冊商標)添加調平劑(DIC公司製造之「F-556」)0.1質量份及聚合起始劑Irg 369 3質量份。進而,以固形物成分濃度成為13%之方式添加環戊酮,並將該等進行混合,藉此獲得水平配向液晶硬化膜形成用聚合性液晶組合物。(3) Preparation of a polymerizable liquid crystal composition for forming a horizontally aligned liquid crystal cured film To the polymerizable liquid crystal compound LC242 represented by the following formula (LC242): Paliocolor LC242 (registered trademark of BASF Corporation), 0.1 parts by mass of a leveling agent ("F-556" manufactured by DIC Corporation) and 3 parts by mass of a polymerization initiator Irg 369 were added. Furthermore, cyclopentanone was added so that solid content density|concentration might become 13 %, and these were mixed, and the polymerizable liquid crystal composition for horizontal alignment liquid crystal cured film formation was obtained.

LC242:PaliocolorLC242(BASF公司,註冊商標) [化26] LC242: PaliocolorLC242 (BASF Corporation, registered trademark) [Chem. 26]

(4)垂直配向液晶硬化膜形成用聚合性液晶組合物之製備 相對於液晶化合物(X2)100質量份,添加調平劑「F-556」(DIC公司製造)0.25質量份、以日本專利特願2016-514802號公報為參考而製備之離子性化合物A(分子量:645)2.0質量份、矽烷偶合劑「KBE-9103」(信越化學工業股份有限公司製造)0.5質量份、及作為光聚合起始劑之2-二甲基胺基-2-苄基-1-(4-𠰌啉基苯基)丁烷-1-酮(BASF Japan股份有限公司製造之「Irgacure(註冊商標)369(Irg369)」)6質量份。進而,以固形物成分濃度成為13%之方式添加N-甲基-2-吡咯啶酮(NMP)。將該混合物於80℃下攪拌1小時,藉此獲得垂直配向液晶硬化膜形成用聚合性液晶組合物。(4) Preparation of a polymerizable liquid crystal composition for forming a vertical alignment liquid crystal cured film With respect to 100 parts by mass of liquid crystal compound (X2), 0.25 parts by mass of leveling agent "F-556" (manufactured by DIC Corporation), 2.0 parts by mass of ionic compound A (molecular weight: 645) prepared with reference to Japanese Patent Application No. 2016-514802, 0.5 parts by mass of silane coupling agent "KBE-9103" (manufactured by Shin-Etsu Chemical Co., Ltd.), and 2-dimethylamino- 6 parts by mass of 2-benzyl-1-(4-𠰌linylphenyl)butan-1-one (“Irgacure (registered trademark) 369 (Irg369)” manufactured by BASF Japan Co., Ltd.). Furthermore, N-methyl-2-pyrrolidone (NMP) was added so that the solid content concentration might become 13%. This mixture was stirred at 80 degreeC for 1 hour, and the polymerizable liquid crystal composition for vertical alignment liquid crystal cured film formation was obtained.

離子性化合物A: [化27] Ionic Compound A: [Chem. 27]

(5)基材之準備 使二季戊四醇六丙烯酸酯(ARONIX M-403 東亞合成股份有限公司製造之多官能丙烯酸酯)50質量份、丙烯酸酯樹脂(Ebecryl 4858 Daicel-UCB股份有限公司製造)50質量份、2-甲基-1[4-(甲硫基)苯基]-2-𠰌啉基丙烷-1-酮(Irgacure 907;Ciba Specialty Chemicals公司製造)3質量份溶解於異丙醇250質量份中,製備溶液,獲得含有丙烯酸酯化合物而成之硬化樹脂層形成用組合物。 繼而,於柯尼卡美能達股份有限公司製造之TAC膜(KC4UY)上利用棒式塗佈機塗佈硬化樹脂層形成用組合物,於50℃下乾燥1分鐘。其後,使用高壓水銀燈(「UNICURE VB-15201BY-A」,牛尾電機股份有限公司製造),照射紫外線(氮氣氛圍下,波長365 nm下之累計光量:400 mJ/cm2 ),藉此形成硬化樹脂層。利用接觸式膜厚計對所獲得之硬化樹脂層之膜厚進行測定,結果為2.0 μm。此時,使用王子計測機器股份有限公司製造之「KOBRA-WPR」,對TAC膜與硬化樹脂層之積層體之相位差值Re550進行測定後,減去源自TAC膜之相位差值Re550,結果確認到相位差值為3 nm以下,光學上各向同性。(5) Preparation of base material: 50 parts by mass of dipentaerythritol hexaacrylate (ARONIX M-403 multifunctional acrylate manufactured by Toa Gosei Co., Ltd.), 50 parts by mass of acrylate resin (Ebecryl 4858 manufactured by Daicel-UCB Co., Ltd.), 2-methyl-1[4-(methylthio)phenyl]-2-𠰌linylpropan-1-one (Irgacure 907; Ciba Specialty Chemical s company) 3 parts by mass were dissolved in 250 parts by mass of isopropyl alcohol to prepare a solution to obtain a composition for forming a cured resin layer containing an acrylate compound. Next, the composition for cured resin layer formation was apply|coated with the bar coater on the TAC film (KC4UY) by Konica Minolta Co., Ltd., and it dried at 50 degreeC for 1 minute. Thereafter, a cured resin layer was formed by irradiating ultraviolet rays (accumulated light intensity at a wavelength of 365 nm in a nitrogen atmosphere: 400 mJ/cm 2 ) using a high-pressure mercury lamp ("UNICURE VB-15201BY-A", manufactured by Ushio Electric Co., Ltd.). The film thickness of the obtained cured resin layer was measured with a contact film thickness gauge, and it was 2.0 μm. At this time, using "KOBRA-WPR" manufactured by Oji Scientific Instruments Co., Ltd., the retardation value Re550 of the laminate of the TAC film and the cured resin layer was measured, and the retardation value Re550 derived from the TAC film was subtracted. As a result, it was confirmed that the retardation value was 3 nm or less and was optically isotropic.

(6)垂直配向液晶硬化膜之製作 使用棒式塗佈機,於如上述般製作之基材上之硬化樹脂層上塗佈垂直配向液晶硬化膜形成用聚合性液晶組合物,於120℃下加熱60秒鐘。繼而,於加熱至120℃之狀態下使用高壓水銀燈(UNICURE VB-15201BY-A,牛尾電機股份有限公司製造),自塗佈有垂直配向液晶硬化膜形成用聚合性液晶組合物之面照射紫外線照射(氮氣氛圍下,波長365 nm下之累計光量:500 mJ/cm2 ),藉此形成垂直配向液晶硬化膜,獲得將基材、硬化樹脂層及垂直配向液晶硬化膜依序鄰接而積層所得之積層體。利用橢圓偏光計(日本分光股份有限公司製造之M-220)對所獲得之垂直配向液晶硬化膜之膜厚進行測定,結果為0.6 μm。(6) Production of vertical alignment liquid crystal cured film Using a bar coater, coat the polymerizable liquid crystal composition for vertical alignment liquid crystal cured film formation on the cured resin layer on the base material prepared as above, and heat at 120° C. for 60 seconds. Then, using a high-pressure mercury lamp (UNICURE VB-15201BY-A, manufactured by Ushio Electric Co., Ltd.), heated to 120°C, irradiated ultraviolet radiation (under a nitrogen atmosphere, cumulative light intensity at a wavelength of 365 nm: 500 mJ/cm 2 ) from the surface coated with a polymerizable liquid crystal composition for forming a vertically aligned liquid crystal cured film, thereby forming a vertically aligned liquid crystal cured film, and obtaining a substrate, a cured resin layer, and a vertically aligned liquid crystal cured film. The laminated body obtained by successive lamination. The film thickness of the obtained vertically aligned liquid crystal cured film was measured with an ellipsometer (M-220 manufactured by JASCO Corporation), and it was 0.6 μm.

<垂直配向液晶硬化膜之相位差值之測定> 對於以上述程序所製作之包含基材、硬化樹脂層及垂直配向液晶硬化膜之積層體之垂直配向液晶硬化膜面實施電暈處理,經由LINTEC公司製造之25 μm感壓式黏著劑貼合於玻璃後,剝離TAC膜及硬化樹脂層。對於所獲得之包含剝離、黏著劑、垂直配向液晶硬化膜之積層體,使用王子計測機器股份有限公司製造之KOBRA-WPR,使光向光學特性測定用樣品之入射角變化,對正面相位差值、及與進相軸中心傾斜40°時之相位差值進行測定。 各波長下之平均折射率係使用日本分光股份有限公司製造之橢圓偏光計M-220所測得。又,膜厚係使用浜松光子股份有限公司製造之Optical NanoGauge膜厚計C12562-01所測得。根據上述之正面相位差值、與進相軸中心傾斜40°時之相位差值、平均折射率、膜厚之值,以王子計測機器技術資料(http://www.oji-keisoku.co.jp/products/kobra/reference.html)為參照算出三維折射率。根據所獲得之三維折射率,依據以下式計算垂直配向液晶硬化膜之光學特性,算出Rth(450)、Rth(550)、αth=Rth(450)/Rth(550)之值。將結果示於表1。 RthC(λ)=((nxC(λ)+nyC(λ))/2-nzC(λ))×dC 再者,RthC(λ)表示波長λnm下之垂直配向液晶硬化膜之膜厚方向之相位差值。又,nxC(λ)表示波長λnm下之垂直配向液晶硬化膜之面內主折射率,nyC(λ)表示波長λnm下之在面內與nxC(λ)正交之方向之折射率,nzC(λ)表示波長λnm下之垂直配向液晶硬化膜之厚度方向之折射率,於nxC(λ)=nyC(λ)之情形時,nxC(λ)可設為膜面內之任意方向之折射率,dC表示垂直配向液晶硬化膜之膜厚。<Measurement of Retardation Value of Vertically Aligned Liquid Crystal Cured Film> Corona treatment was performed on the vertical alignment liquid crystal cured film surface of the laminate including the base material, cured resin layer, and vertical aligned liquid crystal cured film produced by the above procedure, and the TAC film and cured resin layer were peeled off after the 25 μm pressure-sensitive adhesive manufactured by LINTEC was attached to the glass. Using KOBRA-WPR manufactured by Oji Scientific Instruments Co., Ltd. for the obtained laminate including peeling, adhesive, and vertically aligned liquid crystal cured film, the incident angle of light to the sample for measuring optical characteristics was changed, and the front retardation value and the retardation value when it was inclined 40° from the center of the phase advance axis were measured. The average refractive index at each wavelength was measured using an ellipsometer M-220 manufactured by JASCO Corporation. In addition, the film thickness was measured using Optical NanoGauge film thickness meter C12562-01 manufactured by Hamamatsu Photonics Co., Ltd. According to the above front phase difference value, the phase difference value when it is inclined to the center of the phase axis at 40°, the average refractive index, and the value of film thickness, the three-dimensional refractive index is calculated with reference to the technical data of Oji Instruments (http://www.oji-keisoku.co.jp/products/kobra/reference.html). According to the obtained three-dimensional refractive index, the optical properties of the vertically aligned liquid crystal cured film are calculated according to the following formula, and the values of Rth(450), Rth(550), and αth=Rth(450)/Rth(550) are calculated. The results are shown in Table 1. RthC(λ)=((nxC(λ)+nyC(λ))/2-nzC(λ))×dC Furthermore, RthC(λ) represents the retardation value in the film thickness direction of the vertically aligned liquid crystal cured film at a wavelength of λnm. Also, nxC(λ) represents the in-plane principal refractive index of the vertically aligned liquid crystal cured film at a wavelength of λnm, nyC(λ) represents the refractive index in the direction perpendicular to nxC(λ) in the plane at a wavelength of λnm, and nzC(λ) represents the refractive index in the thickness direction of the vertically aligned liquid crystal cured film at a wavelength of λnm. C represents the film thickness of the vertically aligned liquid crystal cured film.

(7)水平配向液晶硬化膜之製作 對於藉由上述方法所製造之包含基材(TAC膜)、硬化樹脂層及垂直配向液晶硬化膜之積層體之垂直配向液晶硬化膜面實施電暈處理,使用棒式塗佈機塗佈水平配向膜形成用組合物,於80℃下乾燥1分鐘。繼而,使用偏光UV照射裝置(SPOT CURE SP-9;牛尾電機股份有限公司製造),以波長313 nm下之累計光量:100 mJ/cm2 實施偏光UV曝光,而獲得水平配向膜。利用橢圓偏光計對所獲得之水平配向膜之膜厚進行測定,結果為200 nm。 繼而,於水平配向膜上塗佈水平配向液晶硬化膜形成用聚合性液晶組合物,於120℃下加熱60秒鐘後,使用高壓水銀燈(UNICURE VB-15201BY-A,牛尾電機股份有限公司製造),自塗佈有水平配向液晶硬化膜形成用聚合性液晶組合物之面照射紫外線(氮氣氛圍下,波長365 nm下之累計光量:500 mJ/cm2 ),藉此形成水平配向液晶硬化膜,獲得將基材、硬化樹脂層、垂直配向液晶硬化膜、水平配向膜、水平配向液晶硬化膜依此順序鄰接地積層而成之積層體。利用橢圓偏光計對所獲得之水平配向液晶硬化膜之膜厚進行測定,結果為1.1 μm。該積層體中之自垂直配向液晶硬化膜之基材側之面至水平配向液晶硬化膜之與水平配向膜為相反側之面的總膜厚T1為1.9 μm。 實施例1中所獲得之積層體係具有基材(TAC膜)/硬化樹脂層/垂直配向液晶硬化膜/水平配向膜/水平配向液晶硬化膜之構成之積層體。(7) Production of horizontal alignment liquid crystal cured film Corona treatment was performed on the surface of the vertical alignment liquid crystal cured film of the laminate comprising the base material (TAC film), cured resin layer, and vertical alignment liquid crystal cured film produced by the above method, and the horizontal alignment film forming composition was coated using a bar coater, and dried at 80° C. for 1 minute. Next, using a polarized UV irradiation device (SPOT CURE SP-9; manufactured by Ushio Electric Co., Ltd.), polarized UV exposure was performed at a wavelength of 313 nm at an integrated light intensity of 100 mJ/cm 2 to obtain a horizontal alignment film. The film thickness of the obtained horizontal alignment film was measured with an ellipsometer, and the result was 200 nm.繼而,於水平配向膜上塗佈水平配向液晶硬化膜形成用聚合性液晶組合物,於120℃下加熱60秒鐘後,使用高壓水銀燈(UNICURE VB-15201BY-A,牛尾電機股份有限公司製造),自塗佈有水平配向液晶硬化膜形成用聚合性液晶組合物之面照射紫外線(氮氣氛圍下,波長365 nm下之累計光量:500 mJ/cm 2 ),藉此形成水平配向液晶硬化膜,獲得將基材、硬化樹脂層、垂直配向液晶硬化膜、水平配向膜、水平配向液晶硬化膜依此順序鄰接地積層而成之積層體。 The film thickness of the obtained horizontally aligned liquid crystal cured film was measured with an ellipsometer, and it was 1.1 μm. In this laminate, the total film thickness T1 from the substrate-side surface of the vertical alignment cured liquid crystal film to the surface of the horizontal alignment cured liquid crystal film opposite to the horizontal alignment film was 1.9 μm. The laminated system obtained in Example 1 has a laminate composed of substrate (TAC film)/cured resin layer/vertical alignment liquid crystal cured film/horizontal alignment film/horizontal aligned liquid crystal cured film.

<水平配向液晶硬化膜之相位差值測定> 對於上述包含基材、硬化樹脂層、垂直配向液晶硬化膜、水平配向膜、水平配向液晶硬化膜之積層體之水平配向液晶硬化膜面實施電暈處理,經由LINTEC公司製造之25 μm感壓式黏著劑貼合至玻璃後,剝離TAC膜及硬化樹脂層。對於所獲得之包含剝離、黏著劑、垂直配向液晶硬化膜、水平配向膜、水平配向液晶硬化膜之積層體,使用王子計測機器股份有限公司製造之KOBRA-WPR進行測定,自所測得之Re(450)、Re(550)之值減去預先利用上述方法所測得之垂直配向液晶硬化膜之Re(450)、Re(550),算出水平配向液晶硬化膜之ReA(450)、ReA(550),進而算出αA=ReA(450)/ReA(550)。將結果示於表1。<Measurement of Retardation Value of Horizontally Aligned Liquid Crystal Cured Film> Corona treatment was performed on the surface of the horizontal alignment liquid crystal cured film of the above-mentioned laminate including the substrate, cured resin layer, vertical alignment liquid crystal cured film, horizontal alignment film, and horizontal aligned liquid crystal cured film, and the TAC film and cured resin layer were peeled off after the 25 μm pressure-sensitive adhesive manufactured by LINTEC was bonded to the glass. For the obtained laminate including peeling, adhesive, vertical alignment liquid crystal cured film, horizontal alignment film, and horizontal alignment liquid crystal cured film, use KOBRA-WPR manufactured by Oji Scientific Instruments Co., Ltd. to measure, and subtract the Re (450) and Re (550) of the vertical alignment liquid crystal cured film measured in advance from the measured values of Re (450) and Re (550) to calculate the ReA (450) and ReA of the horizontal alignment liquid crystal cured film. (550), and further calculate αA=ReA(450)/ReA(550). The results are shown in Table 1.

(8)積層體之評價 <積層體之配向性評價> 將所獲得之積層體經由LINTEC公司製造之感壓式黏著劑(25 μm)貼合於5×5 cm×厚度0.7 mm之玻璃,僅剝離基材。對於所獲得之樣本,使用偏光顯微鏡(Olympus股份有限公司製造之「BX-51」),於倍率200倍之條件下進行觀察,計數視野480 μm×320 μm中之配向缺陷數。此處,作為配向缺陷數,僅計數起因於測定用樣本之配向缺陷,起因於樣本以外之環境異物等之缺陷數除外,不進行計數。根據利用偏光顯微鏡之觀察結果,基於以下之評價基準評價積層體之配向性。若為〇,則判斷為配向性優異,若為△,則判斷為不會對光學特性造成影響之程度之配向性。將結果示於表1。 評價基準: ○(非常良好):配向缺陷數為0個以上且5個以下。 △(良好):配向缺陷數為6個以上且20個以下。 ×(較差):配向缺陷數為21個以上,或者完全未配向。(8) Evaluation of laminated body <Orientation evaluation of laminates> The obtained laminate was bonded to a glass of 5×5 cm×0.7 mm in thickness with a pressure-sensitive adhesive (25 μm) manufactured by LINTEC, and only the substrate was peeled off. The obtained sample was observed at a magnification of 200 times using a polarizing microscope (“BX-51” manufactured by Olympus Co., Ltd.), and the number of alignment defects in a field of view of 480 μm×320 μm was counted. Here, as the number of alignment defects, only the alignment defects caused by the sample for measurement were counted, and the number of defects caused by environmental foreign matter other than the sample was not counted, except for the number of defects. Based on the results of observation with a polarizing microscope, the alignment of the laminate was evaluated based on the following evaluation criteria. If it is 0, it is judged that the alignment property is excellent, and if it is △, it is judged that it is the degree of alignment which does not affect the optical characteristic. The results are shown in Table 1. Evaluation criteria: ○ (very good): The number of alignment defects is 0 or more and 5 or less. Δ (good): The number of alignment defects is 6 or more and 20 or less. × (poor): The number of alignment defects is 21 or more, or there is no alignment at all.

<積層體之密接性試驗> 以JIS K5600-5-6之附著性試驗(十字切割法)為參照,以下述方式實施積層體之密接性試驗。首先,將積層體之水平配向液晶硬化膜側與5×5 cm×厚度0.7 mm之玻璃經由LINTEC公司製造之感壓式黏著劑(25 μm)進行貼合,自積層體僅剝離基材。於所獲得之樣本之積層體側利用切割器製作100塊量之1 mm□之切口。於所獲得之100塊之切口之上貼合Sellotape(註冊商標)(米其邦公司製造),剝離Sellotape後,確認於積層體中之層間所剝離之塊數,並以下述基準判定密接性。將結果示於表1。 評價基準: 〇:Sellotape剝離後,積層體中之層間所剝離之塊數未達30塊。 △:Sellotape剝離後,積層體中之層間所剝離之塊數為30塊以上59塊以下。 ×:Sellotape剝離後,積層體中之層間所剝離之塊數為60塊以上。<Adhesive test of laminated body> With reference to the adhesion test (cross-cut method) of JIS K5600-5-6, the adhesion test of the laminate was carried out in the following manner. First, the horizontal alignment liquid crystal cured film side of the laminate was bonded to glass of 5 x 5 cm x thickness 0.7 mm through a pressure-sensitive adhesive (25 μm) manufactured by LINTEC, and only the substrate was peeled off from the laminate. Incisions of 1 mm□ for 100 pieces were made with a cutter on the laminated body side of the obtained sample. Sellotape (registered trademark) (manufactured by Michbon Corporation) was attached to the cuts of the obtained 100 pieces, and after the Sellotape was peeled off, the number of pieces peeled between the layers in the laminate was confirmed, and the adhesion was judged according to the following criteria. The results are shown in Table 1. Evaluation criteria: 〇: After the Sellotape was peeled off, the number of pieces peeled between the layers in the laminate was less than 30 pieces. △: After Sellotape peeling, the number of peeled pieces between the layers in the laminate is 30 to 59 pieces. ×: After the Sellotape was peeled off, the number of pieces peeled between the layers in the laminate was 60 or more.

2.實施例2 將水平配向液晶硬化膜形成用聚合性液晶組合物之製備、及水平配向液晶硬化膜之形成如下述般變更,除此以外,以與實施例1相同之方式製作將基材、硬化樹脂層、垂直配向液晶硬化膜、水平配向膜及水平配向液晶硬化膜依序鄰接積層而成之積層體,實施積層體之密接性及配向性評價。將結果示於表1。2. Embodiment 2 The preparation of the polymerizable liquid crystal composition for forming the horizontally aligned liquid crystal cured film and the formation of the horizontally aligned liquid crystal cured film were changed as follows. In the same manner as in Example 1, a laminate in which the base material, the cured resin layer, the vertically aligned liquid crystal cured film, the horizontally aligned film, and the horizontally aligned liquid crystal cured film were sequentially laminated was prepared, and the adhesion and alignment of the laminate were evaluated. The results are shown in Table 1.

(1)水平配向液晶硬化膜形成用聚合性液晶組合物之製備 將聚合性液晶化合物(X1)及聚合性液晶化合物(X2)以質量比90:10進行混合而獲得混合物。相對於所獲得之混合物100質量份,添加調平劑「BYK-361N」(BM Chemie公司製造)0.1質量份、及作為光聚合起始劑之2-二甲基胺基-2-苄基-1-(4-𠰌啉基苯基)丁烷-1-酮(BASF Japan股份有限公司製造之「Irgacure(註冊商標)369(Irg 369)」)6質量份。進而,以固形物成分濃度成為13%之方式添加N-甲基-2-吡咯啶酮(NMP)。藉由將該混合物於80℃下攪拌1小時,而獲得水平配向液晶硬化膜形成用聚合性液晶組合物。(1) Preparation of a polymerizable liquid crystal composition for forming a horizontal alignment liquid crystal cured film The polymerizable liquid crystal compound (X1) and the polymerizable liquid crystal compound (X2) were mixed at a mass ratio of 90:10 to obtain a mixture. With respect to 100 parts by mass of the obtained mixture, 0.1 part by mass of a leveling agent "BYK-361N" (manufactured by BM Chemie) and 6 parts by mass of 2-dimethylamino-2-benzyl-1-(4-?olinylphenyl)butan-1-one (manufactured by BASF Japan Co., Ltd. "Irgacure (registered trademark) 369 (Irg 369)") as a photopolymerization initiator were added. Furthermore, N-methyl-2-pyrrolidone (NMP) was added so that the solid content concentration might become 13%. By stirring this mixture at 80 degreeC for 1 hour, the polymeric liquid crystal composition for horizontal alignment liquid crystal cured film formation was obtained.

(2)水平配向液晶硬化膜之形成 對於以與實施例1相同之程序所製作之包含基材(TAC膜)、硬化樹脂層、垂直配向液晶硬化膜之積層體之垂直配向液晶硬化膜面實施電暈處理,使用棒式塗佈機塗佈水平配向膜形成用組合物,於80℃下乾燥1分鐘。繼而,使用偏光UV照射裝置(SPOT CURE SP-9;牛尾電機股份有限公司製造),以波長313 nm下之累計光量:100 mJ/cm2 實施偏光UV曝光,而獲得水平配向膜。利用橢圓偏光計對所獲得之水平配向膜之膜厚進行測定,結果為200 nm。 繼而,於水平配向膜上塗佈水平配向液晶硬化膜形成用聚合性液晶組合物,於120℃下加熱60秒鐘後,使用高壓水銀燈(UNICURE VB-15201BY-A,牛尾電機股份有限公司製造),自塗佈有水平配向液晶硬化膜形成用聚合性液晶組合物之面照射紫外線(氮氣氛圍下,波長365 nm下之累計光量:500 mJ/cm2 ),藉此形成水平配向液晶硬化膜,獲得將基材、硬化樹脂層、垂直配向液晶硬化膜、水平配向膜、水平配向液晶硬化膜依序鄰接積層而成之積層體。利用橢圓偏光計對所獲得之水平配向液晶硬化膜之膜厚進行測定,結果為2.2 μm。(2) Formation of horizontal alignment liquid crystal cured film Corona treatment was performed on the surface of the vertical alignment liquid crystal cured film of the laminate of the base material (TAC film), cured resin layer, and vertical alignment liquid crystal cured film produced by the same procedure as in Example 1, and the composition for forming a horizontal alignment film was coated with a bar coater, and dried at 80° C. for 1 minute. Next, using a polarized UV irradiation device (SPOT CURE SP-9; manufactured by Ushio Electric Co., Ltd.), polarized UV exposure was performed at a wavelength of 313 nm at an integrated light intensity of 100 mJ/cm 2 to obtain a horizontal alignment film. The film thickness of the obtained horizontal alignment film was measured with an ellipsometer, and the result was 200 nm.繼而,於水平配向膜上塗佈水平配向液晶硬化膜形成用聚合性液晶組合物,於120℃下加熱60秒鐘後,使用高壓水銀燈(UNICURE VB-15201BY-A,牛尾電機股份有限公司製造),自塗佈有水平配向液晶硬化膜形成用聚合性液晶組合物之面照射紫外線(氮氣氛圍下,波長365 nm下之累計光量:500 mJ/cm 2 ),藉此形成水平配向液晶硬化膜,獲得將基材、硬化樹脂層、垂直配向液晶硬化膜、水平配向膜、水平配向液晶硬化膜依序鄰接積層而成之積層體。 The film thickness of the obtained horizontally aligned liquid crystal cured film was measured with an ellipsometer and found to be 2.2 μm.

3.實施例3 將垂直配向液晶硬化膜形成用聚合性液晶組合物之製備及垂直配向液晶硬化膜之形成如下述般變更,除此以外,以與實施例2相同之方式製作將基材、硬化樹脂層、垂直配向液晶硬化膜、水平配向膜及水平配向液晶硬化膜依序鄰接積層而成之積層體,實施積層體之密接性及配向性評價。將結果示於表1。3. Embodiment 3 The preparation of the polymerizable liquid crystal composition for forming a vertically aligned liquid crystal cured film and the formation of the vertically aligned liquid crystal cured film were changed as follows. In the same manner as in Example 2, a laminate in which a base material, a cured resin layer, a vertically aligned liquid crystal cured film, a horizontally aligned film, and a horizontally aligned liquid crystal cured film were sequentially laminated was produced, and the adhesion and alignment of the laminate were evaluated. The results are shown in Table 1.

(1)垂直配向液晶硬化膜形成用聚合性液晶組合物之製備 將聚合性液晶化合物(X1)及聚合性液晶化合物(X2)以質量比90:10進行混合而獲得混合物。相對於所獲得之混合物100質量份,添加調平劑「F-556」(DIC公司製造)0.25質量份、以日本專利特願2016-514802號公報為參照所製備之離子性化合物A(分子量:645)2.0質量份、矽烷偶合劑「KBE-9103」(信越化學工業股份有限公司製造)0.5質量份、作為光聚合起始劑之2-二甲基胺基-2-苄基-1-(4-𠰌啉基苯基)丁烷-1-酮(BASF Japan股份有限公司製造之「Irgacure(註冊商標)369(Irg 369)」)6質量份。進而,以固形物成分濃度成為13%之方式添加N-甲基-2-吡咯啶酮(NMP)。藉由將該混合物於80℃下攪拌1小時,而獲得垂直配向液晶硬化膜形成用聚合性液晶組合物。(1) Preparation of a polymerizable liquid crystal composition for forming a vertical alignment liquid crystal cured film The polymerizable liquid crystal compound (X1) and the polymerizable liquid crystal compound (X2) were mixed at a mass ratio of 90:10 to obtain a mixture. With respect to 100 parts by mass of the obtained mixture, 0.25 parts by mass of leveling agent "F-556" (manufactured by DIC Corporation), 2.0 parts by mass of ionic compound A (molecular weight: 645) prepared with reference to Japanese Patent Application No. 2016-514802, 0.5 parts by mass of silane coupling agent "KBE-9103" (manufactured by Shin-Etsu Chemical Co., Ltd.), and 2-dimethylamino-2-benzyl as a photopolymerization initiator were added. 6 parts by mass of 1-(4-?olinylphenyl)butan-1-one ("Irgacure (registered trademark) 369 (Irg 369)" manufactured by BASF Japan Co., Ltd.). Furthermore, N-methyl-2-pyrrolidone (NMP) was added so that the solid content concentration might become 13%. By stirring this mixture at 80 degreeC for 1 hour, the polymeric liquid crystal composition for vertical alignment liquid crystal cured film formation was obtained.

(2)垂直配向液晶硬化膜之製作 於以與實施例1相同之程序所製作之基材上之硬化樹脂層上,使用棒式塗佈機塗佈垂直配向液晶硬化膜形成用聚合性液晶組合物,於120℃下加熱60秒鐘後,使用高壓水銀燈(UNICURE VB-15201BY-A,牛尾電機股份有限公司製造),自塗佈有垂直配向液晶硬化膜形成用聚合性液晶組合物之面照射紫外線(氮氣氛圍下,波長365 nm下之累計光量:500 mJ/cm2 ),藉此形成垂直配向液晶硬化膜。利用橢圓偏光計(日本分光股份有限公司製造之M-220)對所獲得之垂直配向液晶硬化膜之膜厚進行測定,結果為1.2 μm。(2) Production of Vertical Alignment Liquid Crystal Cured Film On the cured resin layer on the base material prepared by the same procedure as in Example 1, a bar coater was used to coat the polymerizable liquid crystal composition for forming a vertical alignment liquid crystal cured film, and after heating at 120° C. for 60 seconds, a high-pressure mercury lamp (UNICURE VB-15201BY-A, manufactured by Ushio Electric Co., Ltd.) was used to irradiate ultraviolet rays (under a nitrogen atmosphere, wavelength 36 Cumulative light intensity at 5 nm: 500 mJ/cm 2 ), thereby forming a vertically aligned liquid crystal cured film. The film thickness of the obtained vertically aligned liquid crystal cured film was measured with an ellipsometer (M-220 manufactured by JASCO Corporation), and it was 1.2 μm.

4.實施例4 將水平配向液晶硬化膜之形成如下述般變更,除此以外,以與實施例3相同之方式製作將基材、硬化樹脂層、垂直配向液晶硬化膜、硬化樹脂層、水平配向膜及水平配向液晶硬化膜依序鄰接積層而成之積層體,實施積層體之密接性及配向性評價。將結果示於表1。4. Embodiment 4 The formation of the horizontal alignment liquid crystal cured film was changed as follows, except that, in the same manner as in Example 3, a laminate in which the base material, the cured resin layer, the vertical alignment liquid crystal cured film, the cured resin layer, the horizontal alignment film, and the horizontal alignment liquid crystal cured film were sequentially laminated was produced, and the adhesiveness and alignment of the laminate were evaluated. The results are shown in Table 1.

(1)水平配向液晶硬化膜之形成 使二季戊四醇六丙烯酸酯(ARONIX M-403 東亞合成股份有限公司製造之多官能丙烯酸酯)50質量份、丙烯酸酯樹脂(Ebecryl 4858 Daicel-UCB股份有限公司製造)50質量份、2-甲基-1[4-(甲硫基)苯基]-2-𠰌啉基丙烷-1-酮(Irgacure 907;Ciba Specialty Chemicals公司製造)3質量份溶解於異丙醇250質量份中,製備溶液,獲得含有丙烯酸酯化合物而成之硬化樹脂層形成用組合物。 繼而,對於包含基材(TAC膜)、硬化樹脂層、垂直配向液晶硬化膜之積層體之垂直配向液晶硬化膜面實施電暈處理,利用棒式塗佈機塗佈硬化樹脂層形成用組合物,於50℃下乾燥1分鐘。其後,使用高壓水銀燈(「UNICURE VB-15201BY-A」,牛尾電機股份有限公司製造),照射紫外線(氮氣氛圍下,波長365 nm下之累計光量:400 mJ/cm2 ),藉此形成硬化樹脂層。利用接觸式膜厚計對所獲得之硬化樹脂層之膜厚進行測定,結果為2.0 μm。 繼而,對於處於藉由上述方法所製作之包含基材(TAC膜)、硬化樹脂層、垂直配向液晶硬化膜、硬化樹脂層之積層體之最外層的硬化樹脂層面實施電暈處理,使用棒式塗佈機塗佈水平配向膜形成用組合物,於80℃下乾燥1分鐘。繼而,使用偏光UV照射裝置(SPOT CURE SP-9;牛尾電機股份有限公司製造),以波長313 nm下之累計光量:100 mJ/cm2 實施偏光UV曝光,獲得水平配向膜。利用橢圓偏光計對所獲得之水平配向膜之膜厚進行測定,結果為200 nm。 繼而,於水平配向膜上塗佈水平配向液晶硬化膜形成用聚合性液晶組合物,於120℃下加熱60秒鐘後,使用高壓水銀燈(UNICURE VB-15201BY-A,牛尾電機股份有限公司製造),自塗佈有水平配向液晶硬化膜形成用聚合性液晶組合物之面照射紫外線(氮氣氛圍下,波長365 nm下之累計光量:500 mJ/cm2 ),藉此形成水平配向液晶硬化膜,獲得將基材、垂直配向液晶硬化膜、水平配向膜、水平配向液晶硬化膜依序鄰接積層而成之積層體。利用橢圓偏光計對所獲得之水平配向液晶硬化膜之膜厚進行測定,結果為2.2 μm。(1) Formation of the horizontally aligned liquid crystal cured film: 50 parts by mass of dipentaerythritol hexaacrylate (ARONIX M-403 multifunctional acrylate manufactured by Toa Gosei Co., Ltd.), 50 parts by mass of acrylate resin (Ebecryl 4858 manufactured by Daicel-UCB Co., Ltd.), 2-methyl-1[4-(methylthio)phenyl]-2-𠰌linylpropan-1-one (Irgacure 907; Ciba Spec Alty Chemicals) 3 parts by mass were dissolved in 250 parts by mass of isopropyl alcohol to prepare a solution to obtain a composition for forming a cured resin layer containing an acrylate compound. Next, corona treatment was performed on the surface of the vertical alignment liquid crystal cured film of the laminate including the substrate (TAC film), the cured resin layer, and the vertical alignment liquid crystal cured film, and the composition for forming the cured resin layer was coated with a bar coater, and dried at 50° C. for 1 minute. Thereafter, a cured resin layer was formed by irradiating ultraviolet rays (accumulated light intensity at a wavelength of 365 nm in a nitrogen atmosphere: 400 mJ/cm 2 ) using a high-pressure mercury lamp ("UNICURE VB-15201BY-A", manufactured by Ushio Electric Co., Ltd.). The film thickness of the obtained cured resin layer was measured with a contact film thickness gauge, and it was 2.0 μm. Next, corona treatment was performed on the cured resin layer which is the outermost layer of the laminate comprising the substrate (TAC film), cured resin layer, vertically aligned liquid crystal cured film, and cured resin layer produced by the above method, and the composition for forming a horizontal alignment film was coated using a bar coater, and dried at 80° C. for 1 minute. Next, using a polarized UV irradiation device (SPOT CURE SP-9; manufactured by Ushio Electric Co., Ltd.), polarized UV exposure was performed at a wavelength of 313 nm at an integrated light intensity of 100 mJ/cm 2 to obtain a horizontal alignment film. The film thickness of the obtained horizontal alignment film was measured with an ellipsometer, and the result was 200 nm.繼而,於水平配向膜上塗佈水平配向液晶硬化膜形成用聚合性液晶組合物,於120℃下加熱60秒鐘後,使用高壓水銀燈(UNICURE VB-15201BY-A,牛尾電機股份有限公司製造),自塗佈有水平配向液晶硬化膜形成用聚合性液晶組合物之面照射紫外線(氮氣氛圍下,波長365 nm下之累計光量:500 mJ/cm 2 ),藉此形成水平配向液晶硬化膜,獲得將基材、垂直配向液晶硬化膜、水平配向膜、水平配向液晶硬化膜依序鄰接積層而成之積層體。 The film thickness of the obtained horizontally aligned liquid crystal cured film was measured with an ellipsometer and found to be 2.2 μm.

5.實施例5 如下述般變更垂直配向液晶硬化膜之製作方法,除此以外,以與實施例3相同之方式製作將基材、垂直配向液晶硬化膜、水平配向膜及水平配向液晶硬化膜依序鄰接積層而成之積層體,實施積層體之密接性及配向性評價。將結果示於表1。5. Embodiment 5 The production method of the vertically aligned liquid crystal cured film was changed as follows, except that, in the same manner as in Example 3, a laminate in which the base material, the vertically aligned liquid crystal cured film, the horizontally aligned liquid crystal film, and the horizontally aligned liquid crystal cured film were sequentially adjacently laminated was produced, and the adhesiveness and alignment of the laminated body were evaluated. The results are shown in Table 1.

(1)垂直配向液晶硬化膜之製作: 對於日本ZEON股份有限公司製造之COP膜(ZF14-23)實施電暈處理後,使用棒式塗佈機塗佈垂直配向液晶硬化膜形成用聚合性液晶組合物,於120℃下加熱60秒鐘。繼而,於加熱至120℃之狀態下使用高壓水銀燈(UNICURE VB-15201BY-A,牛尾電機股份有限公司製造),自塗佈有垂直配向液晶硬化膜形成用聚合性液晶組合物之面照射紫外線(氮氣氛圍下,波長365 nm下之累計光量:500 mJ/cm2 ),藉此形成垂直配向液晶硬化膜,獲得將基材及垂直配向液晶硬化膜依序鄰接積層而成之積層體。利用橢圓偏光計(日本分光股份有限公司製造之M-220)對所獲得之垂直配向液晶硬化膜之膜厚進行測定,結果為1.2 μm。(1) Production of vertically aligned liquid crystal cured film: After corona treatment was performed on the COP film (ZF14-23) manufactured by Japan ZEON Co., Ltd., a polymerizable liquid crystal composition for forming a vertically aligned liquid crystal cured film was coated with a bar coater, and heated at 120° C. for 60 seconds. Next, while heating to 120°C, using a high-pressure mercury lamp (UNICURE VB-15201BY-A, manufactured by Ushio Electric Co., Ltd.), irradiate ultraviolet rays (accumulated light intensity at a wavelength of 365 nm in a nitrogen atmosphere: 500 mJ/cm 2 ) from the surface coated with the polymerizable liquid crystal composition for forming a vertically aligned liquid crystal cured film to form a vertically aligned liquid crystal cured film. laminated body. The film thickness of the obtained vertically aligned liquid crystal cured film was measured with an ellipsometer (M-220 manufactured by JASCO Corporation), and it was 1.2 μm.

6.實施例6 將基材之準備如下述變更,除此以外,以與實施例3相同之方式製作將基材、硬化樹脂層、垂直配向液晶硬化膜、水平配向膜及水平配向液晶硬化膜依序鄰接積層而成之積層體,實施積層體之密接性及配向性評價。將結果示於表1。6. Embodiment 6 The preparation of the base material was changed as follows, except that, in the same manner as in Example 3, a laminate in which the base material, the cured resin layer, the vertical alignment liquid crystal cured film, the horizontal alignment film, and the horizontal alignment liquid crystal cured film were successively laminated was produced, and the adhesiveness and alignment of the laminate were evaluated. The results are shown in Table 1.

(1)基材之準備 使二季戊四醇六丙烯酸酯(ARONIX M-403 東亞合成股份有限公司製造之多官能丙烯酸酯)50質量份、丙烯酸酯樹脂(Ebecryl 4858 Daicel-UCB股份有限公司製造)50質量份、2-甲基-1[4-(甲硫基)苯基]-2-𠰌啉基丙烷-1-酮(Irgacure 907;Ciba Specialty Chemicals公司製造)3質量份溶解於異丙醇250質量份中,製備溶液,而獲得含有丙烯酸酯化合物而成之硬化樹脂層形成用組合物。 繼而,於三菱樹脂股份有限公司製造之PET膜(DIAFOIL T140E25)上,利用棒式塗佈機塗佈硬化樹脂層形成用組合物,於50℃下乾燥1分鐘後,使用高壓水銀燈(「UNICURE VB-15201BY-A」,牛尾電機股份有限公司製造),照射紫外線(氮氣氛圍下,波長365 nm下之累計光量:400 mJ/cm2 ),藉此形成硬化樹脂層。利用接觸式膜厚計對所獲得之硬化樹脂層之膜厚進行測定,結果為2.0 μm。(1) Preparation of base material 50 parts by mass of dipentaerythritol hexaacrylate (ARONIX M-403 multifunctional acrylate manufactured by Toa Gosei Co., Ltd.), 50 parts by mass of acrylate resin (Ebecryl 4858 manufactured by Daicel-UCB Co., Ltd.), 2-methyl-1[4-(methylthio)phenyl]-2-𠰌linylpropan-1-one (Irgacure 907; Ciba Specialty Chemical s company) 3 parts by mass were dissolved in 250 parts by mass of isopropyl alcohol to prepare a solution to obtain a composition for forming a cured resin layer containing an acrylate compound. Next, on a PET film (DIAFOIL T140E25) manufactured by Mitsubishi Plastics Co., Ltd., the composition for forming a cured resin layer was coated with a bar coater, dried at 50°C for 1 minute, and then irradiated with ultraviolet light (accumulated light intensity at a wavelength of 365 nm in a nitrogen atmosphere: 400 mJ/cm 2 ) using a high-pressure mercury lamp ("UNICURE VB-15201BY-A", manufactured by Ushio Electric Co., Ltd.) to form a cured resin. layers. The film thickness of the obtained cured resin layer was measured with a contact film thickness gauge, and it was 2.0 μm.

7.實施例7 將水平配向膜之膜厚變更為30 nm,除此以外,以與實施例5相同之方式製作將基材、垂直配向液晶硬化膜、水平配向膜及水平配向液晶硬化膜依序鄰接積層而成之積層體,實施積層體之密接性及配向性評價。將結果示於表1。7. Embodiment 7 The film thickness of the horizontal alignment film was changed to 30 nm. In the same manner as in Example 5, a laminate was produced in which the base material, the vertically aligned liquid crystal cured film, the horizontal alignment film, and the horizontally aligned liquid crystal cured film were sequentially laminated, and the adhesiveness and alignment of the laminate were evaluated. The results are shown in Table 1.

8.實施例8 將水平配向膜之膜厚變更為500 nm,除此以外,以與實施例5相同之方式製作將基材、垂直配向液晶硬化膜、水平配向膜及水平配向液晶硬化膜依序鄰接積層而成之積層體,實施積層體之密接性及配向性評價。將結果示於表1。8. Embodiment 8 The film thickness of the horizontal alignment film was changed to 500 nm. In the same manner as in Example 5, a laminate was produced in which the base material, the vertical alignment liquid crystal cured film, the horizontal alignment film, and the horizontal alignment liquid crystal cured film were adjacently laminated in sequence, and the adhesiveness and alignment of the laminate were evaluated. The results are shown in Table 1.

9.實施例9 將垂直配向液晶硬化膜形成用聚合性液晶組合物之製備如下述般變更,除此以外,以與實施例5相同之方式製作將基材、垂直配向液晶硬化膜、水平配向膜及水平配向液晶硬化膜依序鄰接積層而成之積層體,實施積層體之密接性及配向性評價。將結果示於表1。9. Embodiment 9 The preparation of the polymerizable liquid crystal composition for forming a vertically aligned liquid crystal cured film was changed as follows, except that, in the same manner as in Example 5, a laminate in which a substrate, a vertically aligned liquid crystal cured film, a horizontally aligned film, and a horizontally aligned liquid crystal cured film were sequentially adjacently laminated was produced, and the adhesiveness and alignment of the laminated body were evaluated. The results are shown in Table 1.

(1)垂直配向液晶硬化膜形成用聚合性液晶組合物之製備 將聚合性液晶化合物(X1)及聚合性液晶化合物(X2)以質量比90:10進行混合而獲得混合物。相對於所獲得之混合物100質量份,添加調平劑「F-556」(DIC公司製造)0.25質量份、以日本專利特願2016-514802號公報為參照所製備之離子性化合物A(分子量:645)2.0質量份、作為光聚合起始劑之2-二甲基胺基-2-苄基-1-(4-𠰌啉基苯基)丁烷-1-酮(BASF Japan股份有限公司製造之「Irgacure(註冊商標)369(Irg 369)」)6質量份。進而,以固形物成分濃度成為13%之方式添加N-甲基-2-吡咯啶酮(NMP)。將該混合物於80℃下攪拌1小時,藉此獲得垂直配向液晶硬化膜形成用聚合性液晶組合物。(1) Preparation of a polymerizable liquid crystal composition for forming a vertical alignment liquid crystal cured film The polymerizable liquid crystal compound (X1) and the polymerizable liquid crystal compound (X2) were mixed at a mass ratio of 90:10 to obtain a mixture. With respect to 100 parts by mass of the obtained mixture, 0.25 parts by mass of leveling agent "F-556" (manufactured by DIC Corporation), 2.0 parts by mass of ionic compound A (molecular weight: 645) prepared with reference to Japanese Patent Application No. 2016-514802, and 2-dimethylamino-2-benzyl-1-(4-? "Irgacure (registered trademark) 369 (Irg 369)" manufactured by Co., Ltd.) 6 parts by mass. Furthermore, N-methyl-2-pyrrolidone (NMP) was added so that the solid content concentration might become 13%. This mixture was stirred at 80 degreeC for 1 hour, and the polymerizable liquid crystal composition for vertical alignment liquid crystal cured film formation was obtained.

10.實施例10 將垂直配向液晶硬化膜形成用聚合性液晶組合物之製備如下述般變更,除此以外,以與實施例5相同之方式製作將基材、垂直配向液晶硬化膜、水平配向膜及水平配向液晶硬化膜依序鄰接積層而成之積層體,實施積層體之密接性及配向性評價。將結果示於表1。10. Example 10 The preparation of the polymerizable liquid crystal composition for forming a vertically aligned liquid crystal cured film was changed as follows, except that, in the same manner as in Example 5, a laminate in which a substrate, a vertically aligned liquid crystal cured film, a horizontally aligned film, and a horizontally aligned liquid crystal cured film were sequentially adjacently laminated was produced, and the adhesiveness and alignment of the laminated body were evaluated. The results are shown in Table 1.

(1)垂直配向液晶硬化膜形成用聚合性液晶組合物之製備 將聚合性液晶化合物(X1)及聚合性液晶化合物(X2)以質量比90:10進行混合而獲得混合物。相對於所獲得之混合物100質量份,添加調平劑「F-556」(DIC公司製造)0.25質量份、矽烷偶合劑「KBE-9103」(信越化學工業股份有限公司製造)0.5質量份、作為光聚合起始劑之2-二甲基胺基-2-苄基-1-(4-𠰌啉基苯基)丁烷-1-酮(BASF Japan股份有限公司製造之「Irgacure(註冊商標)369(Irg369)」)6質量份。進而,以固形物成分濃度成為13%之方式添加N-甲基-2-吡咯啶酮(NMP)。將該混合物於80℃下攪拌1小時,藉此獲得垂直配向液晶硬化膜形成用聚合性液晶組合物。(1) Preparation of a polymerizable liquid crystal composition for forming a vertical alignment liquid crystal cured film The polymerizable liquid crystal compound (X1) and the polymerizable liquid crystal compound (X2) were mixed at a mass ratio of 90:10 to obtain a mixture. With respect to 100 parts by mass of the obtained mixture, 0.25 parts by mass of a leveling agent "F-556" (manufactured by DIC Corporation), 0.5 parts by mass of a silane coupling agent "KBE-9103" (manufactured by Shin-Etsu Chemical Co., Ltd.), and 2-dimethylamino-2-benzyl-1-(4-? 369 (Irg369)") 6 parts by mass. Furthermore, N-methyl-2-pyrrolidone (NMP) was added so that the solid content concentration might become 13%. This mixture was stirred at 80 degreeC for 1 hour, and the polymerizable liquid crystal composition for vertical alignment liquid crystal cured film formation was obtained.

11.比較例1 將垂直配向液晶硬化膜形成用聚合性液晶組合物之製備如下述般變更,除此以外,以與實施例5相同之方式製作將基材、垂直配向液晶硬化膜、水平配向膜及水平配向液晶硬化膜依序鄰接積層而成之積層體,實施積層體之密接性及配向性評價。將結果示於表1。11. Comparative example 1 The preparation of the polymerizable liquid crystal composition for forming a vertically aligned liquid crystal cured film was changed as follows, except that, in the same manner as in Example 5, a laminate in which a substrate, a vertically aligned liquid crystal cured film, a horizontally aligned film, and a horizontally aligned liquid crystal cured film were sequentially adjacently laminated was produced, and the adhesiveness and alignment of the laminated body were evaluated. The results are shown in Table 1.

(1)垂直配向液晶硬化膜形成用聚合性液晶組合物之製備 將聚合性液晶化合物(X1)及聚合性液晶化合物(X2)以質量比90:10進行混合而獲得混合物。相對於所獲得之混合物100質量份,添加調平劑「F-556」(DIC公司製造)0.25質量份、作為光聚合起始劑之2-二甲基胺基-2-苄基-1-(4-𠰌啉基苯基)丁烷-1-酮(BASF Japan股份有限公司製造之「Irgacure(註冊商標)369(Irg 369)」)6質量份。進而,以固形物成分濃度成為13%之方式添加N-甲基-2-吡咯啶酮(NMP)。將該混合物於80℃下攪拌1小時,藉此獲得垂直配向液晶硬化膜形成用聚合性液晶組合物。(1) Preparation of a polymerizable liquid crystal composition for forming a vertical alignment liquid crystal cured film The polymerizable liquid crystal compound (X1) and the polymerizable liquid crystal compound (X2) were mixed at a mass ratio of 90:10 to obtain a mixture. With respect to 100 parts by mass of the obtained mixture, 0.25 parts by mass of a leveling agent "F-556" (manufactured by DIC Corporation) and 6 parts by mass of 2-dimethylamino-2-benzyl-1-(4-alphalinylphenyl)butan-1-one (manufactured by BASF Japan Co., Ltd. "Irgacure (registered trademark) 369 (Irg 369)") as a photopolymerization initiator were added. Furthermore, N-methyl-2-pyrrolidone (NMP) was added so that the solid content concentration might become 13%. This mixture was stirred at 80 degreeC for 1 hour, and the polymerizable liquid crystal composition for vertical alignment liquid crystal cured film formation was obtained.

12.比較例2 將水平配向液晶硬化膜之製造步驟如下述般變更,除此以外,以與實施例5相同之方式製作將基材、垂直配向液晶硬化膜、水平配向膜及水平配向液晶硬化膜依序鄰接積層而成之積層體,實施積層體之密接性及配向性評價。將結果示於表1。12. Comparative example 2 The manufacturing steps of the horizontally aligned liquid crystal cured film were changed as follows, except that, in the same manner as in Example 5, a laminate in which the base material, the vertically aligned liquid crystal cured film, the horizontally aligned film, and the horizontally aligned liquid crystal cured film were sequentially adjacently laminated was produced, and the adhesiveness and alignment of the laminated body were evaluated. The results are shown in Table 1.

(1)水平配向液晶硬化膜形成用聚合性液晶組合物之製備 將聚合性液晶化合物(X1)及聚合性液晶化合物(X2)以質量比90:10進行混合而獲得混合物。相對於所獲得之混合物100質量份,添加調平劑「BYK-361N」(BM Chemie公司製造)0.1質量份、作為光聚合起始劑之2-二甲基胺基-2-苄基-1-(4-𠰌啉基苯基)丁烷-1-酮(BASF Japan股份有限公司製造之「Irgacure(註冊商標)369(Irg 369)」)6質量份。進而,以固形物成分濃度成為13%之方式添加環戊酮。將該混合物於80℃下攪拌1小時,藉此獲得水平配向液晶硬化膜形成用聚合性液晶組合物。(1) Preparation of a polymerizable liquid crystal composition for forming a horizontal alignment liquid crystal cured film The polymerizable liquid crystal compound (X1) and the polymerizable liquid crystal compound (X2) were mixed at a mass ratio of 90:10 to obtain a mixture. With respect to 100 parts by mass of the obtained mixture, 0.1 part by mass of a leveling agent "BYK-361N" (manufactured by BM Chemie Co., Ltd.) and 6 parts by mass of 2-dimethylamino-2-benzyl-1-(4-?olinylphenyl)butan-1-one (manufactured by BASF Japan Co., Ltd. "Irgacure (registered trademark) 369 (Irg 369)") as a photopolymerization initiator were added. Furthermore, cyclopentanone was added so that the solid content concentration might become 13%. The mixture was stirred at 80° C. for 1 hour, whereby a polymerizable liquid crystal composition for forming a horizontal alignment liquid crystal cured film was obtained.

(2)水平配向液晶硬化膜之形成 於藉由上述方法所製造之包含基材及垂直配向液晶硬化膜之積層體之垂直配向液晶硬化膜上實施電暈處理。繼而,塗佈聚乙烯醇(聚乙烯醇1000完全皂化型,和光純藥工業股份有限公司製造)之4質量%水溶液,於乾燥後形成厚度0.2 μm之膜。繼而,於所獲得之膜之表面實施摩擦處理,而獲得水平配向膜。摩擦處理係使用半自動摩擦裝置(商品名:LQ-008型,常陽工學股份有限公司製造),藉由布(商品名:YA-20-RW,吉川化工股份有限公司製造)於壓入量0.15 mm、轉數500 rpm、16.7 mm/s之條件下進行。 繼而,於水平配向膜上塗佈水平配向液晶硬化膜形成用聚合性液晶組合物,於120℃下加熱60秒鐘後,使用高壓水銀燈(UNICURE VB-15201BY-A,牛尾電機股份有限公司製造),自塗佈有水平配向液晶硬化膜形成用聚合性液晶組合物之面照射紫外線(氮氣氛圍下,波長365 nm下之累計光量:500 mJ/cm2 ),藉此形成水平配向液晶硬化膜,獲得將基材、垂直配向液晶硬化膜、水平配向膜、水平配向液晶硬化膜依序鄰接積層而成之積層體。利用橢圓偏光計對所獲得之水平配向液晶硬化膜之膜厚進行測定,結果為2.2 μm。(2) Formation of Horizontally Aligned Liquid Crystal Cured Film Corona treatment was performed on the vertically aligned liquid crystal cured film of the laminate comprising the base material and the vertically aligned liquid crystal cured film produced by the above method. Next, a 4% by mass aqueous solution of polyvinyl alcohol (polyvinyl alcohol 1000 complete saponification type, manufactured by Wako Pure Chemical Industries, Ltd.) was applied and dried to form a film with a thickness of 0.2 μm. Then, rubbing treatment was performed on the surface of the obtained film to obtain a horizontal alignment film. The rubbing treatment was carried out using a semi-automatic rubbing device (trade name: LQ-008, manufactured by Changyang Engineering Co., Ltd.) with a cloth (trade name: YA-20-RW, manufactured by Yoshikawa Chemical Co., Ltd.) under the conditions of 0.15 mm indentation, 500 rpm, and 16.7 mm/s.繼而,於水平配向膜上塗佈水平配向液晶硬化膜形成用聚合性液晶組合物,於120℃下加熱60秒鐘後,使用高壓水銀燈(UNICURE VB-15201BY-A,牛尾電機股份有限公司製造),自塗佈有水平配向液晶硬化膜形成用聚合性液晶組合物之面照射紫外線(氮氣氛圍下,波長365 nm下之累計光量:500 mJ/cm 2 ),藉此形成水平配向液晶硬化膜,獲得將基材、垂直配向液晶硬化膜、水平配向膜、水平配向液晶硬化膜依序鄰接積層而成之積層體。 The film thickness of the obtained horizontally aligned liquid crystal cured film was measured with an ellipsometer and found to be 2.2 μm.

[表1] [Table 1]

根據本發明,能夠不形成垂直配向膜而製作垂直配向液晶硬化膜,確認到可同時提高液晶配向性及密接性(實施例1~10)。相對於此,於使用不包含垂直配向促進劑之聚合性液晶組合物之情形時,無法不形成垂直配向膜而獲得垂直配向液晶硬化膜,因此無法算出水平配向液晶硬化膜之相位差值(比較例1)。進而於水平配向膜並非光配向膜之比較例2中,垂直配向液晶硬化膜與水平配向液晶硬化膜之密接性較差。According to the present invention, it was possible to produce a vertically aligned liquid crystal cured film without forming a vertically aligned film, and it was confirmed that both liquid crystal alignment and adhesiveness could be improved (Examples 1 to 10). On the other hand, in the case of using a polymerizable liquid crystal composition that does not contain a vertical alignment promoter, a vertically aligned liquid crystal cured film cannot be obtained without forming a vertical alignment film, so the retardation value of the horizontally aligned liquid crystal cured film cannot be calculated (Comparative Example 1). Furthermore, in Comparative Example 2 in which the horizontal alignment film was not a photo-alignment film, the adhesiveness between the vertical alignment cured liquid crystal film and the horizontal alignment liquid crystal cured film was poor.

1‧‧‧基材 2‧‧‧垂直配向液晶硬化膜 3‧‧‧水平配向膜 4‧‧‧水平配向液晶硬化膜 5‧‧‧硬化樹脂層 11‧‧‧積層體1‧‧‧Substrate 2‧‧‧Vertically aligned liquid crystal cured film 3‧‧‧Horizontal alignment film 4‧‧‧Horizontal alignment liquid crystal cured film 5‧‧‧hardened resin layer 11‧‧‧Laminated body

圖1係表示本發明之積層體之層構成之一例的概略剖視圖。 圖2係表示本發明之積層體之層構成之一例的概略剖視圖。 圖3係表示本發明之積層體之層構成之一例的概略剖視圖。Fig. 1 is a schematic cross-sectional view showing an example of the layer configuration of the laminate of the present invention. Fig. 2 is a schematic cross-sectional view showing an example of the layer configuration of the laminate of the present invention. Fig. 3 is a schematic cross-sectional view showing an example of the layer configuration of the laminate of the present invention.

Claims (21)

一種積層體,其係依以下順序包含基材、垂直配向液晶硬化膜、水平配向膜及水平配向液晶硬化膜者,上述垂直配向液晶硬化膜係聚合性液晶化合物於相對於該液晶硬化膜平面朝垂直方向配向之狀態下硬化而成的聚合性液晶組合物之硬化物,上述水平配向液晶硬化膜係聚合性液晶化合物於相對於該液晶硬化膜平面朝水平方向配向之狀態下硬化而成的聚合性液晶組合物之硬化物,並滿足下述式(1):ReA(450)/ReA(550)≦1 (1)[式(1)中,ReA(450)表示水平配向液晶硬化膜之面內方向之波長450nm下之面內相位差值,ReA(550)表示水平配向液晶硬化膜之面內方向之波長550nm下之面內相位差值],上述垂直配向液晶硬化膜含有垂直配向促進劑,上述水平配向膜為由具有(甲基)丙烯醯基之聚合物形成而成之光配向膜,且自上述垂直配向液晶硬化膜之基材側之面至水平配向液晶硬化膜之與水平配向膜為相反側之面的總膜厚為10μm以下。 A laminate comprising a substrate, a vertically aligned liquid crystal cured film, a horizontally aligned film, and a horizontally aligned liquid crystal cured film in the following order. The vertically aligned liquid crystal cured film is a cured product of a polymeric liquid crystal composition formed by hardening a polymerizable liquid crystal compound in a state aligned vertically relative to the plane of the liquid crystal cured film. The horizontally aligned liquid crystal cured film is a cured product of a polymeric liquid crystal composition formed by curing a polymerizable liquid crystal compound in a state aligned horizontally relative to the plane of the liquid crystal cured film, and satisfies the following formula (1): ReA(450)/ReA(550)≦1 (1)[In the formula (1), ReA(450) represents the in-plane retardation value at a wavelength of 450nm in the in-plane direction of the horizontally aligned liquid crystal cured film, and ReA(550) represents the in-plane retardation value at a wavelength of 550nm in the in-plane direction of the horizontally aligned liquid crystal cured film], the above-mentioned vertically aligned liquid crystal cured film contains a vertical alignment promoter, and the above-mentioned horizontal alignment film is made of (meth)acryl A photo-alignment film made of a polymer, and the total film thickness from the surface of the vertical alignment cured liquid crystal film on the substrate side to the surface of the horizontal alignment cured liquid crystal film opposite to the horizontal alignment film is 10 μm or less. 一種積層體,其係依以下順序包含基材、垂直配向液晶硬化膜、水平配向膜及水平配向液晶硬化膜者,上述垂直配向液晶硬化膜係聚合性液晶化合物於相對於該液晶硬化膜平面朝垂直方向配向之狀態下硬化而成的聚合性液晶組合物之硬化物,並滿足下述式(2): RthC(450)/RthC(550)≦1 (2)[式(2)中,RthC(450)表示垂直配向液晶硬化膜於波長450nm下之厚度方向之相位差值,RthC(550)表示垂直配向液晶硬化膜於波長550nm下之厚度方向之相位差值],上述水平配向液晶硬化膜係聚合性液晶化合物於相對於該液晶硬化膜平面朝水平方向配向之狀態下硬化而成的聚合性液晶組合物之硬化物,上述垂直配向液晶硬化膜含有垂直配向促進劑,上述水平配向膜為由具有(甲基)丙烯醯基之聚合物形成而成之光配向膜,且自上述垂直配向液晶硬化膜之基材側之面至水平配向液晶硬化膜之與水平配向膜為相反側之面的總膜厚為10μm以下。 A laminate comprising a base material, a vertically aligned liquid crystal cured film, a horizontally aligned film, and a horizontally aligned liquid crystal cured film in the following order, wherein the vertically aligned liquid crystal cured film is a cured product of a polymeric liquid crystal composition that is cured in a state where a polymerizable liquid crystal compound is aligned vertically relative to the plane of the liquid crystal cured film, and satisfies the following formula (2): RthC(450)/RthC(550)≦1 (2)[In the formula (2), RthC(450) represents the retardation value of the vertically aligned liquid crystal cured film in the thickness direction at a wavelength of 450nm, and RthC(550) represents the retardation value of the vertically aligned liquid crystal cured film in the thickness direction at a wavelength of 550nm], the above-mentioned horizontally aligned liquid crystal cured film is a polymerized liquid crystal compound that is cured in a state aligned horizontally with respect to the plane of the liquid crystal cured film. A cured product of a non-volatile liquid crystal composition, wherein the above-mentioned vertical alignment liquid crystal cured film contains a vertical alignment promoter, the above-mentioned horizontal alignment film is a photo-alignment film formed of a polymer having a (meth)acryl group, and the total film thickness from the surface of the above-mentioned vertical alignment liquid crystal cured film on the substrate side to the surface of the horizontal alignment liquid crystal cured film opposite to the horizontal alignment film is 10 μm or less. 如請求項1或2之積層體,其中基材為能夠剝離之基材。 The laminate according to claim 1 or 2, wherein the substrate is a peelable substrate. 如請求項1或2之積層體,其中基材、垂直配向液晶硬化膜、水平配向膜、水平配向液晶硬化膜依此順序鄰接地存在。 The laminate according to claim 1 or 2, wherein the base material, the vertically aligned liquid crystal cured film, the horizontally aligned liquid crystal cured film, and the horizontally aligned liquid crystal cured film exist adjacently in this order. 如請求項1或2之積層體,其中水平配向膜之膜厚為10~5000nm。 The laminate of claim 1 or 2, wherein the film thickness of the horizontal alignment film is 10-5000 nm. 如請求項1或2之積層體,其中水平配向膜為由具有偶氮基或桂皮醯基之聚合物形成而成之光配向膜。 The laminate according to claim 1 or 2, wherein the horizontal alignment film is a photo-alignment film formed of a polymer having an azo group or a cinnamonyl group. 如請求項1或2之積層體,其中水平配向液晶硬化膜於波長300~400nm之間具有至少1個以上之極大吸收。 The laminate according to claim 1 or 2, wherein the horizontally aligned liquid crystal cured film has at least one maximum absorption between 300 and 400 nm in wavelength. 如請求項1或2之積層體,其中垂直配向液晶硬化膜含有非離子性矽烷化合物作為垂直配向促進劑。 The laminate according to claim 1 or 2, wherein the vertical alignment liquid crystal cured film contains a nonionic silane compound as a vertical alignment promoter. 如請求項1或2之積層體,其中垂直配向液晶硬化膜含有非離子性矽烷化合物作為垂直配向促進劑,且上述非離子性矽烷化合物為矽烷偶合劑。 The laminate according to claim 1 or 2, wherein the vertically aligned liquid crystal cured film contains a nonionic silane compound as a vertical alignment promoter, and the nonionic silane compound is a silane coupling agent. 如請求項1或2之積層體,其中垂直配向液晶硬化膜含有包含非金屬原子之離子性化合物作為垂直配向促進劑。 The laminate according to claim 1 or 2, wherein the vertical alignment liquid crystal cured film contains an ionic compound containing non-metal atoms as a vertical alignment promoter. 如請求項1或2之積層體,其中垂直配向液晶硬化膜含有包含非金屬原子之離子性化合物作為垂直配向促進劑,且該離子性化合物之分子量為100以上10,000以下。 The laminate according to claim 1 or 2, wherein the vertical alignment liquid crystal cured film contains an ionic compound containing non-metal atoms as a vertical alignment promoter, and the molecular weight of the ionic compound is 100 to 10,000. 如請求項1或2之積層體,其中垂直配向液晶硬化膜含有非離子性矽烷化合物及包含非金屬原子之離子性化合物作為垂直配向促進劑。 The laminate according to claim 1 or 2, wherein the vertically aligned liquid crystal cured film contains a nonionic silane compound and an ionic compound containing nonmetal atoms as a vertical alignment promoter. 如請求項1或2之積層體,其中水平配向液晶硬化膜係具有至少1個自由基聚合性基之聚合性液晶化合物於相對於該液晶硬化膜之面內方向水平地配向之狀態下硬化而成的液晶硬化膜,且垂直配向液晶硬化膜係具有至少1個自由基聚合性基之聚合性液晶化合物於相對於該液晶硬化膜之面內方向垂直地配向之狀態下硬化而成的液晶硬化膜。 The laminate according to claim 1 or 2, wherein the horizontal alignment cured liquid crystal film is a cured liquid crystal film formed by curing a polymerizable liquid crystal compound having at least one radically polymerizable group in a state aligned horizontally with respect to the in-plane direction of the cured liquid crystal film, and the vertically aligned liquid crystal cured film is a cured liquid crystal film cured by curing a polymerizable liquid crystal compound having at least one radically polymerizable group in a state aligned vertically with respect to the in-plane direction of the cured liquid crystal film. 如請求項1或2之積層體,其中垂直配向液晶硬化膜於波長300~400nm之間具有至少1個極大吸收。 The laminate according to claim 1 or 2, wherein the vertically aligned liquid crystal cured film has at least one maximum absorption at a wavelength of 300-400 nm. 如請求項1之積層體,其中垂直配向液晶硬化膜滿足下述式(2):RthC(450)/RthC(550)≦1 (2)[式(2)中,RthC(450)表示垂直配向液晶硬化膜於波長450nm下之厚度方向之相位差值,RthC(550)表示垂直配向液晶硬化膜於波長550nm下之厚度方向之相位差值]。 The laminated body of claim item 1, wherein the vertically aligned liquid crystal cured film satisfies the following formula (2): RthC(450)/RthC(550)≦1 (2) [In the formula (2), RthC(450) represents the retardation value of the vertically aligned liquid crystal cured film in the thickness direction at a wavelength of 450nm, and RthC(550) represents the retardation value of the vertically aligned liquid crystal cured film in the thickness direction at a wavelength of 550nm]. 一種橢圓偏光板,其包含如請求項1至15中任一項之積層體及偏光膜。 An elliptically polarizing plate comprising the laminate according to any one of Claims 1 to 15 and a polarizing film. 一種橢圓偏光板,其包含自如請求項1至15中任一項之積層體去除基材所得之積層體及偏光膜。 An elliptically polarizing plate comprising a laminate obtained by removing a substrate from the laminate according to any one of claims 1 to 15, and a polarizing film. 如請求項16或17之橢圓偏光板,其中構成積層體之水平配向液晶硬化膜之遲相軸與偏光膜之吸收軸所成之角為45±5°。 The elliptically polarizing plate according to claim 16 or 17, wherein the angle formed by the retardation axis of the horizontally aligned liquid crystal cured film constituting the laminate and the absorption axis of the polarizing film is 45±5°. 一種有機EL顯示裝置,其包含如請求項16至18中任一項之橢圓偏光板。 An organic EL display device comprising the elliptically polarizing plate according to any one of claims 16-18. 一種如請求項1至15中任一項之積層體之製造方法,其依以下順序包 括如下步驟:形成含有聚合性液晶化合物之垂直配向液晶硬化膜形成用聚合性液晶組合物之塗膜,由該塗膜形成垂直配向液晶硬化膜;形成水平配向膜形成用組合物之塗膜,由該塗膜形成水平配向膜;及形成含有聚合性液晶化合物之水平配向液晶硬化膜形成用聚合性液晶組合物之塗膜,由該塗膜形成水平配向液晶硬化膜。 A method for manufacturing a laminate according to any one of Claims 1 to 15, which comprises the following steps: The method comprises the following steps: forming a coating film of a polymerizable liquid crystal composition for forming a vertical alignment liquid crystal cured film containing a polymerizable liquid crystal compound, forming a vertical alignment liquid crystal cured film from the coating film; forming a coating film of a composition for forming a horizontal alignment film, forming a horizontal alignment film from the coating film; 如請求項20之製造方法,其依以下順序連續地實施形成垂直配向液晶硬化膜之步驟、形成水平配向膜之步驟及形成水平配向液晶硬化膜之步驟。 According to the manufacturing method of Claim 20, the step of forming a vertically aligned liquid crystal cured film, the step of forming a horizontally aligned liquid crystal film, and the step of forming a horizontally aligned liquid crystal cured film are continuously performed in the following order.
TW108104558A 2018-02-14 2019-02-12 Laminated body and manufacturing method thereof TWI808127B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2018-024566 2018-02-14
JP2018024566 2018-02-14
JP2019-007263 2019-01-18
JP2019007263A JP7329926B2 (en) 2018-02-14 2019-01-18 Laminate and its manufacturing method

Publications (2)

Publication Number Publication Date
TW201936908A TW201936908A (en) 2019-09-16
TWI808127B true TWI808127B (en) 2023-07-11

Family

ID=67693910

Family Applications (3)

Application Number Title Priority Date Filing Date
TW108104558A TWI808127B (en) 2018-02-14 2019-02-12 Laminated body and manufacturing method thereof
TW108104557A TWI798354B (en) 2018-02-14 2019-02-12 combination
TW108104578A TWI791764B (en) 2018-02-14 2019-02-12 Laminated body and manufacturing method thereof

Family Applications After (2)

Application Number Title Priority Date Filing Date
TW108104557A TWI798354B (en) 2018-02-14 2019-02-12 combination
TW108104578A TWI791764B (en) 2018-02-14 2019-02-12 Laminated body and manufacturing method thereof

Country Status (4)

Country Link
JP (3) JP7398868B2 (en)
KR (3) KR102836846B1 (en)
CN (3) CN111684328B (en)
TW (3) TWI808127B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6916940B2 (en) * 2019-10-31 2021-08-11 住友化学株式会社 Image display device
CN115151847B (en) 2020-02-20 2023-11-03 富士胶片株式会社 Optical laminate, polarizing plate, and image display device
WO2021182280A1 (en) * 2020-03-11 2021-09-16 住友化学株式会社 Polymerizable liquid crystal composition, retardation film, elliptical polarizer and optical display
TWI900690B (en) * 2020-11-09 2025-10-11 日商積水化學工業股份有限公司 Film for liquid crystal device, liquid crystal device, and dimming device
CN116559990A (en) * 2023-04-24 2023-08-08 成都瑞波科材料科技有限公司 Viewing angle compensation film, manufacturing method thereof and liquid crystal display panel

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1932613A (en) * 2005-09-16 2007-03-21 富士胶片株式会社 Optically anisotropic body, polarizing plate and liquid crystal display device
WO2014054769A1 (en) * 2012-10-04 2014-04-10 富士フイルム株式会社 Circular polarizing plate and method for producing same, optical laminated body
CN105992970A (en) * 2014-07-15 2016-10-05 Dic株式会社 Liquid crystal display device

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001100208A (en) 1995-11-17 2001-04-13 Fuji Photo Film Co Ltd Liquid crystal display device
JP4187616B2 (en) * 2002-09-06 2008-11-26 大日本印刷株式会社 Laminated retardation optical element, manufacturing method thereof, and liquid crystal display device
JP4390540B2 (en) * 2003-12-02 2009-12-24 大日本印刷株式会社 OPTICAL ELEMENT AND ITS MANUFACTURING METHOD, AND LIQUID CRYSTAL ORIENTATION SUBSTRATE AND LIQUID CRYSTAL DISPLAY
JP4168922B2 (en) * 2003-12-12 2008-10-22 ソニーケミカル&インフォメーションデバイス株式会社 Liquid crystal film forming composition, optically anisotropic film, and production method thereof
CN100392488C (en) * 2004-08-02 2008-06-04 日东电工株式会社 Liquid crystal alignment film and its manufacturing method, optical film and image display device
US7333157B2 (en) * 2005-03-16 2008-02-19 Canon Kabushiki Kaisha Image display device
JP4548727B2 (en) * 2005-04-28 2010-09-22 大日本印刷株式会社 Optical element in which liquid crystal molecules are homeotropically aligned, liquid crystal display device using the same, and liquid crystal display device
JP2007225912A (en) * 2006-02-23 2007-09-06 Fujifilm Corp Liquid crystal display
JP2007241011A (en) 2006-03-10 2007-09-20 Fujifilm Corp Optically anisotropic film, retardation plate, and liquid crystal display device
KR20090003296A (en) * 2006-03-31 2009-01-09 니폰 제온 가부시키가이샤 Polarizer, liquid crystal display and protective film
KR101310467B1 (en) * 2006-04-03 2013-09-24 스미또모 가가꾸 가부시끼가이샤 Film, process for producing film, and use thereof
JP4900597B2 (en) * 2006-06-13 2012-03-21 大日本印刷株式会社 Liquid crystal composition, color filter, and liquid crystal display device
WO2008001582A1 (en) 2006-06-28 2008-01-03 Sharp Kabushiki Kaisha Complex birefringent medium, polarizing plate, and liquid crystal device
JP4911297B2 (en) 2006-10-16 2012-04-04 大日本印刷株式会社 Optical element, liquid crystal display device, and method of manufacturing optical element
KR101356999B1 (en) * 2006-11-08 2014-02-03 디아이씨 가부시끼가이샤 Composition for photo-alignment film, photo-alignment film, and optical isomer
JP5401032B2 (en) * 2006-12-15 2014-01-29 富士フイルム株式会社 Optically anisotropic film, brightness enhancement film, retardation plate, and liquid crystal display device
JP2009040984A (en) * 2007-08-13 2009-02-26 Dainippon Printing Co Ltd Liquid crystal composition, retardation control member using the liquid crystal composition, and liquid crystal display device
JP2009288259A (en) * 2008-05-27 2009-12-10 Konica Minolta Opto Inc Optical compensation film, polarizing plate and liquid crystal display device
JP2012058266A (en) * 2009-01-09 2012-03-22 Sharp Corp Liquid crystal display device and composition for forming liquid crystal layer
JP5899607B2 (en) * 2009-03-16 2016-04-06 住友化学株式会社 Compound, optical film and method for producing optical film
JP5924877B2 (en) * 2011-06-09 2016-05-25 林テレンプ株式会社 Optical film laminate
KR101945053B1 (en) * 2011-07-07 2019-02-01 스미또모 가가꾸 가부시키가이샤 Photoreactive liquid crystal aligning agent, and liquid crystal alignment device and method for production thereof
JP2015038598A (en) * 2013-07-18 2015-02-26 富士フイルム株式会社 Retardation film, polarizing plate and liquid crystal display device
JP2015043073A (en) * 2013-07-25 2015-03-05 富士フイルム株式会社 Retardation film, polarizing plate, and liquid crystal display device
CN104339796B (en) 2013-08-09 2018-03-02 住友化学株式会社 Layered product
TWI653149B (en) * 2013-08-09 2019-03-11 住友化學股份有限公司 Optical film
KR101731148B1 (en) * 2013-08-09 2017-04-27 스미또모 가가꾸 가부시키가이샤 Optical film
CN104345368B (en) * 2013-08-09 2018-10-16 住友化学株式会社 Elliptical polarization plate
CN105492935B (en) * 2013-08-26 2018-01-02 富士胶片株式会社 Brightness enhancement film, optics chip part and liquid crystal display device
CN105659122B (en) * 2013-10-28 2018-11-16 日本瑞翁株式会社 Multilayer film, optical anisotropy laminated body, circular polarizing disk, organic el display and manufacturing method
JPWO2015111474A1 (en) * 2014-01-22 2017-03-23 富士フイルム株式会社 Polarizing plate, liquid crystal display
JP2015143786A (en) * 2014-01-31 2015-08-06 住友化学株式会社 Liquid crystal cured film
KR20150113886A (en) * 2014-03-31 2015-10-08 후지필름 가부시키가이샤 Optical film, polarizing plate, and method of producing optical film
JP2016004142A (en) * 2014-06-17 2016-01-12 林テレンプ株式会社 Optical film laminate and production method of the same, and liquid crystal display panel containing laminate
JP6476783B2 (en) * 2014-11-18 2019-03-06 日本ゼオン株式会社 Polymerizable liquid crystal composition, polymer, optical anisotropic body, and polarizing plate
JP2016105127A (en) * 2014-12-01 2016-06-09 富士フイルム株式会社 Alignment layer, laminate, optical film, method for producing optical film, polarizing plate, liquid crystal display device and alignment layer forming composition
KR102274545B1 (en) * 2014-12-01 2021-07-06 삼성전자주식회사 Composition for optical film and films and display device
KR101623086B1 (en) * 2014-12-08 2016-05-20 삼성전자 주식회사 Antireflection film and organic light emitting device provided with the same
KR101882636B1 (en) * 2015-01-09 2018-07-26 후지필름 가부시키가이샤 Optical film, liquid crystal display device and method for producing optical film
KR102444525B1 (en) * 2015-01-16 2022-09-20 디아이씨 가부시끼가이샤 Polymeric composition and optically anisotropic body using same
JP6668605B2 (en) * 2015-04-15 2020-03-18 大日本印刷株式会社 Optical film
JPWO2016171041A1 (en) * 2015-04-24 2018-02-15 日本ゼオン株式会社 Multilayer film manufacturing method and multilayer film
JP6497241B2 (en) * 2015-06-30 2019-04-10 Jnc株式会社 Polymerizable liquid crystal compound, composition and polymer thereof
CN106371163B (en) * 2015-07-24 2020-08-25 住友化学株式会社 Liquid crystal cured film, optical film comprising liquid crystal cured film and display device
WO2017022592A1 (en) 2015-07-31 2017-02-09 富士フイルム株式会社 Laminate and window
JP6507072B2 (en) * 2015-09-30 2019-04-24 富士フイルム株式会社 Method of manufacturing optically anisotropic layer and method of manufacturing polarizing plate
CN108139532B (en) * 2015-10-23 2020-06-16 富士胶片株式会社 Composition for photo-alignment film, photo-alignment film, optical laminate, and image display device
JP6527076B2 (en) 2015-12-01 2019-06-05 富士フイルム株式会社 Polarized film
WO2017145935A1 (en) * 2016-02-22 2017-08-31 富士フイルム株式会社 Optical film, optical film manufacturing method, and display device
US10669482B2 (en) * 2016-03-08 2020-06-02 Zeon Corporation Liquid crystal composition, liquid crystal cured layer, and method for producing said liquid crystal cured layer
CN107193072B (en) * 2016-03-15 2018-08-28 住友化学株式会社 Elliptical polarization plate
JP6285529B2 (en) * 2016-03-15 2018-02-28 住友化学株式会社 Elliptical polarizing plate
CN108885292B (en) * 2016-03-30 2022-03-11 日本瑞翁株式会社 Optically anisotropic layer and method for producing the same, optically anisotropic laminate and method for producing the same, optically anisotropic transfer body, polarizing plate, and image display device
CN109477925B (en) * 2016-07-21 2022-10-25 住友化学株式会社 Elliptical polarizing plate
CN110088653B (en) * 2016-12-28 2021-07-06 富士胶片株式会社 Optical film and method for producing the same, polarizing plate, and image display device
JP7165491B2 (en) * 2017-02-23 2022-11-04 住友化学株式会社 Optical film and its manufacturing method

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1932613A (en) * 2005-09-16 2007-03-21 富士胶片株式会社 Optically anisotropic body, polarizing plate and liquid crystal display device
WO2014054769A1 (en) * 2012-10-04 2014-04-10 富士フイルム株式会社 Circular polarizing plate and method for producing same, optical laminated body
CN105992970A (en) * 2014-07-15 2016-10-05 Dic株式会社 Liquid crystal display device

Also Published As

Publication number Publication date
TWI798354B (en) 2023-04-11
CN111684328A (en) 2020-09-18
KR20200120652A (en) 2020-10-21
CN111712740A (en) 2020-09-25
JP2019139221A (en) 2019-08-22
TW201939133A (en) 2019-10-01
CN111684328B (en) 2022-08-09
JP7329926B2 (en) 2023-08-21
KR20200120651A (en) 2020-10-21
CN111684326B (en) 2023-01-10
JP2019139219A (en) 2019-08-22
JP7398868B2 (en) 2023-12-15
KR20200120653A (en) 2020-10-21
KR102836847B1 (en) 2025-07-21
CN111684326A (en) 2020-09-18
CN111712740B (en) 2022-08-23
TWI791764B (en) 2023-02-11
TW201936908A (en) 2019-09-16
KR102836846B1 (en) 2025-07-21
TW201936662A (en) 2019-09-16
JP2019139220A (en) 2019-08-22
KR102780815B1 (en) 2025-03-12

Similar Documents

Publication Publication Date Title
JP7311958B2 (en) Vertically aligned liquid crystal cured film and laminate including the same
TWI808127B (en) Laminated body and manufacturing method thereof
KR102890509B1 (en) Composition for forming laminated and vertically aligned liquid crystal cured films
TW202106863A (en) Composition for forming liquid crystal cured film and use of same
WO2022196632A1 (en) Optical laminated body
KR102853460B1 (en) Laminate, elliptically polarizing plate and polymerizable liquid crystal composition
WO2019159888A1 (en) Layered body and method for manufacturing same
WO2019159889A1 (en) Layered body and method for manufacturing same
TW202442444A (en) Laminated body, polarizing plate and image display device
TW202448675A (en) Laminated body, polarizing plate and image display device
TW202443272A (en) Laminated body, polarizing plate and image display device
JP2024144160A (en) Laminate, polarizing plate and image display device
TW202447313A (en) Laminated body, polarizing plate and image display device
JP2024144162A (en) Laminate, polarizing plate and image display device
JP2024144161A (en) Laminate, polarizing plate and image display device
JP2024144163A (en) Laminate, polarizing plate and image display device